{"entity":"medtronic","name":"Medtronic plc","kind":"money","summary":"Medtronic plc's timeline holds 351 money & deals claims from 2012 to 2026. The latest took effect on August 28, 2026.","counts":{"total":363,"by_kind":{"people":2,"money":351,"products":0,"models":0,"other":10}},"events":[{"date":"2012-04-27","until":"2013-04-26","published":"2015-06-23","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Medtronic plc cash and equivalents: 1,172,000,000 United States dollar\", as of 2012-04-27 (until 2013-04-26). Claim clm_B9592B812804, https://asof.is/claim/clm_B9592B812804, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/1613103/000161310315000028/0001613103-15-000028-index.htm.","url":"https://asof.is/claim/clm_B9592B812804","accessed":"2026-11-10"},"kind":"money","predicate":"cash_and_equivalents","value":"1,172,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_B9592B812804","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:CashAndCashEquivalentsAtCarryingValue in 10-K FY2015, filed 2015-06-23"}},{"date":"2012-04-27","until":"2013-04-26","published":"2015-06-23","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Medtronic plc total equity: 17,113,000,000 United States dollar\", as of 2012-04-27 (until 2013-04-26). Claim clm_CE404E6A8429, https://asof.is/claim/clm_CE404E6A8429, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/1613103/000161310315000028/0001613103-15-000028-index.htm.","url":"https://asof.is/claim/clm_CE404E6A8429","accessed":"2026-11-10"},"kind":"money","predicate":"total_equity","value":"17,113,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_CE404E6A8429","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:StockholdersEquity in 10-K FY2015, filed 2015-06-23"}},{"date":"2013-04-26","until":"2014-04-25","published":"2015-06-23","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Medtronic plc operating income: 4,402,000,000 United States dollar\", as of 2013-04-26 (until 2014-04-25). Claim clm_136360BFF25F, https://asof.is/claim/clm_136360BFF25F, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/1613103/000161310315000028/0001613103-15-000028-index.htm.","url":"https://asof.is/claim/clm_136360BFF25F","accessed":"2026-11-10"},"kind":"money","predicate":"operating_income","value":"4,402,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_136360BFF25F","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:OperatingIncomeLoss in 10-K FY2015, filed 2015-06-23"}},{"date":"2013-04-26","until":"2014-04-25","published":"2015-06-23","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Medtronic plc revenue: 16,590,000,000 United States dollar\", as of 2013-04-26 (until 2014-04-25). Claim clm_26A7D574D1E1, https://asof.is/claim/clm_26A7D574D1E1, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/1613103/000161310315000028/0001613103-15-000028-index.htm.","url":"https://asof.is/claim/clm_26A7D574D1E1","accessed":"2026-11-10"},"kind":"money","predicate":"revenue","value":"16,590,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_26A7D574D1E1","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:SalesRevenueNet in 10-K FY2015, filed 2015-06-23"}},{"date":"2013-04-26","until":"2014-04-25","published":"2015-06-23","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Medtronic plc cash and equivalents: 919,000,000 United States dollar\", as of 2013-04-26 (until 2014-04-25). Claim clm_4A48F87DA5A3, https://asof.is/claim/clm_4A48F87DA5A3, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/1613103/000161310315000028/0001613103-15-000028-index.htm.","url":"https://asof.is/claim/clm_4A48F87DA5A3","accessed":"2026-11-10"},"kind":"money","predicate":"cash_and_equivalents","value":"919,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_4A48F87DA5A3","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:CashAndCashEquivalentsAtCarryingValue in 10-K FY2015, filed 2015-06-23"}},{"date":"2013-04-26","until":"2014-04-25","published":"2015-06-23","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Medtronic plc net income: 3,467,000,000 United States dollar\", as of 2013-04-26 (until 2014-04-25). Claim clm_EE6C4061D46C, https://asof.is/claim/clm_EE6C4061D46C, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/1613103/000161310315000028/0001613103-15-000028-index.htm.","url":"https://asof.is/claim/clm_EE6C4061D46C","accessed":"2026-11-10"},"kind":"money","predicate":"net_income","value":"3,467,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_EE6C4061D46C","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:NetIncomeLoss in 10-K FY2015, filed 2015-06-23"}},{"date":"2013-04-26","until":"2014-04-25","published":"2015-06-23","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Medtronic plc total equity: 18,671,000,000 United States dollar\", as of 2013-04-26 (until 2014-04-25). Claim clm_FC6C94C53C26, https://asof.is/claim/clm_FC6C94C53C26, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/1613103/000161310315000028/0001613103-15-000028-index.htm.","url":"https://asof.is/claim/clm_FC6C94C53C26","accessed":"2026-11-10"},"kind":"money","predicate":"total_equity","value":"18,671,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_FC6C94C53C26","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:StockholdersEquity in 10-K FY2015, filed 2015-06-23"}},{"date":"2014-04-25","until":"2014-06-12","published":"2015-06-23","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Medtronic plc cash and equivalents: 1,403,000,000 United States dollar\", as of 2014-04-25 (until 2014-06-12). Claim clm_04651C051AA3, https://asof.is/claim/clm_04651C051AA3, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/1613103/000161310315000028/0001613103-15-000028-index.htm.","url":"https://asof.is/claim/clm_04651C051AA3","accessed":"2026-11-10"},"kind":"money","predicate":"cash_and_equivalents","value":"1,403,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_04651C051AA3","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:CashAndCashEquivalentsAtCarryingValue in 10-K FY2015, filed 2015-06-23"}},{"date":"2014-04-25","until":"2015-04-24","published":"2015-06-23","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Medtronic plc net income: 3,065,000,000 United States dollar\", as of 2014-04-25 (until 2015-04-24). Claim clm_133074D0555D, https://asof.is/claim/clm_133074D0555D, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/1613103/000161310315000028/0001613103-15-000028-index.htm.","url":"https://asof.is/claim/clm_133074D0555D","accessed":"2026-11-10"},"kind":"money","predicate":"net_income","value":"3,065,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_133074D0555D","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:NetIncomeLoss in 10-K FY2015, filed 2015-06-23"}},{"date":"2014-04-25","until":"2015-04-24","published":"2015-06-23","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Medtronic plc revenue: 17,005,000,000 United States dollar\", as of 2014-04-25 (until 2015-04-24). Claim clm_2AFFCF87BF30, https://asof.is/claim/clm_2AFFCF87BF30, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/1613103/000161310315000028/0001613103-15-000028-index.htm.","url":"https://asof.is/claim/clm_2AFFCF87BF30","accessed":"2026-11-10"},"kind":"money","predicate":"revenue","value":"17,005,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_2AFFCF87BF30","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:SalesRevenueNet in 10-K FY2015, filed 2015-06-23"}},{"date":"2014-04-25","until":"2015-01-23","published":"2015-06-23","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Medtronic plc total equity: 19,443,000,000 United States dollar\", as of 2014-04-25 (until 2015-01-23). Claim clm_93F79245FB43, https://asof.is/claim/clm_93F79245FB43, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/1613103/000161310315000028/0001613103-15-000028-index.htm.","url":"https://asof.is/claim/clm_93F79245FB43","accessed":"2026-11-10"},"kind":"money","predicate":"total_equity","value":"19,443,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_93F79245FB43","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:StockholdersEquity in 10-K FY2015, filed 2015-06-23"}},{"date":"2014-04-25","until":"2015-04-24","published":"2015-06-23","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Medtronic plc operating income: 3,813,000,000 United States dollar\", as of 2014-04-25 (until 2015-04-24). Claim clm_DB0956D536CC, https://asof.is/claim/clm_DB0956D536CC, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/1613103/000161310315000028/0001613103-15-000028-index.htm.","url":"https://asof.is/claim/clm_DB0956D536CC","accessed":"2026-11-10"},"kind":"money","predicate":"operating_income","value":"3,813,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_DB0956D536CC","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:OperatingIncomeLoss in 10-K FY2015, filed 2015-06-23"}},{"date":"2014-04-25","until":"2015-01-23","published":"2015-06-23","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Medtronic plc total assets: 37,943,000,000 United States dollar\", as of 2014-04-25 (until 2015-01-23). Claim clm_FBFE34E530A1, https://asof.is/claim/clm_FBFE34E530A1, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/1613103/000161310315000028/0001613103-15-000028-index.htm.","url":"https://asof.is/claim/clm_FBFE34E530A1","accessed":"2026-11-10"},"kind":"money","predicate":"total_assets","value":"37,943,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_FBFE34E530A1","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:Assets in 10-K FY2015, filed 2015-06-23"}},{"date":"2014-06-12","until":"2014-07-25","published":"2015-02-27","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Medtronic plc cash and equivalents: 0 United States dollar\", as of 2014-06-12 (until 2014-07-25). Claim clm_BC6B86225079, https://asof.is/claim/clm_BC6B86225079, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/1613103/000161310315000008/0001613103-15-000008-index.htm.","url":"https://asof.is/claim/clm_BC6B86225079","accessed":"2026-11-10"},"kind":"money","predicate":"cash_and_equivalents","value":"0 United States dollar","status":"superseded","assertable":true,"id":"clm_BC6B86225079","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:CashAndCashEquivalentsAtCarryingValue in 10-Q Q3 FY2015, filed 2015-02-27"}},{"date":"2014-07-25","until":"2014-10-24","published":"2015-09-09","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Medtronic plc quarterly operating income: 1,088,000,000 United States dollar\", as of 2014-07-25 (until 2014-10-24). Claim clm_1E2BD657D88E, https://asof.is/claim/clm_1E2BD657D88E, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/1613103/000161310315000038/0001613103-15-000038-index.htm.","url":"https://asof.is/claim/clm_1E2BD657D88E","accessed":"2026-11-10"},"kind":"money","predicate":"quarterly_operating_income","value":"1,088,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_1E2BD657D88E","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:OperatingIncomeLoss in 10-Q Q1 FY2016, filed 2015-09-09"}},{"date":"2014-07-25","until":"2014-10-24","published":"2015-09-09","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Medtronic plc quarterly net income: 871,000,000 United States dollar\", as of 2014-07-25 (until 2014-10-24). Claim clm_662A39CC98CB, https://asof.is/claim/clm_662A39CC98CB, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/1613103/000161310315000038/0001613103-15-000038-index.htm.","url":"https://asof.is/claim/clm_662A39CC98CB","accessed":"2026-11-10"},"kind":"money","predicate":"quarterly_net_income","value":"871,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_662A39CC98CB","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:NetIncomeLoss in 10-Q Q1 FY2016, filed 2015-09-09"}},{"date":"2014-07-25","until":"2014-10-24","published":"2015-09-09","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Medtronic plc cash and equivalents: 1,336,000,000 United States dollar\", as of 2014-07-25 (until 2014-10-24). Claim clm_97D39540E69A, https://asof.is/claim/clm_97D39540E69A, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/1613103/000161310315000038/0001613103-15-000038-index.htm.","url":"https://asof.is/claim/clm_97D39540E69A","accessed":"2026-11-10"},"kind":"money","predicate":"cash_and_equivalents","value":"1,336,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_97D39540E69A","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:CashAndCashEquivalentsAtCarryingValue in 10-Q Q1 FY2016, filed 2015-09-09"}},{"date":"2014-07-25","until":"2014-10-24","published":"2015-09-09","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Medtronic plc quarterly revenue: 4,273,000,000 United States dollar\", as of 2014-07-25 (until 2014-10-24). Claim clm_D8F351640B15, https://asof.is/claim/clm_D8F351640B15, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/1613103/000161310315000038/0001613103-15-000038-index.htm.","url":"https://asof.is/claim/clm_D8F351640B15","accessed":"2026-11-10"},"kind":"money","predicate":"quarterly_revenue","value":"4,273,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_D8F351640B15","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:SalesRevenueNet in 10-Q Q1 FY2016, filed 2015-09-09"}},{"date":"2014-10-24","until":"2015-01-23","published":"2015-12-09","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Medtronic plc quarterly revenue: 4,366,000,000 United States dollar\", as of 2014-10-24 (until 2015-01-23). Claim clm_51C7BDAE1018, https://asof.is/claim/clm_51C7BDAE1018, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/1613103/000161310315000053/0001613103-15-000053-index.htm.","url":"https://asof.is/claim/clm_51C7BDAE1018","accessed":"2026-11-10"},"kind":"money","predicate":"quarterly_revenue","value":"4,366,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_51C7BDAE1018","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:SalesRevenueNet in 10-Q Q2 FY2016, filed 2015-12-09"}},{"date":"2014-10-24","until":"2015-01-23","published":"2015-12-09","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Medtronic plc quarterly net income: 828,000,000 United States dollar\", as of 2014-10-24 (until 2015-01-23). Claim clm_62B4ECCDDA6B, https://asof.is/claim/clm_62B4ECCDDA6B, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/1613103/000161310315000053/0001613103-15-000053-index.htm.","url":"https://asof.is/claim/clm_62B4ECCDDA6B","accessed":"2026-11-10"},"kind":"money","predicate":"quarterly_net_income","value":"828,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_62B4ECCDDA6B","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:NetIncomeLoss in 10-Q Q2 FY2016, filed 2015-12-09"}},{"date":"2014-10-24","until":"2015-01-23","published":"2015-12-09","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Medtronic plc quarterly operating income: 1,030,000,000 United States dollar\", as of 2014-10-24 (until 2015-01-23). Claim clm_84C766BA46CE, https://asof.is/claim/clm_84C766BA46CE, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/1613103/000161310315000053/0001613103-15-000053-index.htm.","url":"https://asof.is/claim/clm_84C766BA46CE","accessed":"2026-11-10"},"kind":"money","predicate":"quarterly_operating_income","value":"1,030,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_84C766BA46CE","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:OperatingIncomeLoss in 10-Q Q2 FY2016, filed 2015-12-09"}},{"date":"2014-10-24","until":"2015-01-23","published":"2015-12-09","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Medtronic plc cash and equivalents: 1,287,000,000 United States dollar\", as of 2014-10-24 (until 2015-01-23). Claim clm_FC703B74AD76, https://asof.is/claim/clm_FC703B74AD76, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/1613103/000161310315000053/0001613103-15-000053-index.htm.","url":"https://asof.is/claim/clm_FC703B74AD76","accessed":"2026-11-10"},"kind":"money","predicate":"cash_and_equivalents","value":"1,287,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_FC703B74AD76","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:CashAndCashEquivalentsAtCarryingValue in 10-Q Q2 FY2016, filed 2015-12-09"}},{"date":"2015-01-23","until":"2015-04-24","published":"2015-02-27","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Medtronic plc total equity: -36,954,000 United States dollar\", as of 2015-01-23 (until 2015-04-24). Claim clm_1E852E336D8A, https://asof.is/claim/clm_1E852E336D8A, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/1613103/000161310315000008/0001613103-15-000008-index.htm.","url":"https://asof.is/claim/clm_1E852E336D8A","accessed":"2026-11-10"},"kind":"money","predicate":"total_equity","value":"-36,954,000 United States dollar","status":"superseded","assertable":true,"id":"clm_1E852E336D8A","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:StockholdersEquity in 10-Q Q3 FY2015, filed 2015-02-27"}},{"date":"2015-01-23","until":"2015-07-31","published":"2015-02-27","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Medtronic plc quarterly net income: -37,075,000 United States dollar\", as of 2015-01-23 (until 2015-07-31). Claim clm_40EFF62649AD, https://asof.is/claim/clm_40EFF62649AD, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/1613103/000161310315000008/0001613103-15-000008-index.htm.","url":"https://asof.is/claim/clm_40EFF62649AD","accessed":"2026-11-10"},"kind":"money","predicate":"quarterly_net_income","value":"-37,075,000 United States dollar","status":"superseded","assertable":true,"id":"clm_40EFF62649AD","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:NetIncomeLoss in 10-Q Q3 FY2015, filed 2015-02-27"}},{"date":"2015-01-23","until":"2015-04-24","published":"2015-02-27","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Medtronic plc total assets: 46,000 United States dollar\", as of 2015-01-23 (until 2015-04-24). Claim clm_6EE675E6EFFE, https://asof.is/claim/clm_6EE675E6EFFE, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/1613103/000161310315000008/0001613103-15-000008-index.htm.","url":"https://asof.is/claim/clm_6EE675E6EFFE","accessed":"2026-11-10"},"kind":"money","predicate":"total_assets","value":"46,000 United States dollar","status":"superseded","assertable":true,"id":"clm_6EE675E6EFFE","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:Assets in 10-Q Q3 FY2015, filed 2015-02-27"}},{"date":"2015-01-23","until":"2015-04-24","published":"2015-02-27","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Medtronic plc cash and equivalents: 46,000 United States dollar\", as of 2015-01-23 (until 2015-04-24). Claim clm_A2880AC8AEA0, https://asof.is/claim/clm_A2880AC8AEA0, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/1613103/000161310315000008/0001613103-15-000008-index.htm.","url":"https://asof.is/claim/clm_A2880AC8AEA0","accessed":"2026-11-10"},"kind":"money","predicate":"cash_and_equivalents","value":"46,000 United States dollar","status":"superseded","assertable":true,"id":"clm_A2880AC8AEA0","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:CashAndCashEquivalentsAtCarryingValue in 10-Q Q3 FY2015, filed 2015-02-27"}},{"date":"2015-01-23","until":"2015-07-31","published":"2015-02-27","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Medtronic plc quarterly revenue: 0 United States dollar\", as of 2015-01-23 (until 2015-07-31). Claim clm_B93C5DDBD354, https://asof.is/claim/clm_B93C5DDBD354, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/1613103/000161310315000008/0001613103-15-000008-index.htm.","url":"https://asof.is/claim/clm_B93C5DDBD354","accessed":"2026-11-10"},"kind":"money","predicate":"quarterly_revenue","value":"0 United States dollar","status":"superseded","assertable":true,"id":"clm_B93C5DDBD354","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:SalesRevenueNet in 10-Q Q3 FY2015, filed 2015-02-27"}},{"date":"2015-01-23","until":"2015-07-31","published":"2016-03-09","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Medtronic plc quarterly operating income: 1,275,000,000 United States dollar\", as of 2015-01-23 (until 2015-07-31). Claim clm_CF85B2F40372, https://asof.is/claim/clm_CF85B2F40372, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/1613103/000161310316000071/0001613103-16-000071-index.htm.","url":"https://asof.is/claim/clm_CF85B2F40372","accessed":"2026-11-10"},"kind":"money","predicate":"quarterly_operating_income","value":"1,275,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_CF85B2F40372","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:OperatingIncomeLoss in 10-Q Q3 FY2016, filed 2016-03-09"}},{"date":"2015-02-24","until":"2015-06-16","published":"2015-02-27","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Medtronic plc shares outstanding: 1,425,066,824 shares\", as of 2015-02-24 (until 2015-06-16). Claim clm_657CDE6BFDB2, https://asof.is/claim/clm_657CDE6BFDB2, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/1613103/000161310315000008/0001613103-15-000008-index.htm.","url":"https://asof.is/claim/clm_657CDE6BFDB2","accessed":"2026-11-10"},"kind":"money","predicate":"shares_outstanding","value":"1,425,066,824 shares","status":"superseded","assertable":true,"id":"clm_657CDE6BFDB2","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"dei:EntityCommonStockSharesOutstanding in 10-Q Q3 FY2015, filed 2015-02-27"}},{"date":"2015-04-24","until":"2015-07-31","published":"2015-06-23","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Medtronic plc cash and equivalents: 4,843,000,000 United States dollar\", as of 2015-04-24 (until 2015-07-31). Claim clm_10616CE86A18, https://asof.is/claim/clm_10616CE86A18, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/1613103/000161310315000028/0001613103-15-000028-index.htm.","url":"https://asof.is/claim/clm_10616CE86A18","accessed":"2026-11-10"},"kind":"money","predicate":"cash_and_equivalents","value":"4,843,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_10616CE86A18","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:CashAndCashEquivalentsAtCarryingValue in 10-K FY2015, filed 2015-06-23"}},{"date":"2015-04-24","until":"2016-04-29","published":"2015-06-23","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Medtronic plc revenue: 20,261,000,000 United States dollar\", as of 2015-04-24 (until 2016-04-29). Claim clm_476365ACEA5E, https://asof.is/claim/clm_476365ACEA5E, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/1613103/000161310315000028/0001613103-15-000028-index.htm.","url":"https://asof.is/claim/clm_476365ACEA5E","accessed":"2026-11-10"},"kind":"money","predicate":"revenue","value":"20,261,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_476365ACEA5E","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:SalesRevenueNet in 10-K FY2015, filed 2015-06-23"}},{"date":"2015-04-24","until":"2015-07-31","published":"2015-06-23","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Medtronic plc total assets: 106,685,000,000 United States dollar\", as of 2015-04-24 (until 2015-07-31). Claim clm_8517D8DF59AF, https://asof.is/claim/clm_8517D8DF59AF, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/1613103/000161310315000028/0001613103-15-000028-index.htm.","url":"https://asof.is/claim/clm_8517D8DF59AF","accessed":"2026-11-10"},"kind":"money","predicate":"total_assets","value":"106,685,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_8517D8DF59AF","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:Assets in 10-K FY2015, filed 2015-06-23"}},{"date":"2015-04-24","until":"2016-04-29","published":"2015-06-23","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Medtronic plc operating income: 3,766,000,000 United States dollar\", as of 2015-04-24 (until 2016-04-29). Claim clm_924622784778, https://asof.is/claim/clm_924622784778, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/1613103/000161310315000028/0001613103-15-000028-index.htm.","url":"https://asof.is/claim/clm_924622784778","accessed":"2026-11-10"},"kind":"money","predicate":"operating_income","value":"3,766,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_924622784778","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:OperatingIncomeLoss in 10-K FY2015, filed 2015-06-23"}},{"date":"2015-04-24","until":"2016-04-29","published":"2015-06-23","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Medtronic plc net income: 2,675,000,000 United States dollar\", as of 2015-04-24 (until 2016-04-29). Claim clm_D34DB14BA021, https://asof.is/claim/clm_D34DB14BA021, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/1613103/000161310315000028/0001613103-15-000028-index.htm.","url":"https://asof.is/claim/clm_D34DB14BA021","accessed":"2026-11-10"},"kind":"money","predicate":"net_income","value":"2,675,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_D34DB14BA021","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:NetIncomeLoss in 10-K FY2015, filed 2015-06-23"}},{"date":"2015-04-24","until":"2015-07-31","published":"2015-06-23","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Medtronic plc total equity: 53,230,000,000 United States dollar\", as of 2015-04-24 (until 2015-07-31). Claim clm_F827795B2CAB, https://asof.is/claim/clm_F827795B2CAB, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/1613103/000161310315000028/0001613103-15-000028-index.htm.","url":"https://asof.is/claim/clm_F827795B2CAB","accessed":"2026-11-10"},"kind":"money","predicate":"total_equity","value":"53,230,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_F827795B2CAB","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:StockholdersEquity in 10-K FY2015, filed 2015-06-23"}},{"date":"2015-06-16","until":"2015-09-03","published":"2015-06-23","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Medtronic plc shares outstanding: 1,416,351,117 shares\", as of 2015-06-16 (until 2015-09-03). Claim clm_C066190E195C, https://asof.is/claim/clm_C066190E195C, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/1613103/000161310315000028/0001613103-15-000028-index.htm.","url":"https://asof.is/claim/clm_C066190E195C","accessed":"2026-11-10"},"kind":"money","predicate":"shares_outstanding","value":"1,416,351,117 shares","status":"superseded","assertable":true,"id":"clm_C066190E195C","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"dei:EntityCommonStockSharesOutstanding in 10-K FY2015, filed 2015-06-23"}},{"date":"2015-07-31","until":"2015-10-30","published":"2015-09-09","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Medtronic plc quarterly net income: 820,000,000 United States dollar\", as of 2015-07-31 (until 2015-10-30). Claim clm_0EC1B503CF4B, https://asof.is/claim/clm_0EC1B503CF4B, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/1613103/000161310315000038/0001613103-15-000038-index.htm.","url":"https://asof.is/claim/clm_0EC1B503CF4B","accessed":"2026-11-10"},"kind":"money","predicate":"quarterly_net_income","value":"820,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_0EC1B503CF4B","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:NetIncomeLoss in 10-Q Q1 FY2016, filed 2015-09-09"}},{"date":"2015-07-31","until":"2015-10-30","published":"2015-09-09","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Medtronic plc total assets: 104,626,000,000 United States dollar\", as of 2015-07-31 (until 2015-10-30). Claim clm_38A7D87C86D6, https://asof.is/claim/clm_38A7D87C86D6, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/1613103/000161310315000038/0001613103-15-000038-index.htm.","url":"https://asof.is/claim/clm_38A7D87C86D6","accessed":"2026-11-10"},"kind":"money","predicate":"total_assets","value":"104,626,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_38A7D87C86D6","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:Assets in 10-Q Q1 FY2016, filed 2015-09-09"}},{"date":"2015-07-31","until":"2015-10-30","published":"2015-09-09","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Medtronic plc total equity: 52,809,000,000 United States dollar\", as of 2015-07-31 (until 2015-10-30). Claim clm_4EB0377461EC, https://asof.is/claim/clm_4EB0377461EC, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/1613103/000161310315000038/0001613103-15-000038-index.htm.","url":"https://asof.is/claim/clm_4EB0377461EC","accessed":"2026-11-10"},"kind":"money","predicate":"total_equity","value":"52,809,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_4EB0377461EC","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:StockholdersEquity in 10-Q Q1 FY2016, filed 2015-09-09"}},{"date":"2015-07-31","until":"2015-10-30","published":"2015-09-09","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Medtronic plc quarterly revenue: 7,274,000,000 United States dollar\", as of 2015-07-31 (until 2015-10-30). Claim clm_A8CE624064A7, https://asof.is/claim/clm_A8CE624064A7, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/1613103/000161310315000038/0001613103-15-000038-index.htm.","url":"https://asof.is/claim/clm_A8CE624064A7","accessed":"2026-11-10"},"kind":"money","predicate":"quarterly_revenue","value":"7,274,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_A8CE624064A7","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:SalesRevenueNet in 10-Q Q1 FY2016, filed 2015-09-09"}},{"date":"2015-07-31","until":"2015-10-30","published":"2015-09-09","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Medtronic plc quarterly operating income: 1,131,000,000 United States dollar\", as of 2015-07-31 (until 2015-10-30). Claim clm_F337E59131E6, https://asof.is/claim/clm_F337E59131E6, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/1613103/000161310315000038/0001613103-15-000038-index.htm.","url":"https://asof.is/claim/clm_F337E59131E6","accessed":"2026-11-10"},"kind":"money","predicate":"quarterly_operating_income","value":"1,131,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_F337E59131E6","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:OperatingIncomeLoss in 10-Q Q1 FY2016, filed 2015-09-09"}},{"date":"2015-07-31","until":"2015-10-30","published":"2015-09-09","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Medtronic plc cash and equivalents: 2,979,000,000 United States dollar\", as of 2015-07-31 (until 2015-10-30). Claim clm_F39C9C3E421C, https://asof.is/claim/clm_F39C9C3E421C, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/1613103/000161310315000038/0001613103-15-000038-index.htm.","url":"https://asof.is/claim/clm_F39C9C3E421C","accessed":"2026-11-10"},"kind":"money","predicate":"cash_and_equivalents","value":"2,979,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_F39C9C3E421C","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:CashAndCashEquivalentsAtCarryingValue in 10-Q Q1 FY2016, filed 2015-09-09"}},{"date":"2015-09-03","until":"2015-12-03","published":"2015-09-09","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Medtronic plc shares outstanding: 1,413,614,665 shares\", as of 2015-09-03 (until 2015-12-03). Claim clm_224EA5DBA60F, https://asof.is/claim/clm_224EA5DBA60F, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/1613103/000161310315000038/0001613103-15-000038-index.htm.","url":"https://asof.is/claim/clm_224EA5DBA60F","accessed":"2026-11-10"},"kind":"money","predicate":"shares_outstanding","value":"1,413,614,665 shares","status":"superseded","assertable":true,"id":"clm_224EA5DBA60F","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"dei:EntityCommonStockSharesOutstanding in 10-Q Q1 FY2016, filed 2015-09-09"}},{"date":"2015-10-30","until":"2016-01-29","published":"2015-12-09","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Medtronic plc quarterly revenue: 7,058,000,000 United States dollar\", as of 2015-10-30 (until 2016-01-29). Claim clm_56E745B66772, https://asof.is/claim/clm_56E745B66772, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/1613103/000161310315000053/0001613103-15-000053-index.htm.","url":"https://asof.is/claim/clm_56E745B66772","accessed":"2026-11-10"},"kind":"money","predicate":"quarterly_revenue","value":"7,058,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_56E745B66772","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:SalesRevenueNet in 10-Q Q2 FY2016, filed 2015-12-09"}},{"date":"2015-10-30","until":"2016-01-29","published":"2015-12-09","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Medtronic plc cash and equivalents: 2,378,000,000 United States dollar\", as of 2015-10-30 (until 2016-01-29). Claim clm_587994CAB032, https://asof.is/claim/clm_587994CAB032, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/1613103/000161310315000053/0001613103-15-000053-index.htm.","url":"https://asof.is/claim/clm_587994CAB032","accessed":"2026-11-10"},"kind":"money","predicate":"cash_and_equivalents","value":"2,378,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_587994CAB032","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:CashAndCashEquivalentsAtCarryingValue in 10-Q Q2 FY2016, filed 2015-12-09"}},{"date":"2015-10-30","until":"2016-01-29","published":"2015-12-09","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Medtronic plc quarterly operating income: 1,300,000,000 United States dollar\", as of 2015-10-30 (until 2016-01-29). Claim clm_84F57D5E95B9, https://asof.is/claim/clm_84F57D5E95B9, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/1613103/000161310315000053/0001613103-15-000053-index.htm.","url":"https://asof.is/claim/clm_84F57D5E95B9","accessed":"2026-11-10"},"kind":"money","predicate":"quarterly_operating_income","value":"1,300,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_84F57D5E95B9","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:OperatingIncomeLoss in 10-Q Q2 FY2016, filed 2015-12-09"}},{"date":"2015-10-30","until":"2016-01-29","published":"2015-12-09","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Medtronic plc quarterly net income: 520,000,000 United States dollar\", as of 2015-10-30 (until 2016-01-29). Claim clm_D562CC732A96, https://asof.is/claim/clm_D562CC732A96, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/1613103/000161310315000053/0001613103-15-000053-index.htm.","url":"https://asof.is/claim/clm_D562CC732A96","accessed":"2026-11-10"},"kind":"money","predicate":"quarterly_net_income","value":"520,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_D562CC732A96","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:NetIncomeLoss in 10-Q Q2 FY2016, filed 2015-12-09"}},{"date":"2015-10-30","until":"2016-01-29","published":"2015-12-09","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Medtronic plc total equity: 52,269,000,000 United States dollar\", as of 2015-10-30 (until 2016-01-29). Claim clm_D5E87BABAC26, https://asof.is/claim/clm_D5E87BABAC26, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/1613103/000161310315000053/0001613103-15-000053-index.htm.","url":"https://asof.is/claim/clm_D5E87BABAC26","accessed":"2026-11-10"},"kind":"money","predicate":"total_equity","value":"52,269,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_D5E87BABAC26","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:StockholdersEquity in 10-Q Q2 FY2016, filed 2015-12-09"}},{"date":"2015-10-30","until":"2016-01-29","published":"2015-12-09","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Medtronic plc total assets: 104,945,000,000 United States dollar\", as of 2015-10-30 (until 2016-01-29). Claim clm_F13FA315E331, https://asof.is/claim/clm_F13FA315E331, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/1613103/000161310315000053/0001613103-15-000053-index.htm.","url":"https://asof.is/claim/clm_F13FA315E331","accessed":"2026-11-10"},"kind":"money","predicate":"total_assets","value":"104,945,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_F13FA315E331","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:Assets in 10-Q Q2 FY2016, filed 2015-12-09"}},{"date":"2015-12-03","until":"2016-03-03","published":"2015-12-09","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Medtronic plc shares outstanding: 1,406,155,722 shares\", as of 2015-12-03 (until 2016-03-03). Claim clm_485A7B08D21D, https://asof.is/claim/clm_485A7B08D21D, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/1613103/000161310315000053/0001613103-15-000053-index.htm.","url":"https://asof.is/claim/clm_485A7B08D21D","accessed":"2026-11-10"},"kind":"money","predicate":"shares_outstanding","value":"1,406,155,722 shares","status":"superseded","assertable":true,"id":"clm_485A7B08D21D","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"dei:EntityCommonStockSharesOutstanding in 10-Q Q2 FY2016, filed 2015-12-09"}},{"date":"2016-01-29","until":"2016-07-29","published":"2016-03-09","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Medtronic plc quarterly operating income: 1,355,000,000 United States dollar\", as of 2016-01-29 (until 2016-07-29). Claim clm_585563FF3C79, https://asof.is/claim/clm_585563FF3C79, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/1613103/000161310316000071/0001613103-16-000071-index.htm.","url":"https://asof.is/claim/clm_585563FF3C79","accessed":"2026-11-10"},"kind":"money","predicate":"quarterly_operating_income","value":"1,355,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_585563FF3C79","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:OperatingIncomeLoss in 10-Q Q3 FY2016, filed 2016-03-09"}},{"date":"2016-01-29","until":"2016-07-29","published":"2016-03-09","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Medtronic plc quarterly revenue: 6,934,000,000 United States dollar\", as of 2016-01-29 (until 2016-07-29). Claim clm_6ACE3572E7E8, https://asof.is/claim/clm_6ACE3572E7E8, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/1613103/000161310316000071/0001613103-16-000071-index.htm.","url":"https://asof.is/claim/clm_6ACE3572E7E8","accessed":"2026-11-10"},"kind":"money","predicate":"quarterly_revenue","value":"6,934,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_6ACE3572E7E8","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:SalesRevenueNet in 10-Q Q3 FY2016, filed 2016-03-09"}},{"date":"2016-01-29","until":"2016-07-29","published":"2016-03-09","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Medtronic plc quarterly net income: 1,095,000,000 United States dollar\", as of 2016-01-29 (until 2016-07-29). Claim clm_6F829E272A73, https://asof.is/claim/clm_6F829E272A73, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/1613103/000161310316000071/0001613103-16-000071-index.htm.","url":"https://asof.is/claim/clm_6F829E272A73","accessed":"2026-11-10"},"kind":"money","predicate":"quarterly_net_income","value":"1,095,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_6F829E272A73","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:NetIncomeLoss in 10-Q Q3 FY2016, filed 2016-03-09"}},{"date":"2016-01-29","until":"2016-04-29","published":"2016-03-09","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Medtronic plc total assets: 102,706,000,000 United States dollar\", as of 2016-01-29 (until 2016-04-29). Claim clm_72C17700819B, https://asof.is/claim/clm_72C17700819B, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/1613103/000161310316000071/0001613103-16-000071-index.htm.","url":"https://asof.is/claim/clm_72C17700819B","accessed":"2026-11-10"},"kind":"money","predicate":"total_assets","value":"102,706,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_72C17700819B","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:Assets in 10-Q Q3 FY2016, filed 2016-03-09"}},{"date":"2016-01-29","until":"2016-04-29","published":"2016-03-09","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Medtronic plc cash and equivalents: 2,721,000,000 United States dollar\", as of 2016-01-29 (until 2016-04-29). Claim clm_851260124C55, https://asof.is/claim/clm_851260124C55, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/1613103/000161310316000071/0001613103-16-000071-index.htm.","url":"https://asof.is/claim/clm_851260124C55","accessed":"2026-11-10"},"kind":"money","predicate":"cash_and_equivalents","value":"2,721,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_851260124C55","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:CashAndCashEquivalentsAtCarryingValue in 10-Q Q3 FY2016, filed 2016-03-09"}},{"date":"2016-01-29","until":"2016-04-29","published":"2016-03-09","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Medtronic plc total equity: 50,816,000,000 United States dollar\", as of 2016-01-29 (until 2016-04-29). Claim clm_E19D89E883BA, https://asof.is/claim/clm_E19D89E883BA, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/1613103/000161310316000071/0001613103-16-000071-index.htm.","url":"https://asof.is/claim/clm_E19D89E883BA","accessed":"2026-11-10"},"kind":"money","predicate":"total_equity","value":"50,816,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_E19D89E883BA","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:StockholdersEquity in 10-Q Q3 FY2016, filed 2016-03-09"}},{"date":"2016-03-03","until":"2016-06-20","published":"2016-03-09","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Medtronic plc shares outstanding: 1,401,043,252 shares\", as of 2016-03-03 (until 2016-06-20). Claim clm_FEDD405CBE94, https://asof.is/claim/clm_FEDD405CBE94, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/1613103/000161310316000071/0001613103-16-000071-index.htm.","url":"https://asof.is/claim/clm_FEDD405CBE94","accessed":"2026-11-10"},"kind":"money","predicate":"shares_outstanding","value":"1,401,043,252 shares","status":"superseded","assertable":true,"id":"clm_FEDD405CBE94","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"dei:EntityCommonStockSharesOutstanding in 10-Q Q3 FY2016, filed 2016-03-09"}},{"date":"2016-04-29","until":"2017-04-28","published":"2016-06-28","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Medtronic plc operating income: 5,291,000,000 United States dollar\", as of 2016-04-29 (until 2017-04-28). Claim clm_22932BDBA3C2, https://asof.is/claim/clm_22932BDBA3C2, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/1613103/000161310316000093/0001613103-16-000093-index.htm.","url":"https://asof.is/claim/clm_22932BDBA3C2","accessed":"2026-11-10"},"kind":"money","predicate":"operating_income","value":"5,291,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_22932BDBA3C2","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:OperatingIncomeLoss in 10-K FY2016, filed 2016-06-28"}},{"date":"2016-04-29","until":"2016-07-29","published":"2016-06-28","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Medtronic plc cash and equivalents: 2,876,000,000 United States dollar\", as of 2016-04-29 (until 2016-07-29). Claim clm_2D3D1B04E22A, https://asof.is/claim/clm_2D3D1B04E22A, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/1613103/000161310316000093/0001613103-16-000093-index.htm.","url":"https://asof.is/claim/clm_2D3D1B04E22A","accessed":"2026-11-10"},"kind":"money","predicate":"cash_and_equivalents","value":"2,876,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_2D3D1B04E22A","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:CashAndCashEquivalentsAtCarryingValue in 10-K FY2016, filed 2016-06-28"}},{"date":"2016-04-29","until":"2016-07-29","published":"2016-06-28","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Medtronic plc total equity: 52,063,000,000 United States dollar\", as of 2016-04-29 (until 2016-07-29). Claim clm_8AD4069224DA, https://asof.is/claim/clm_8AD4069224DA, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/1613103/000161310316000093/0001613103-16-000093-index.htm.","url":"https://asof.is/claim/clm_8AD4069224DA","accessed":"2026-11-10"},"kind":"money","predicate":"total_equity","value":"52,063,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_8AD4069224DA","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:StockholdersEquity in 10-K FY2016, filed 2016-06-28"}},{"date":"2016-04-29","until":"2017-04-28","published":"2016-06-28","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Medtronic plc net income: 3,538,000,000 United States dollar\", as of 2016-04-29 (until 2017-04-28). Claim clm_B5EBB0DEFB11, https://asof.is/claim/clm_B5EBB0DEFB11, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/1613103/000161310316000093/0001613103-16-000093-index.htm.","url":"https://asof.is/claim/clm_B5EBB0DEFB11","accessed":"2026-11-10"},"kind":"money","predicate":"net_income","value":"3,538,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_B5EBB0DEFB11","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:NetIncomeLoss in 10-K FY2016, filed 2016-06-28"}},{"date":"2016-04-29","until":"2017-04-28","published":"2016-06-28","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Medtronic plc revenue: 28,833,000,000 United States dollar\", as of 2016-04-29 (until 2017-04-28). Claim clm_E24B8D5A2678, https://asof.is/claim/clm_E24B8D5A2678, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/1613103/000161310316000093/0001613103-16-000093-index.htm.","url":"https://asof.is/claim/clm_E24B8D5A2678","accessed":"2026-11-10"},"kind":"money","predicate":"revenue","value":"28,833,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_E24B8D5A2678","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:SalesRevenueNet in 10-K FY2016, filed 2016-06-28"}},{"date":"2016-04-29","until":"2016-07-29","published":"2016-06-28","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Medtronic plc total assets: 99,782,000,000 United States dollar\", as of 2016-04-29 (until 2016-07-29). Claim clm_EFB89A55947E, https://asof.is/claim/clm_EFB89A55947E, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/1613103/000161310316000093/0001613103-16-000093-index.htm.","url":"https://asof.is/claim/clm_EFB89A55947E","accessed":"2026-11-10"},"kind":"money","predicate":"total_assets","value":"99,782,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_EFB89A55947E","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:Assets in 10-K FY2016, filed 2016-06-28"}},{"date":"2016-06-20","until":"2016-08-26","published":"2016-06-28","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Medtronic plc shares outstanding: 1,394,731,892 shares\", as of 2016-06-20 (until 2016-08-26). Claim clm_03FF005E69CB, https://asof.is/claim/clm_03FF005E69CB, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/1613103/000161310316000093/0001613103-16-000093-index.htm.","url":"https://asof.is/claim/clm_03FF005E69CB","accessed":"2026-11-10"},"kind":"money","predicate":"shares_outstanding","value":"1,394,731,892 shares","status":"superseded","assertable":true,"id":"clm_03FF005E69CB","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"dei:EntityCommonStockSharesOutstanding in 10-K FY2016, filed 2016-06-28"}},{"date":"2016-07-29","until":"2016-10-28","published":"2016-09-07","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Medtronic plc cash and equivalents: 3,060,000,000 United States dollar\", as of 2016-07-29 (until 2016-10-28). Claim clm_40BB0270177D, https://asof.is/claim/clm_40BB0270177D, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/1613103/000161310316000100/0001613103-16-000100-index.htm.","url":"https://asof.is/claim/clm_40BB0270177D","accessed":"2026-11-10"},"kind":"money","predicate":"cash_and_equivalents","value":"3,060,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_40BB0270177D","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:CashAndCashEquivalentsAtCarryingValue in 10-Q Q1 FY2017, filed 2016-09-07"}},{"date":"2016-07-29","until":"2016-10-28","published":"2016-09-07","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Medtronic plc total assets: 98,601,000,000 United States dollar\", as of 2016-07-29 (until 2016-10-28). Claim clm_4E245F27FBBB, https://asof.is/claim/clm_4E245F27FBBB, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/1613103/000161310316000100/0001613103-16-000100-index.htm.","url":"https://asof.is/claim/clm_4E245F27FBBB","accessed":"2026-11-10"},"kind":"money","predicate":"total_assets","value":"98,601,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_4E245F27FBBB","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:Assets in 10-Q Q1 FY2017, filed 2016-09-07"}},{"date":"2016-07-29","until":"2016-10-28","published":"2016-09-07","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Medtronic plc quarterly revenue: 7,166,000,000 United States dollar\", as of 2016-07-29 (until 2016-10-28). Claim clm_6F95ECF4F19B, https://asof.is/claim/clm_6F95ECF4F19B, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/1613103/000161310316000100/0001613103-16-000100-index.htm.","url":"https://asof.is/claim/clm_6F95ECF4F19B","accessed":"2026-11-10"},"kind":"money","predicate":"quarterly_revenue","value":"7,166,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_6F95ECF4F19B","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:SalesRevenueNet in 10-Q Q1 FY2017, filed 2016-09-07"}},{"date":"2016-07-29","until":"2016-10-28","published":"2016-09-07","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Medtronic plc quarterly operating income: 1,167,000,000 United States dollar\", as of 2016-07-29 (until 2016-10-28). Claim clm_BF030D446993, https://asof.is/claim/clm_BF030D446993, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/1613103/000161310316000100/0001613103-16-000100-index.htm.","url":"https://asof.is/claim/clm_BF030D446993","accessed":"2026-11-10"},"kind":"money","predicate":"quarterly_operating_income","value":"1,167,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_BF030D446993","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:OperatingIncomeLoss in 10-Q Q1 FY2017, filed 2016-09-07"}},{"date":"2016-07-29","until":"2016-10-28","published":"2016-09-07","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Medtronic plc quarterly net income: 929,000,000 United States dollar\", as of 2016-07-29 (until 2016-10-28). Claim clm_C7D170B4D530, https://asof.is/claim/clm_C7D170B4D530, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/1613103/000161310316000100/0001613103-16-000100-index.htm.","url":"https://asof.is/claim/clm_C7D170B4D530","accessed":"2026-11-10"},"kind":"money","predicate":"quarterly_net_income","value":"929,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_C7D170B4D530","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:NetIncomeLoss in 10-Q Q1 FY2017, filed 2016-09-07"}},{"date":"2016-07-29","until":"2016-10-28","published":"2016-09-07","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Medtronic plc total equity: 50,824,000,000 United States dollar\", as of 2016-07-29 (until 2016-10-28). Claim clm_EC0FA324681E, https://asof.is/claim/clm_EC0FA324681E, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/1613103/000161310316000100/0001613103-16-000100-index.htm.","url":"https://asof.is/claim/clm_EC0FA324681E","accessed":"2026-11-10"},"kind":"money","predicate":"total_equity","value":"50,824,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_EC0FA324681E","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:StockholdersEquity in 10-Q Q1 FY2017, filed 2016-09-07"}},{"date":"2016-08-26","until":"2016-12-01","published":"2016-09-07","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Medtronic plc shares outstanding: 1,381,935,603 shares\", as of 2016-08-26 (until 2016-12-01). Claim clm_8C670CEF6AB3, https://asof.is/claim/clm_8C670CEF6AB3, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/1613103/000161310316000100/0001613103-16-000100-index.htm.","url":"https://asof.is/claim/clm_8C670CEF6AB3","accessed":"2026-11-10"},"kind":"money","predicate":"shares_outstanding","value":"1,381,935,603 shares","status":"superseded","assertable":true,"id":"clm_8C670CEF6AB3","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"dei:EntityCommonStockSharesOutstanding in 10-Q Q1 FY2017, filed 2016-09-07"}},{"date":"2016-10-28","until":"2017-01-27","published":"2016-12-05","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Medtronic plc quarterly operating income: 1,385,000,000 United States dollar\", as of 2016-10-28 (until 2017-01-27). Claim clm_062671209390, https://asof.is/claim/clm_062671209390, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/1613103/000161310316000123/0001613103-16-000123-index.htm.","url":"https://asof.is/claim/clm_062671209390","accessed":"2026-11-10"},"kind":"money","predicate":"quarterly_operating_income","value":"1,385,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_062671209390","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:OperatingIncomeLoss in 10-Q Q2 FY2017, filed 2016-12-05"}},{"date":"2016-10-28","until":"2017-01-27","published":"2016-12-05","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Medtronic plc quarterly net income: 1,115,000,000 United States dollar\", as of 2016-10-28 (until 2017-01-27). Claim clm_25E745C03D63, https://asof.is/claim/clm_25E745C03D63, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/1613103/000161310316000123/0001613103-16-000123-index.htm.","url":"https://asof.is/claim/clm_25E745C03D63","accessed":"2026-11-10"},"kind":"money","predicate":"quarterly_net_income","value":"1,115,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_25E745C03D63","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:NetIncomeLoss in 10-Q Q2 FY2017, filed 2016-12-05"}},{"date":"2016-10-28","until":"2017-01-27","published":"2016-12-05","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Medtronic plc total equity: 50,186,000,000 United States dollar\", as of 2016-10-28 (until 2017-01-27). Claim clm_5C0909162C74, https://asof.is/claim/clm_5C0909162C74, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/1613103/000161310316000123/0001613103-16-000123-index.htm.","url":"https://asof.is/claim/clm_5C0909162C74","accessed":"2026-11-10"},"kind":"money","predicate":"total_equity","value":"50,186,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_5C0909162C74","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:StockholdersEquity in 10-Q Q2 FY2017, filed 2016-12-05"}},{"date":"2016-10-28","until":"2017-01-27","published":"2016-12-05","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Medtronic plc cash and equivalents: 2,954,000,000 United States dollar\", as of 2016-10-28 (until 2017-01-27). Claim clm_6018A9787332, https://asof.is/claim/clm_6018A9787332, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/1613103/000161310316000123/0001613103-16-000123-index.htm.","url":"https://asof.is/claim/clm_6018A9787332","accessed":"2026-11-10"},"kind":"money","predicate":"cash_and_equivalents","value":"2,954,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_6018A9787332","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:CashAndCashEquivalentsAtCarryingValue in 10-Q Q2 FY2017, filed 2016-12-05"}},{"date":"2016-10-28","until":"2017-01-27","published":"2016-12-05","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Medtronic plc total assets: 98,406,000,000 United States dollar\", as of 2016-10-28 (until 2017-01-27). Claim clm_7934D30E0B54, https://asof.is/claim/clm_7934D30E0B54, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/1613103/000161310316000123/0001613103-16-000123-index.htm.","url":"https://asof.is/claim/clm_7934D30E0B54","accessed":"2026-11-10"},"kind":"money","predicate":"total_assets","value":"98,406,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_7934D30E0B54","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:Assets in 10-Q Q2 FY2017, filed 2016-12-05"}},{"date":"2016-10-28","until":"2017-01-27","published":"2016-12-05","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Medtronic plc quarterly revenue: 7,345,000,000 United States dollar\", as of 2016-10-28 (until 2017-01-27). Claim clm_88D2CF2BD972, https://asof.is/claim/clm_88D2CF2BD972, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/1613103/000161310316000123/0001613103-16-000123-index.htm.","url":"https://asof.is/claim/clm_88D2CF2BD972","accessed":"2026-11-10"},"kind":"money","predicate":"quarterly_revenue","value":"7,345,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_88D2CF2BD972","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:SalesRevenueNet in 10-Q Q2 FY2017, filed 2016-12-05"}},{"date":"2016-12-01","until":"2017-03-01","published":"2016-12-05","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Medtronic plc shares outstanding: 1,373,047,310 shares\", as of 2016-12-01 (until 2017-03-01). Claim clm_9ABAE095795D, https://asof.is/claim/clm_9ABAE095795D, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/1613103/000161310316000123/0001613103-16-000123-index.htm.","url":"https://asof.is/claim/clm_9ABAE095795D","accessed":"2026-11-10"},"kind":"money","predicate":"shares_outstanding","value":"1,373,047,310 shares","status":"superseded","assertable":true,"id":"clm_9ABAE095795D","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"dei:EntityCommonStockSharesOutstanding in 10-Q Q2 FY2017, filed 2016-12-05"}},{"date":"2017-01-27","until":"2017-07-28","published":"2017-03-03","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Medtronic plc quarterly net income: 821,000,000 United States dollar\", as of 2017-01-27 (until 2017-07-28). Claim clm_05A984366E3D, https://asof.is/claim/clm_05A984366E3D, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/1613103/000161310317000008/0001613103-17-000008-index.htm.","url":"https://asof.is/claim/clm_05A984366E3D","accessed":"2026-11-10"},"kind":"money","predicate":"quarterly_net_income","value":"821,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_05A984366E3D","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:NetIncomeLoss in 10-Q Q3 FY2017, filed 2017-03-03"}},{"date":"2017-01-27","until":"2017-07-28","published":"2017-03-03","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Medtronic plc quarterly revenue: 7,283,000,000 United States dollar\", as of 2017-01-27 (until 2017-07-28). Claim clm_41506301E658, https://asof.is/claim/clm_41506301E658, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/1613103/000161310317000008/0001613103-17-000008-index.htm.","url":"https://asof.is/claim/clm_41506301E658","accessed":"2026-11-10"},"kind":"money","predicate":"quarterly_revenue","value":"7,283,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_41506301E658","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:SalesRevenueNet in 10-Q Q3 FY2017, filed 2017-03-03"}},{"date":"2017-01-27","until":"2017-04-28","published":"2017-03-03","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Medtronic plc total equity: 49,387,000,000 United States dollar\", as of 2017-01-27 (until 2017-04-28). Claim clm_475F64C21E44, https://asof.is/claim/clm_475F64C21E44, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/1613103/000161310317000008/0001613103-17-000008-index.htm.","url":"https://asof.is/claim/clm_475F64C21E44","accessed":"2026-11-10"},"kind":"money","predicate":"total_equity","value":"49,387,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_475F64C21E44","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:StockholdersEquity in 10-Q Q3 FY2017, filed 2017-03-03"}},{"date":"2017-01-27","until":"2017-07-28","published":"2017-03-03","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Medtronic plc quarterly operating income: 1,147,000,000 United States dollar\", as of 2017-01-27 (until 2017-07-28). Claim clm_588061E8A790, https://asof.is/claim/clm_588061E8A790, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/1613103/000161310317000008/0001613103-17-000008-index.htm.","url":"https://asof.is/claim/clm_588061E8A790","accessed":"2026-11-10"},"kind":"money","predicate":"quarterly_operating_income","value":"1,147,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_588061E8A790","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:OperatingIncomeLoss in 10-Q Q3 FY2017, filed 2017-03-03"}},{"date":"2017-01-27","until":"2017-04-28","published":"2017-03-03","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Medtronic plc total assets: 97,578,000,000 United States dollar\", as of 2017-01-27 (until 2017-04-28). Claim clm_7913D691A0CD, https://asof.is/claim/clm_7913D691A0CD, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/1613103/000161310317000008/0001613103-17-000008-index.htm.","url":"https://asof.is/claim/clm_7913D691A0CD","accessed":"2026-11-10"},"kind":"money","predicate":"total_assets","value":"97,578,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_7913D691A0CD","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:Assets in 10-Q Q3 FY2017, filed 2017-03-03"}},{"date":"2017-01-27","until":"2017-04-28","published":"2017-03-03","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Medtronic plc cash and equivalents: 2,768,000,000 United States dollar\", as of 2017-01-27 (until 2017-04-28). Claim clm_EAA9127C4FA1, https://asof.is/claim/clm_EAA9127C4FA1, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/1613103/000161310317000008/0001613103-17-000008-index.htm.","url":"https://asof.is/claim/clm_EAA9127C4FA1","accessed":"2026-11-10"},"kind":"money","predicate":"cash_and_equivalents","value":"2,768,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_EAA9127C4FA1","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:CashAndCashEquivalentsAtCarryingValue in 10-Q Q3 FY2017, filed 2017-03-03"}},{"date":"2017-03-01","until":"2017-06-21","published":"2017-03-03","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Medtronic plc shares outstanding: 1,368,884,991 shares\", as of 2017-03-01 (until 2017-06-21). Claim clm_48EA845391DB, https://asof.is/claim/clm_48EA845391DB, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/1613103/000161310317000008/0001613103-17-000008-index.htm.","url":"https://asof.is/claim/clm_48EA845391DB","accessed":"2026-11-10"},"kind":"money","predicate":"shares_outstanding","value":"1,368,884,991 shares","status":"superseded","assertable":true,"id":"clm_48EA845391DB","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"dei:EntityCommonStockSharesOutstanding in 10-Q Q3 FY2017, filed 2017-03-03"}},{"date":"2017-04-28","until":"2018-04-27","published":"2017-06-27","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Medtronic plc operating income: 5,330,000,000 United States dollar\", as of 2017-04-28 (until 2018-04-27). Claim clm_1B1A420A0CE0, https://asof.is/claim/clm_1B1A420A0CE0, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/1613103/000161310317000018/0001613103-17-000018-index.htm.","url":"https://asof.is/claim/clm_1B1A420A0CE0","accessed":"2026-11-10"},"kind":"money","predicate":"operating_income","value":"5,330,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_1B1A420A0CE0","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:OperatingIncomeLoss in 10-K FY2017, filed 2017-06-27"}},{"date":"2017-04-28","until":"2017-07-28","published":"2017-06-27","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Medtronic plc cash and equivalents: 4,967,000,000 United States dollar\", as of 2017-04-28 (until 2017-07-28). Claim clm_1F712BE9A602, https://asof.is/claim/clm_1F712BE9A602, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/1613103/000161310317000018/0001613103-17-000018-index.htm.","url":"https://asof.is/claim/clm_1F712BE9A602","accessed":"2026-11-10"},"kind":"money","predicate":"cash_and_equivalents","value":"4,967,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_1F712BE9A602","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:CashAndCashEquivalentsAtCarryingValue in 10-K FY2017, filed 2017-06-27"}},{"date":"2017-04-28","until":"2018-04-27","published":"2019-06-21","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Medtronic plc revenue: 29,710,000,000 United States dollar\", as of 2017-04-28 (until 2018-04-27). Claim clm_41C2C6ED3D43, https://asof.is/claim/clm_41C2C6ED3D43, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/1613103/000161310319000028/0001613103-19-000028-index.htm.","url":"https://asof.is/claim/clm_41C2C6ED3D43","accessed":"2026-11-10"},"kind":"money","predicate":"revenue","value":"29,710,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_41C2C6ED3D43","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax in 10-K FY2019, filed 2019-06-21"}},{"date":"2017-04-28","until":"2017-07-28","published":"2017-06-27","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Medtronic plc total assets: 99,816,000,000 United States dollar\", as of 2017-04-28 (until 2017-07-28). Claim clm_C2401DCD13E2, https://asof.is/claim/clm_C2401DCD13E2, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/1613103/000161310317000018/0001613103-17-000018-index.htm.","url":"https://asof.is/claim/clm_C2401DCD13E2","accessed":"2026-11-10"},"kind":"money","predicate":"total_assets","value":"99,816,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_C2401DCD13E2","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:Assets in 10-K FY2017, filed 2017-06-27"}},{"date":"2017-04-28","until":"2017-07-28","published":"2017-06-27","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Medtronic plc total equity: 50,294,000,000 United States dollar\", as of 2017-04-28 (until 2017-07-28). Claim clm_EEF81E06C0FE, https://asof.is/claim/clm_EEF81E06C0FE, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/1613103/000161310317000018/0001613103-17-000018-index.htm.","url":"https://asof.is/claim/clm_EEF81E06C0FE","accessed":"2026-11-10"},"kind":"money","predicate":"total_equity","value":"50,294,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_EEF81E06C0FE","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:StockholdersEquity in 10-K FY2017, filed 2017-06-27"}},{"date":"2017-04-28","until":"2018-04-27","published":"2017-06-27","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Medtronic plc net income: 4,028,000,000 United States dollar\", as of 2017-04-28 (until 2018-04-27). Claim clm_FB2E99BC240A, https://asof.is/claim/clm_FB2E99BC240A, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/1613103/000161310317000018/0001613103-17-000018-index.htm.","url":"https://asof.is/claim/clm_FB2E99BC240A","accessed":"2026-11-10"},"kind":"money","predicate":"net_income","value":"4,028,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_FB2E99BC240A","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:NetIncomeLoss in 10-K FY2017, filed 2017-06-27"}},{"date":"2017-06-21","until":"2017-08-29","published":"2017-06-27","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Medtronic plc shares outstanding: 1,359,026,669 shares\", as of 2017-06-21 (until 2017-08-29). Claim clm_E45654A9CC60, https://asof.is/claim/clm_E45654A9CC60, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/1613103/000161310317000018/0001613103-17-000018-index.htm.","url":"https://asof.is/claim/clm_E45654A9CC60","accessed":"2026-11-10"},"kind":"money","predicate":"shares_outstanding","value":"1,359,026,669 shares","status":"superseded","assertable":true,"id":"clm_E45654A9CC60","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"dei:EntityCommonStockSharesOutstanding in 10-K FY2017, filed 2017-06-27"}},{"date":"2017-07-28","until":"2017-10-27","published":"2018-08-31","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Medtronic plc quarterly revenue: 7,390,000,000 United States dollar\", as of 2017-07-28 (until 2017-10-27). Claim clm_0D4811D29537, https://asof.is/claim/clm_0D4811D29537, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/1613103/000161310318000032/0001613103-18-000032-index.htm.","url":"https://asof.is/claim/clm_0D4811D29537","accessed":"2026-11-10"},"kind":"money","predicate":"quarterly_revenue","value":"7,390,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_0D4811D29537","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax in 10-Q Q1 FY2019, filed 2018-08-31"}},{"date":"2017-07-28","until":"2017-10-27","published":"2017-09-01","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Medtronic plc total equity: 50,672,000,000 United States dollar\", as of 2017-07-28 (until 2017-10-27). Claim clm_230376012C50, https://asof.is/claim/clm_230376012C50, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/1613103/000161310317000027/0001613103-17-000027-index.htm.","url":"https://asof.is/claim/clm_230376012C50","accessed":"2026-11-10"},"kind":"money","predicate":"total_equity","value":"50,672,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_230376012C50","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:StockholdersEquity in 10-Q Q1 FY2018, filed 2017-09-01"}},{"date":"2017-07-28","until":"2017-10-27","published":"2017-09-01","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Medtronic plc quarterly operating income: 1,389,000,000 United States dollar\", as of 2017-07-28 (until 2017-10-27). Claim clm_2A0B30C877E2, https://asof.is/claim/clm_2A0B30C877E2, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/1613103/000161310317000027/0001613103-17-000027-index.htm.","url":"https://asof.is/claim/clm_2A0B30C877E2","accessed":"2026-11-10"},"kind":"money","predicate":"quarterly_operating_income","value":"1,389,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_2A0B30C877E2","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:OperatingIncomeLoss in 10-Q Q1 FY2018, filed 2017-09-01"}},{"date":"2017-07-28","until":"2017-10-27","published":"2017-09-01","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Medtronic plc quarterly net income: 1,016,000,000 United States dollar\", as of 2017-07-28 (until 2017-10-27). Claim clm_97055FD1CD3E, https://asof.is/claim/clm_97055FD1CD3E, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/1613103/000161310317000027/0001613103-17-000027-index.htm.","url":"https://asof.is/claim/clm_97055FD1CD3E","accessed":"2026-11-10"},"kind":"money","predicate":"quarterly_net_income","value":"1,016,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_97055FD1CD3E","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:NetIncomeLoss in 10-Q Q1 FY2018, filed 2017-09-01"}},{"date":"2017-07-28","until":"2017-10-27","published":"2017-09-01","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Medtronic plc cash and equivalents: 4,691,000,000 United States dollar\", as of 2017-07-28 (until 2017-10-27). Claim clm_DF2958F57D4F, https://asof.is/claim/clm_DF2958F57D4F, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/1613103/000161310317000027/0001613103-17-000027-index.htm.","url":"https://asof.is/claim/clm_DF2958F57D4F","accessed":"2026-11-10"},"kind":"money","predicate":"cash_and_equivalents","value":"4,691,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_DF2958F57D4F","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:CashAndCashEquivalentsAtCarryingValue in 10-Q Q1 FY2018, filed 2017-09-01"}},{"date":"2017-07-28","until":"2017-10-27","published":"2017-09-01","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Medtronic plc total assets: 100,250,000,000 United States dollar\", as of 2017-07-28 (until 2017-10-27). Claim clm_F448A4E941FA, https://asof.is/claim/clm_F448A4E941FA, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/1613103/000161310317000027/0001613103-17-000027-index.htm.","url":"https://asof.is/claim/clm_F448A4E941FA","accessed":"2026-11-10"},"kind":"money","predicate":"total_assets","value":"100,250,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_F448A4E941FA","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:Assets in 10-Q Q1 FY2018, filed 2017-09-01"}},{"date":"2017-08-29","until":"2017-11-28","published":"2017-09-01","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Medtronic plc shares outstanding: 1,354,591,435 shares\", as of 2017-08-29 (until 2017-11-28). Claim clm_F9C29B1B84D6, https://asof.is/claim/clm_F9C29B1B84D6, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/1613103/000161310317000027/0001613103-17-000027-index.htm.","url":"https://asof.is/claim/clm_F9C29B1B84D6","accessed":"2026-11-10"},"kind":"money","predicate":"shares_outstanding","value":"1,354,591,435 shares","status":"superseded","assertable":true,"id":"clm_F9C29B1B84D6","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"dei:EntityCommonStockSharesOutstanding in 10-Q Q1 FY2018, filed 2017-09-01"}},{"date":"2017-10-27","until":"2018-01-26","published":"2017-12-04","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Medtronic plc cash and equivalents: 5,529,000,000 United States dollar\", as of 2017-10-27 (until 2018-01-26). Claim clm_0A3BE79233EF, https://asof.is/claim/clm_0A3BE79233EF, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/1613103/000161310317000047/0001613103-17-000047-index.htm.","url":"https://asof.is/claim/clm_0A3BE79233EF","accessed":"2026-11-10"},"kind":"money","predicate":"cash_and_equivalents","value":"5,529,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_0A3BE79233EF","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:CashAndCashEquivalentsAtCarryingValue in 10-Q Q2 FY2018, filed 2017-12-04"}},{"date":"2017-10-27","until":"2018-01-26","published":"2017-12-04","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Medtronic plc quarterly net income: 2,017,000,000 United States dollar\", as of 2017-10-27 (until 2018-01-26). Claim clm_98981357542B, https://asof.is/claim/clm_98981357542B, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/1613103/000161310317000047/0001613103-17-000047-index.htm.","url":"https://asof.is/claim/clm_98981357542B","accessed":"2026-11-10"},"kind":"money","predicate":"quarterly_net_income","value":"2,017,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_98981357542B","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:NetIncomeLoss in 10-Q Q2 FY2018, filed 2017-12-04"}},{"date":"2017-10-27","until":"2018-01-26","published":"2018-11-29","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Medtronic plc quarterly revenue: 7,050,000,000 United States dollar\", as of 2017-10-27 (until 2018-01-26). Claim clm_A7109B19CCB4, https://asof.is/claim/clm_A7109B19CCB4, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/1613103/000161310318000044/0001613103-18-000044-index.htm.","url":"https://asof.is/claim/clm_A7109B19CCB4","accessed":"2026-11-10"},"kind":"money","predicate":"quarterly_revenue","value":"7,050,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_A7109B19CCB4","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax in 10-Q Q2 FY2019, filed 2018-11-29"}},{"date":"2017-10-27","until":"2018-01-26","published":"2017-12-04","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Medtronic plc quarterly operating income: 1,901,000,000 United States dollar\", as of 2017-10-27 (until 2018-01-26). Claim clm_BF5725B97F76, https://asof.is/claim/clm_BF5725B97F76, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/1613103/000161310317000047/0001613103-17-000047-index.htm.","url":"https://asof.is/claim/clm_BF5725B97F76","accessed":"2026-11-10"},"kind":"money","predicate":"quarterly_operating_income","value":"1,901,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_BF5725B97F76","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:OperatingIncomeLoss in 10-Q Q2 FY2018, filed 2017-12-04"}},{"date":"2017-10-27","until":"2018-01-26","published":"2017-12-04","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Medtronic plc total assets: 94,458,000,000 United States dollar\", as of 2017-10-27 (until 2018-01-26). Claim clm_C17F98BD8BDE, https://asof.is/claim/clm_C17F98BD8BDE, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/1613103/000161310317000047/0001613103-17-000047-index.htm.","url":"https://asof.is/claim/clm_C17F98BD8BDE","accessed":"2026-11-10"},"kind":"money","predicate":"total_assets","value":"94,458,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_C17F98BD8BDE","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:Assets in 10-Q Q2 FY2018, filed 2017-12-04"}},{"date":"2017-10-27","until":"2018-01-26","published":"2017-12-04","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Medtronic plc total equity: 51,469,000,000 United States dollar\", as of 2017-10-27 (until 2018-01-26). Claim clm_C4336406E307, https://asof.is/claim/clm_C4336406E307, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/1613103/000161310317000047/0001613103-17-000047-index.htm.","url":"https://asof.is/claim/clm_C4336406E307","accessed":"2026-11-10"},"kind":"money","predicate":"total_equity","value":"51,469,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_C4336406E307","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:StockholdersEquity in 10-Q Q2 FY2018, filed 2017-12-04"}},{"date":"2017-11-28","until":"2018-02-28","published":"2017-12-04","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Medtronic plc shares outstanding: 1,353,498,000 shares\", as of 2017-11-28 (until 2018-02-28). Claim clm_416968D585EC, https://asof.is/claim/clm_416968D585EC, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/1613103/000161310317000047/0001613103-17-000047-index.htm.","url":"https://asof.is/claim/clm_416968D585EC","accessed":"2026-11-10"},"kind":"money","predicate":"shares_outstanding","value":"1,353,498,000 shares","status":"superseded","assertable":true,"id":"clm_416968D585EC","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"dei:EntityCommonStockSharesOutstanding in 10-Q Q2 FY2018, filed 2017-12-04"}},{"date":"2018-01-26","until":"2018-04-27","published":"2018-03-02","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Medtronic plc total equity: 50,234,000,000 United States dollar\", as of 2018-01-26 (until 2018-04-27). Claim clm_3F80516C6CBC, https://asof.is/claim/clm_3F80516C6CBC, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/1613103/000161310318000009/0001613103-18-000009-index.htm.","url":"https://asof.is/claim/clm_3F80516C6CBC","accessed":"2026-11-10"},"kind":"money","predicate":"total_equity","value":"50,234,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_3F80516C6CBC","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:StockholdersEquity in 10-Q Q3 FY2018, filed 2018-03-02"}},{"date":"2018-01-26","until":"2018-04-27","published":"2018-03-02","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Medtronic plc cash and equivalents: 6,358,000,000 United States dollar\", as of 2018-01-26 (until 2018-04-27). Claim clm_56867F03A3B0, https://asof.is/claim/clm_56867F03A3B0, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/1613103/000161310318000009/0001613103-18-000009-index.htm.","url":"https://asof.is/claim/clm_56867F03A3B0","accessed":"2026-11-10"},"kind":"money","predicate":"cash_and_equivalents","value":"6,358,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_56867F03A3B0","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:CashAndCashEquivalentsAtCarryingValue in 10-Q Q3 FY2018, filed 2018-03-02"}},{"date":"2018-01-26","until":"2018-07-27","published":"2019-03-01","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Medtronic plc quarterly revenue: 7,369,000,000 United States dollar\", as of 2018-01-26 (until 2018-07-27). Claim clm_90E5ED91F9D3, https://asof.is/claim/clm_90E5ED91F9D3, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/1613103/000161310319000012/0001613103-19-000012-index.htm.","url":"https://asof.is/claim/clm_90E5ED91F9D3","accessed":"2026-11-10"},"kind":"money","predicate":"quarterly_revenue","value":"7,369,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_90E5ED91F9D3","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax in 10-Q Q3 FY2019, filed 2019-03-01"}},{"date":"2018-01-26","until":"2018-07-27","published":"2018-03-02","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Medtronic plc quarterly net income: -1,389,000,000 United States dollar\", as of 2018-01-26 (until 2018-07-27). Claim clm_937F4D57A278, https://asof.is/claim/clm_937F4D57A278, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/1613103/000161310318000009/0001613103-18-000009-index.htm.","url":"https://asof.is/claim/clm_937F4D57A278","accessed":"2026-11-10"},"kind":"money","predicate":"quarterly_net_income","value":"-1,389,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_937F4D57A278","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:NetIncomeLoss in 10-Q Q3 FY2018, filed 2018-03-02"}},{"date":"2018-01-26","until":"2018-04-27","published":"2018-03-02","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Medtronic plc total assets: 95,800,000,000 United States dollar\", as of 2018-01-26 (until 2018-04-27). Claim clm_9FEEBE229A5F, https://asof.is/claim/clm_9FEEBE229A5F, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/1613103/000161310318000009/0001613103-18-000009-index.htm.","url":"https://asof.is/claim/clm_9FEEBE229A5F","accessed":"2026-11-10"},"kind":"money","predicate":"total_assets","value":"95,800,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_9FEEBE229A5F","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:Assets in 10-Q Q3 FY2018, filed 2018-03-02"}},{"date":"2018-01-26","until":"2018-07-27","published":"2018-03-02","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Medtronic plc quarterly operating income: 1,426,000,000 United States dollar\", as of 2018-01-26 (until 2018-07-27). Claim clm_E3877660F522, https://asof.is/claim/clm_E3877660F522, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/1613103/000161310318000009/0001613103-18-000009-index.htm.","url":"https://asof.is/claim/clm_E3877660F522","accessed":"2026-11-10"},"kind":"money","predicate":"quarterly_operating_income","value":"1,426,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_E3877660F522","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:OperatingIncomeLoss in 10-Q Q3 FY2018, filed 2018-03-02"}},{"date":"2018-02-28","until":"2018-06-20","published":"2018-03-02","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Medtronic plc shares outstanding: 1,355,373,428 shares\", as of 2018-02-28 (until 2018-06-20). Claim clm_C36C3B674A81, https://asof.is/claim/clm_C36C3B674A81, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/1613103/000161310318000009/0001613103-18-000009-index.htm.","url":"https://asof.is/claim/clm_C36C3B674A81","accessed":"2026-11-10"},"kind":"money","predicate":"shares_outstanding","value":"1,355,373,428 shares","status":"superseded","assertable":true,"id":"clm_C36C3B674A81","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"dei:EntityCommonStockSharesOutstanding in 10-Q Q3 FY2018, filed 2018-03-02"}},{"date":"2018-04-27","until":"2019-04-26","published":"2018-06-22","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Medtronic plc net income: 3,104,000,000 United States dollar\", as of 2018-04-27 (until 2019-04-26). Claim clm_1D350C62378D, https://asof.is/claim/clm_1D350C62378D, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/1613103/000161310318000024/0001613103-18-000024-index.htm.","url":"https://asof.is/claim/clm_1D350C62378D","accessed":"2026-11-10"},"kind":"money","predicate":"net_income","value":"3,104,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_1D350C62378D","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:NetIncomeLoss in 10-K FY2018, filed 2018-06-22"}},{"date":"2018-04-27","until":"2018-07-27","published":"2018-06-22","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Medtronic plc total equity: 50,720,000,000 United States dollar\", as of 2018-04-27 (until 2018-07-27). Claim clm_5F7EC435D37B, https://asof.is/claim/clm_5F7EC435D37B, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/1613103/000161310318000024/0001613103-18-000024-index.htm.","url":"https://asof.is/claim/clm_5F7EC435D37B","accessed":"2026-11-10"},"kind":"money","predicate":"total_equity","value":"50,720,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_5F7EC435D37B","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:StockholdersEquity in 10-K FY2018, filed 2018-06-22"}},{"date":"2018-04-27","until":"2019-04-26","published":"2018-06-22","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Medtronic plc operating income: 6,651,000,000 United States dollar\", as of 2018-04-27 (until 2019-04-26). Claim clm_6049C30FBFCA, https://asof.is/claim/clm_6049C30FBFCA, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/1613103/000161310318000024/0001613103-18-000024-index.htm.","url":"https://asof.is/claim/clm_6049C30FBFCA","accessed":"2026-11-10"},"kind":"money","predicate":"operating_income","value":"6,651,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_6049C30FBFCA","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:OperatingIncomeLoss in 10-K FY2018, filed 2018-06-22"}},{"date":"2018-04-27","until":"2018-07-27","published":"2018-06-22","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Medtronic plc cash and equivalents: 3,669,000,000 United States dollar\", as of 2018-04-27 (until 2018-07-27). Claim clm_65AC21F43262, https://asof.is/claim/clm_65AC21F43262, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/1613103/000161310318000024/0001613103-18-000024-index.htm.","url":"https://asof.is/claim/clm_65AC21F43262","accessed":"2026-11-10"},"kind":"money","predicate":"cash_and_equivalents","value":"3,669,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_65AC21F43262","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:CashAndCashEquivalentsAtCarryingValue in 10-K FY2018, filed 2018-06-22"}},{"date":"2018-04-27","until":"2018-07-27","published":"2018-06-22","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Medtronic plc total assets: 91,393,000,000 United States dollar\", as of 2018-04-27 (until 2018-07-27). Claim clm_7C629CA745CD, https://asof.is/claim/clm_7C629CA745CD, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/1613103/000161310318000024/0001613103-18-000024-index.htm.","url":"https://asof.is/claim/clm_7C629CA745CD","accessed":"2026-11-10"},"kind":"money","predicate":"total_assets","value":"91,393,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_7C629CA745CD","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:Assets in 10-K FY2018, filed 2018-06-22"}},{"date":"2018-04-27","until":"2019-04-26","published":"2019-06-21","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Medtronic plc revenue: 29,953,000,000 United States dollar\", as of 2018-04-27 (until 2019-04-26). Claim clm_9D3EF5C9B280, https://asof.is/claim/clm_9D3EF5C9B280, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/1613103/000161310319000028/0001613103-19-000028-index.htm.","url":"https://asof.is/claim/clm_9D3EF5C9B280","accessed":"2026-11-10"},"kind":"money","predicate":"revenue","value":"29,953,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_9D3EF5C9B280","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax in 10-K FY2019, filed 2019-06-21"}},{"date":"2018-06-20","until":"2018-08-29","published":"2018-06-22","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Medtronic plc shares outstanding: 1,351,709,097 shares\", as of 2018-06-20 (until 2018-08-29). Claim clm_23192C82342B, https://asof.is/claim/clm_23192C82342B, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/1613103/000161310318000024/0001613103-18-000024-index.htm.","url":"https://asof.is/claim/clm_23192C82342B","accessed":"2026-11-10"},"kind":"money","predicate":"shares_outstanding","value":"1,351,709,097 shares","status":"superseded","assertable":true,"id":"clm_23192C82342B","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"dei:EntityCommonStockSharesOutstanding in 10-K FY2018, filed 2018-06-22"}},{"date":"2018-07-27","until":"2018-10-26","published":"2018-08-31","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Medtronic plc quarterly operating income: 1,236,000,000 United States dollar\", as of 2018-07-27 (until 2018-10-26). Claim clm_0BDBD672E63A, https://asof.is/claim/clm_0BDBD672E63A, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/1613103/000161310318000032/0001613103-18-000032-index.htm.","url":"https://asof.is/claim/clm_0BDBD672E63A","accessed":"2026-11-10"},"kind":"money","predicate":"quarterly_operating_income","value":"1,236,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_0BDBD672E63A","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:OperatingIncomeLoss in 10-Q Q1 FY2019, filed 2018-08-31"}},{"date":"2018-07-27","until":"2018-10-26","published":"2018-08-31","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Medtronic plc total equity: 50,224,000,000 United States dollar\", as of 2018-07-27 (until 2018-10-26). Claim clm_163478678504, https://asof.is/claim/clm_163478678504, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/1613103/000161310318000032/0001613103-18-000032-index.htm.","url":"https://asof.is/claim/clm_163478678504","accessed":"2026-11-10"},"kind":"money","predicate":"total_equity","value":"50,224,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_163478678504","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:StockholdersEquity in 10-Q Q1 FY2019, filed 2018-08-31"}},{"date":"2018-07-27","until":"2018-10-26","published":"2018-08-31","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Medtronic plc quarterly net income: 1,075,000,000 United States dollar\", as of 2018-07-27 (until 2018-10-26). Claim clm_404BE8D71326, https://asof.is/claim/clm_404BE8D71326, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/1613103/000161310318000032/0001613103-18-000032-index.htm.","url":"https://asof.is/claim/clm_404BE8D71326","accessed":"2026-11-10"},"kind":"money","predicate":"quarterly_net_income","value":"1,075,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_404BE8D71326","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:NetIncomeLoss in 10-Q Q1 FY2019, filed 2018-08-31"}},{"date":"2018-07-27","until":"2018-10-26","published":"2018-08-31","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Medtronic plc cash and equivalents: 4,380,000,000 United States dollar\", as of 2018-07-27 (until 2018-10-26). Claim clm_5628A8B9FD9C, https://asof.is/claim/clm_5628A8B9FD9C, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/1613103/000161310318000032/0001613103-18-000032-index.htm.","url":"https://asof.is/claim/clm_5628A8B9FD9C","accessed":"2026-11-10"},"kind":"money","predicate":"cash_and_equivalents","value":"4,380,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_5628A8B9FD9C","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:CashAndCashEquivalentsAtCarryingValue in 10-Q Q1 FY2019, filed 2018-08-31"}},{"date":"2018-07-27","until":"2018-10-26","published":"2018-08-31","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Medtronic plc quarterly revenue: 7,384,000,000 United States dollar\", as of 2018-07-27 (until 2018-10-26). Claim clm_B1E5110AD718, https://asof.is/claim/clm_B1E5110AD718, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/1613103/000161310318000032/0001613103-18-000032-index.htm.","url":"https://asof.is/claim/clm_B1E5110AD718","accessed":"2026-11-10"},"kind":"money","predicate":"quarterly_revenue","value":"7,384,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_B1E5110AD718","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax in 10-Q Q1 FY2019, filed 2018-08-31"}},{"date":"2018-07-27","until":"2018-10-26","published":"2018-08-31","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Medtronic plc total assets: 89,721,000,000 United States dollar\", as of 2018-07-27 (until 2018-10-26). Claim clm_D5A6FCB1C8B0, https://asof.is/claim/clm_D5A6FCB1C8B0, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/1613103/000161310318000032/0001613103-18-000032-index.htm.","url":"https://asof.is/claim/clm_D5A6FCB1C8B0","accessed":"2026-11-10"},"kind":"money","predicate":"total_assets","value":"89,721,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_D5A6FCB1C8B0","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:Assets in 10-Q Q1 FY2019, filed 2018-08-31"}},{"date":"2018-08-29","until":"2018-11-27","published":"2018-08-31","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Medtronic plc shares outstanding: 1,350,511,193 shares\", as of 2018-08-29 (until 2018-11-27). Claim clm_7CC3292BE3B1, https://asof.is/claim/clm_7CC3292BE3B1, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/1613103/000161310318000032/0001613103-18-000032-index.htm.","url":"https://asof.is/claim/clm_7CC3292BE3B1","accessed":"2026-11-10"},"kind":"money","predicate":"shares_outstanding","value":"1,350,511,193 shares","status":"superseded","assertable":true,"id":"clm_7CC3292BE3B1","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"dei:EntityCommonStockSharesOutstanding in 10-Q Q1 FY2019, filed 2018-08-31"}},{"date":"2018-10-26","until":"2019-01-25","published":"2018-11-29","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Medtronic plc cash and equivalents: 3,911,000,000 United States dollar\", as of 2018-10-26 (until 2019-01-25). Claim clm_46919521610B, https://asof.is/claim/clm_46919521610B, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/1613103/000161310318000044/0001613103-18-000044-index.htm.","url":"https://asof.is/claim/clm_46919521610B","accessed":"2026-11-10"},"kind":"money","predicate":"cash_and_equivalents","value":"3,911,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_46919521610B","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:CashAndCashEquivalentsAtCarryingValue in 10-Q Q2 FY2019, filed 2018-11-29"}},{"date":"2018-10-26","until":"2019-01-25","published":"2018-11-29","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Medtronic plc quarterly net income: 1,115,000,000 United States dollar\", as of 2018-10-26 (until 2019-01-25). Claim clm_9F0B8103AEBE, https://asof.is/claim/clm_9F0B8103AEBE, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/1613103/000161310318000044/0001613103-18-000044-index.htm.","url":"https://asof.is/claim/clm_9F0B8103AEBE","accessed":"2026-11-10"},"kind":"money","predicate":"quarterly_net_income","value":"1,115,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_9F0B8103AEBE","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:NetIncomeLoss in 10-Q Q2 FY2019, filed 2018-11-29"}},{"date":"2018-10-26","until":"2019-01-25","published":"2018-11-29","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Medtronic plc total equity: 49,607,000,000 United States dollar\", as of 2018-10-26 (until 2019-01-25). Claim clm_A20BFFCCAB66, https://asof.is/claim/clm_A20BFFCCAB66, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/1613103/000161310318000044/0001613103-18-000044-index.htm.","url":"https://asof.is/claim/clm_A20BFFCCAB66","accessed":"2026-11-10"},"kind":"money","predicate":"total_equity","value":"49,607,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_A20BFFCCAB66","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:StockholdersEquity in 10-Q Q2 FY2019, filed 2018-11-29"}},{"date":"2018-10-26","until":"2019-01-25","published":"2018-11-29","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Medtronic plc quarterly revenue: 7,481,000,000 United States dollar\", as of 2018-10-26 (until 2019-01-25). Claim clm_D419727C14A4, https://asof.is/claim/clm_D419727C14A4, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/1613103/000161310318000044/0001613103-18-000044-index.htm.","url":"https://asof.is/claim/clm_D419727C14A4","accessed":"2026-11-10"},"kind":"money","predicate":"quarterly_revenue","value":"7,481,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_D419727C14A4","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax in 10-Q Q2 FY2019, filed 2018-11-29"}},{"date":"2018-10-26","until":"2019-01-25","published":"2018-11-29","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Medtronic plc quarterly operating income: 1,544,000,000 United States dollar\", as of 2018-10-26 (until 2019-01-25). Claim clm_E6C4FF4AB440, https://asof.is/claim/clm_E6C4FF4AB440, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/1613103/000161310318000044/0001613103-18-000044-index.htm.","url":"https://asof.is/claim/clm_E6C4FF4AB440","accessed":"2026-11-10"},"kind":"money","predicate":"quarterly_operating_income","value":"1,544,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_E6C4FF4AB440","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:OperatingIncomeLoss in 10-Q Q2 FY2019, filed 2018-11-29"}},{"date":"2018-10-26","until":"2019-01-25","published":"2018-11-29","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Medtronic plc total assets: 88,150,000,000 United States dollar\", as of 2018-10-26 (until 2019-01-25). Claim clm_FBF333586648, https://asof.is/claim/clm_FBF333586648, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/1613103/000161310318000044/0001613103-18-000044-index.htm.","url":"https://asof.is/claim/clm_FBF333586648","accessed":"2026-11-10"},"kind":"money","predicate":"total_assets","value":"88,150,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_FBF333586648","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:Assets in 10-Q Q2 FY2019, filed 2018-11-29"}},{"date":"2018-11-27","until":"2019-02-27","published":"2018-11-29","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Medtronic plc shares outstanding: 1,343,045,417 shares\", as of 2018-11-27 (until 2019-02-27). Claim clm_4C7A460E196A, https://asof.is/claim/clm_4C7A460E196A, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/1613103/000161310318000044/0001613103-18-000044-index.htm.","url":"https://asof.is/claim/clm_4C7A460E196A","accessed":"2026-11-10"},"kind":"money","predicate":"shares_outstanding","value":"1,343,045,417 shares","status":"superseded","assertable":true,"id":"clm_4C7A460E196A","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"dei:EntityCommonStockSharesOutstanding in 10-Q Q2 FY2019, filed 2018-11-29"}},{"date":"2019-01-25","until":"2019-04-26","published":"2019-03-01","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Medtronic plc total assets: 88,730,000,000 United States dollar\", as of 2019-01-25 (until 2019-04-26). Claim clm_0EA45C5F3414, https://asof.is/claim/clm_0EA45C5F3414, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/1613103/000161310319000012/0001613103-19-000012-index.htm.","url":"https://asof.is/claim/clm_0EA45C5F3414","accessed":"2026-11-10"},"kind":"money","predicate":"total_assets","value":"88,730,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_0EA45C5F3414","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:Assets in 10-Q Q3 FY2019, filed 2019-03-01"}},{"date":"2019-01-25","until":"2019-07-26","published":"2019-03-01","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Medtronic plc quarterly operating income: 1,542,000,000 United States dollar\", as of 2019-01-25 (until 2019-07-26). Claim clm_484BB135F1E2, https://asof.is/claim/clm_484BB135F1E2, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/1613103/000161310319000012/0001613103-19-000012-index.htm.","url":"https://asof.is/claim/clm_484BB135F1E2","accessed":"2026-11-10"},"kind":"money","predicate":"quarterly_operating_income","value":"1,542,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_484BB135F1E2","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:OperatingIncomeLoss in 10-Q Q3 FY2019, filed 2019-03-01"}},{"date":"2019-01-25","until":"2019-04-26","published":"2019-03-01","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Medtronic plc cash and equivalents: 3,703,000,000 United States dollar\", as of 2019-01-25 (until 2019-04-26). Claim clm_6054C7910FB2, https://asof.is/claim/clm_6054C7910FB2, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/1613103/000161310319000012/0001613103-19-000012-index.htm.","url":"https://asof.is/claim/clm_6054C7910FB2","accessed":"2026-11-10"},"kind":"money","predicate":"cash_and_equivalents","value":"3,703,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_6054C7910FB2","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:CashAndCashEquivalentsAtCarryingValue in 10-Q Q3 FY2019, filed 2019-03-01"}},{"date":"2019-01-25","until":"2019-04-26","published":"2019-03-01","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Medtronic plc total equity: 49,829,000,000 United States dollar\", as of 2019-01-25 (until 2019-04-26). Claim clm_9D19EFDBD2A3, https://asof.is/claim/clm_9D19EFDBD2A3, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/1613103/000161310319000012/0001613103-19-000012-index.htm.","url":"https://asof.is/claim/clm_9D19EFDBD2A3","accessed":"2026-11-10"},"kind":"money","predicate":"total_equity","value":"49,829,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_9D19EFDBD2A3","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:StockholdersEquity in 10-Q Q3 FY2019, filed 2019-03-01"}},{"date":"2019-01-25","until":"2019-07-26","published":"2019-03-01","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Medtronic plc quarterly revenue: 7,546,000,000 United States dollar\", as of 2019-01-25 (until 2019-07-26). Claim clm_B2999BC5FF39, https://asof.is/claim/clm_B2999BC5FF39, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/1613103/000161310319000012/0001613103-19-000012-index.htm.","url":"https://asof.is/claim/clm_B2999BC5FF39","accessed":"2026-11-10"},"kind":"money","predicate":"quarterly_revenue","value":"7,546,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_B2999BC5FF39","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax in 10-Q Q3 FY2019, filed 2019-03-01"}},{"date":"2019-01-25","until":"2019-07-26","published":"2019-03-01","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Medtronic plc quarterly net income: 1,269,000,000 United States dollar\", as of 2019-01-25 (until 2019-07-26). Claim clm_BD510F84A18A, https://asof.is/claim/clm_BD510F84A18A, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/1613103/000161310319000012/0001613103-19-000012-index.htm.","url":"https://asof.is/claim/clm_BD510F84A18A","accessed":"2026-11-10"},"kind":"money","predicate":"quarterly_net_income","value":"1,269,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_BD510F84A18A","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:NetIncomeLoss in 10-Q Q3 FY2019, filed 2019-03-01"}},{"date":"2019-02-27","until":"2019-06-18","published":"2019-03-01","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Medtronic plc shares outstanding: 1,341,150,970 shares\", as of 2019-02-27 (until 2019-06-18). Claim clm_BEA377BA2F58, https://asof.is/claim/clm_BEA377BA2F58, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/1613103/000161310319000012/0001613103-19-000012-index.htm.","url":"https://asof.is/claim/clm_BEA377BA2F58","accessed":"2026-11-10"},"kind":"money","predicate":"shares_outstanding","value":"1,341,150,970 shares","status":"superseded","assertable":true,"id":"clm_BEA377BA2F58","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"dei:EntityCommonStockSharesOutstanding in 10-Q Q3 FY2019, filed 2019-03-01"}},{"date":"2019-04-26","until":"2020-04-24","published":"2019-06-21","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Medtronic plc operating income: 6,268,000,000 United States dollar\", as of 2019-04-26 (until 2020-04-24). Claim clm_0067F00D4CDE, https://asof.is/claim/clm_0067F00D4CDE, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/1613103/000161310319000028/0001613103-19-000028-index.htm.","url":"https://asof.is/claim/clm_0067F00D4CDE","accessed":"2026-11-10"},"kind":"money","predicate":"operating_income","value":"6,268,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_0067F00D4CDE","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:OperatingIncomeLoss in 10-K FY2019, filed 2019-06-21"}},{"date":"2019-04-26","until":"2020-04-24","published":"2019-06-21","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Medtronic plc revenue: 30,557,000,000 United States dollar\", as of 2019-04-26 (until 2020-04-24). Claim clm_1227E23E21F9, https://asof.is/claim/clm_1227E23E21F9, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/1613103/000161310319000028/0001613103-19-000028-index.htm.","url":"https://asof.is/claim/clm_1227E23E21F9","accessed":"2026-11-10"},"kind":"money","predicate":"revenue","value":"30,557,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_1227E23E21F9","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax in 10-K FY2019, filed 2019-06-21"}},{"date":"2019-04-26","until":"2019-07-26","published":"2019-06-21","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Medtronic plc total assets: 89,694,000,000 United States dollar\", as of 2019-04-26 (until 2019-07-26). Claim clm_14BADA215086, https://asof.is/claim/clm_14BADA215086, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/1613103/000161310319000028/0001613103-19-000028-index.htm.","url":"https://asof.is/claim/clm_14BADA215086","accessed":"2026-11-10"},"kind":"money","predicate":"total_assets","value":"89,694,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_14BADA215086","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:Assets in 10-K FY2019, filed 2019-06-21"}},{"date":"2019-04-26","until":"2020-04-24","published":"2019-06-21","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Medtronic plc net income: 4,631,000,000 United States dollar\", as of 2019-04-26 (until 2020-04-24). Claim clm_1821662E3259, https://asof.is/claim/clm_1821662E3259, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/1613103/000161310319000028/0001613103-19-000028-index.htm.","url":"https://asof.is/claim/clm_1821662E3259","accessed":"2026-11-10"},"kind":"money","predicate":"net_income","value":"4,631,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_1821662E3259","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:NetIncomeLoss in 10-K FY2019, filed 2019-06-21"}},{"date":"2019-04-26","until":"2019-07-26","published":"2019-06-21","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Medtronic plc cash and equivalents: 4,393,000,000 United States dollar\", as of 2019-04-26 (until 2019-07-26). Claim clm_6C081FC7A5BE, https://asof.is/claim/clm_6C081FC7A5BE, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/1613103/000161310319000028/0001613103-19-000028-index.htm.","url":"https://asof.is/claim/clm_6C081FC7A5BE","accessed":"2026-11-10"},"kind":"money","predicate":"cash_and_equivalents","value":"4,393,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_6C081FC7A5BE","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:CashAndCashEquivalentsAtCarryingValue in 10-K FY2019, filed 2019-06-21"}},{"date":"2019-04-26","until":"2019-07-26","published":"2019-06-21","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Medtronic plc total equity: 50,091,000,000 United States dollar\", as of 2019-04-26 (until 2019-07-26). Claim clm_8E1FEF7D6D04, https://asof.is/claim/clm_8E1FEF7D6D04, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/1613103/000161310319000028/0001613103-19-000028-index.htm.","url":"https://asof.is/claim/clm_8E1FEF7D6D04","accessed":"2026-11-10"},"kind":"money","predicate":"total_equity","value":"50,091,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_8E1FEF7D6D04","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:StockholdersEquity in 10-K FY2019, filed 2019-06-21"}},{"date":"2019-06-18","until":"2019-08-27","published":"2019-06-21","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Medtronic plc shares outstanding: 1,341,156,703 shares\", as of 2019-06-18 (until 2019-08-27). Claim clm_CE61468DA19E, https://asof.is/claim/clm_CE61468DA19E, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/1613103/000161310319000028/0001613103-19-000028-index.htm.","url":"https://asof.is/claim/clm_CE61468DA19E","accessed":"2026-11-10"},"kind":"money","predicate":"shares_outstanding","value":"1,341,156,703 shares","status":"superseded","assertable":true,"id":"clm_CE61468DA19E","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"dei:EntityCommonStockSharesOutstanding in 10-K FY2019, filed 2019-06-21"}},{"date":"2019-07-26","until":"2019-10-25","published":"2019-08-30","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Medtronic plc quarterly revenue: 7,493,000,000 United States dollar\", as of 2019-07-26 (until 2019-10-25). Claim clm_75AE288702B8, https://asof.is/claim/clm_75AE288702B8, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/1613103/000161310319000038/0001613103-19-000038-index.htm.","url":"https://asof.is/claim/clm_75AE288702B8","accessed":"2026-11-10"},"kind":"money","predicate":"quarterly_revenue","value":"7,493,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_75AE288702B8","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax in 10-Q Q1 FY2020, filed 2019-08-30"}},{"date":"2019-07-26","until":"2019-10-25","published":"2019-08-30","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Medtronic plc cash and equivalents: 5,080,000,000 United States dollar\", as of 2019-07-26 (until 2019-10-25). Claim clm_777BB5E82BAE, https://asof.is/claim/clm_777BB5E82BAE, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/1613103/000161310319000038/0001613103-19-000038-index.htm.","url":"https://asof.is/claim/clm_777BB5E82BAE","accessed":"2026-11-10"},"kind":"money","predicate":"cash_and_equivalents","value":"5,080,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_777BB5E82BAE","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:CashAndCashEquivalentsAtCarryingValue in 10-Q Q1 FY2020, filed 2019-08-30"}},{"date":"2019-07-26","until":"2019-10-25","published":"2019-08-30","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Medtronic plc quarterly operating income: 1,485,000,000 United States dollar\", as of 2019-07-26 (until 2019-10-25). Claim clm_847D9D4FF785, https://asof.is/claim/clm_847D9D4FF785, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/1613103/000161310319000038/0001613103-19-000038-index.htm.","url":"https://asof.is/claim/clm_847D9D4FF785","accessed":"2026-11-10"},"kind":"money","predicate":"quarterly_operating_income","value":"1,485,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_847D9D4FF785","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:OperatingIncomeLoss in 10-Q Q1 FY2020, filed 2019-08-30"}},{"date":"2019-07-26","until":"2019-10-25","published":"2019-08-30","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Medtronic plc total equity: 50,363,000,000 United States dollar\", as of 2019-07-26 (until 2019-10-25). Claim clm_8A1DF5A7E9FD, https://asof.is/claim/clm_8A1DF5A7E9FD, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/1613103/000161310319000038/0001613103-19-000038-index.htm.","url":"https://asof.is/claim/clm_8A1DF5A7E9FD","accessed":"2026-11-10"},"kind":"money","predicate":"total_equity","value":"50,363,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_8A1DF5A7E9FD","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:StockholdersEquity in 10-Q Q1 FY2020, filed 2019-08-30"}},{"date":"2019-07-26","until":"2019-10-25","published":"2019-08-30","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Medtronic plc total assets: 91,268,000,000 United States dollar\", as of 2019-07-26 (until 2019-10-25). Claim clm_DBDDF77F8B5A, https://asof.is/claim/clm_DBDDF77F8B5A, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/1613103/000161310319000038/0001613103-19-000038-index.htm.","url":"https://asof.is/claim/clm_DBDDF77F8B5A","accessed":"2026-11-10"},"kind":"money","predicate":"total_assets","value":"91,268,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_DBDDF77F8B5A","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:Assets in 10-Q Q1 FY2020, filed 2019-08-30"}},{"date":"2019-07-26","until":"2019-10-25","published":"2019-08-30","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Medtronic plc quarterly net income: 864,000,000 United States dollar\", as of 2019-07-26 (until 2019-10-25). Claim clm_E6C78A6A8D47, https://asof.is/claim/clm_E6C78A6A8D47, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/1613103/000161310319000038/0001613103-19-000038-index.htm.","url":"https://asof.is/claim/clm_E6C78A6A8D47","accessed":"2026-11-10"},"kind":"money","predicate":"quarterly_net_income","value":"864,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_E6C78A6A8D47","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:NetIncomeLoss in 10-Q Q1 FY2020, filed 2019-08-30"}},{"date":"2019-08-27","until":"2019-11-27","published":"2019-08-30","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Medtronic plc shares outstanding: 1,341,669,471 shares\", as of 2019-08-27 (until 2019-11-27). Claim clm_452BC361C963, https://asof.is/claim/clm_452BC361C963, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/1613103/000161310319000038/0001613103-19-000038-index.htm.","url":"https://asof.is/claim/clm_452BC361C963","accessed":"2026-11-10"},"kind":"money","predicate":"shares_outstanding","value":"1,341,669,471 shares","status":"superseded","assertable":true,"id":"clm_452BC361C963","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"dei:EntityCommonStockSharesOutstanding in 10-Q Q1 FY2020, filed 2019-08-30"}},{"date":"2019-10-25","until":"2020-01-24","published":"2019-12-03","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Medtronic plc quarterly operating income: 1,351,000,000 United States dollar\", as of 2019-10-25 (until 2020-01-24). Claim clm_76CF0E9C5D01, https://asof.is/claim/clm_76CF0E9C5D01, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/1613103/000161310319000056/0001613103-19-000056-index.htm.","url":"https://asof.is/claim/clm_76CF0E9C5D01","accessed":"2026-11-10"},"kind":"money","predicate":"quarterly_operating_income","value":"1,351,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_76CF0E9C5D01","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:OperatingIncomeLoss in 10-Q Q2 FY2020, filed 2019-12-03"}},{"date":"2019-10-25","until":"2020-01-24","published":"2019-12-03","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Medtronic plc total assets: 91,053,000,000 United States dollar\", as of 2019-10-25 (until 2020-01-24). Claim clm_8D6E98F70391, https://asof.is/claim/clm_8D6E98F70391, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/1613103/000161310319000056/0001613103-19-000056-index.htm.","url":"https://asof.is/claim/clm_8D6E98F70391","accessed":"2026-11-10"},"kind":"money","predicate":"total_assets","value":"91,053,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_8D6E98F70391","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:Assets in 10-Q Q2 FY2020, filed 2019-12-03"}},{"date":"2019-10-25","until":"2020-01-24","published":"2019-12-03","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Medtronic plc total equity: 50,578,000,000 United States dollar\", as of 2019-10-25 (until 2020-01-24). Claim clm_C8C06B828EFC, https://asof.is/claim/clm_C8C06B828EFC, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/1613103/000161310319000056/0001613103-19-000056-index.htm.","url":"https://asof.is/claim/clm_C8C06B828EFC","accessed":"2026-11-10"},"kind":"money","predicate":"total_equity","value":"50,578,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_C8C06B828EFC","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:StockholdersEquity in 10-Q Q2 FY2020, filed 2019-12-03"}},{"date":"2019-10-25","until":"2020-01-24","published":"2019-12-03","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Medtronic plc quarterly net income: 1,364,000,000 United States dollar\", as of 2019-10-25 (until 2020-01-24). Claim clm_CB67B1B0A972, https://asof.is/claim/clm_CB67B1B0A972, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/1613103/000161310319000056/0001613103-19-000056-index.htm.","url":"https://asof.is/claim/clm_CB67B1B0A972","accessed":"2026-11-10"},"kind":"money","predicate":"quarterly_net_income","value":"1,364,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_CB67B1B0A972","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:NetIncomeLoss in 10-Q Q2 FY2020, filed 2019-12-03"}},{"date":"2019-10-25","until":"2020-01-24","published":"2019-12-03","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Medtronic plc cash and equivalents: 3,962,000,000 United States dollar\", as of 2019-10-25 (until 2020-01-24). Claim clm_E0F778E4FBF7, https://asof.is/claim/clm_E0F778E4FBF7, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/1613103/000161310319000056/0001613103-19-000056-index.htm.","url":"https://asof.is/claim/clm_E0F778E4FBF7","accessed":"2026-11-10"},"kind":"money","predicate":"cash_and_equivalents","value":"3,962,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_E0F778E4FBF7","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:CashAndCashEquivalentsAtCarryingValue in 10-Q Q2 FY2020, filed 2019-12-03"}},{"date":"2019-10-25","until":"2020-01-24","published":"2019-12-03","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Medtronic plc quarterly revenue: 7,706,000,000 United States dollar\", as of 2019-10-25 (until 2020-01-24). Claim clm_E83D50C88280, https://asof.is/claim/clm_E83D50C88280, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/1613103/000161310319000056/0001613103-19-000056-index.htm.","url":"https://asof.is/claim/clm_E83D50C88280","accessed":"2026-11-10"},"kind":"money","predicate":"quarterly_revenue","value":"7,706,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_E83D50C88280","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax in 10-Q Q2 FY2020, filed 2019-12-03"}},{"date":"2019-11-27","until":"2020-02-25","published":"2019-12-03","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Medtronic plc shares outstanding: 1,340,377,511 shares\", as of 2019-11-27 (until 2020-02-25). Claim clm_F8E994F4C73A, https://asof.is/claim/clm_F8E994F4C73A, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/1613103/000161310319000056/0001613103-19-000056-index.htm.","url":"https://asof.is/claim/clm_F8E994F4C73A","accessed":"2026-11-10"},"kind":"money","predicate":"shares_outstanding","value":"1,340,377,511 shares","status":"superseded","assertable":true,"id":"clm_F8E994F4C73A","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"dei:EntityCommonStockSharesOutstanding in 10-Q Q2 FY2020, filed 2019-12-03"}},{"date":"2020-01-24","until":"2020-04-24","published":"2020-02-28","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Medtronic plc total equity: 51,808,000,000 United States dollar\", as of 2020-01-24 (until 2020-04-24). Claim clm_340BB97B1D16, https://asof.is/claim/clm_340BB97B1D16, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/1613103/000161310320000007/0001613103-20-000007-index.htm.","url":"https://asof.is/claim/clm_340BB97B1D16","accessed":"2026-11-10"},"kind":"money","predicate":"total_equity","value":"51,808,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_340BB97B1D16","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:StockholdersEquity in 10-Q Q3 FY2020, filed 2020-02-28"}},{"date":"2020-01-24","until":"2020-07-31","published":"2020-02-28","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Medtronic plc quarterly operating income: 1,639,000,000 United States dollar\", as of 2020-01-24 (until 2020-07-31). Claim clm_487D8E9DC86B, https://asof.is/claim/clm_487D8E9DC86B, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/1613103/000161310320000007/0001613103-20-000007-index.htm.","url":"https://asof.is/claim/clm_487D8E9DC86B","accessed":"2026-11-10"},"kind":"money","predicate":"quarterly_operating_income","value":"1,639,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_487D8E9DC86B","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:OperatingIncomeLoss in 10-Q Q3 FY2020, filed 2020-02-28"}},{"date":"2020-01-24","until":"2020-04-24","published":"2020-02-28","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Medtronic plc cash and equivalents: 3,709,000,000 United States dollar\", as of 2020-01-24 (until 2020-04-24). Claim clm_4D4F45CB9A34, https://asof.is/claim/clm_4D4F45CB9A34, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/1613103/000161310320000007/0001613103-20-000007-index.htm.","url":"https://asof.is/claim/clm_4D4F45CB9A34","accessed":"2026-11-10"},"kind":"money","predicate":"cash_and_equivalents","value":"3,709,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_4D4F45CB9A34","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:CashAndCashEquivalentsAtCarryingValue in 10-Q Q3 FY2020, filed 2020-02-28"}},{"date":"2020-01-24","until":"2020-07-31","published":"2020-02-28","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Medtronic plc quarterly revenue: 7,717,000,000 United States dollar\", as of 2020-01-24 (until 2020-07-31). Claim clm_85A9357A3FE4, https://asof.is/claim/clm_85A9357A3FE4, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/1613103/000161310320000007/0001613103-20-000007-index.htm.","url":"https://asof.is/claim/clm_85A9357A3FE4","accessed":"2026-11-10"},"kind":"money","predicate":"quarterly_revenue","value":"7,717,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_85A9357A3FE4","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax in 10-Q Q3 FY2020, filed 2020-02-28"}},{"date":"2020-01-24","until":"2020-04-24","published":"2020-02-28","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Medtronic plc total assets: 92,822,000,000 United States dollar\", as of 2020-01-24 (until 2020-04-24). Claim clm_DD76E60D2B7E, https://asof.is/claim/clm_DD76E60D2B7E, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/1613103/000161310320000007/0001613103-20-000007-index.htm.","url":"https://asof.is/claim/clm_DD76E60D2B7E","accessed":"2026-11-10"},"kind":"money","predicate":"total_assets","value":"92,822,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_DD76E60D2B7E","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:Assets in 10-Q Q3 FY2020, filed 2020-02-28"}},{"date":"2020-01-24","until":"2020-07-31","published":"2020-02-28","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Medtronic plc quarterly net income: 1,915,000,000 United States dollar\", as of 2020-01-24 (until 2020-07-31). Claim clm_E09CA8931836, https://asof.is/claim/clm_E09CA8931836, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/1613103/000161310320000007/0001613103-20-000007-index.htm.","url":"https://asof.is/claim/clm_E09CA8931836","accessed":"2026-11-10"},"kind":"money","predicate":"quarterly_net_income","value":"1,915,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_E09CA8931836","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:NetIncomeLoss in 10-Q Q3 FY2020, filed 2020-02-28"}},{"date":"2020-02-25","until":"2020-06-17","published":"2020-02-28","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Medtronic plc shares outstanding: 1,340,166,137 shares\", as of 2020-02-25 (until 2020-06-17). Claim clm_10B51698BD17, https://asof.is/claim/clm_10B51698BD17, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/1613103/000161310320000007/0001613103-20-000007-index.htm.","url":"https://asof.is/claim/clm_10B51698BD17","accessed":"2026-11-10"},"kind":"money","predicate":"shares_outstanding","value":"1,340,166,137 shares","status":"superseded","assertable":true,"id":"clm_10B51698BD17","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"dei:EntityCommonStockSharesOutstanding in 10-Q Q3 FY2020, filed 2020-02-28"}},{"date":"2020-04-24","until":"2021-04-30","published":"2020-06-19","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Medtronic plc revenue: 28,913,000,000 United States dollar\", as of 2020-04-24 (until 2021-04-30). Claim clm_2A3B86E439F9, https://asof.is/claim/clm_2A3B86E439F9, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/1613103/000161310320000021/0001613103-20-000021-index.htm.","url":"https://asof.is/claim/clm_2A3B86E439F9","accessed":"2026-11-10"},"kind":"money","predicate":"revenue","value":"28,913,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_2A3B86E439F9","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax in 10-K FY2020, filed 2020-06-19"}},{"date":"2020-04-24","until":"2020-07-31","published":"2020-06-19","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Medtronic plc cash and equivalents: 4,140,000,000 United States dollar\", as of 2020-04-24 (until 2020-07-31). Claim clm_484275AB75BD, https://asof.is/claim/clm_484275AB75BD, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/1613103/000161310320000021/0001613103-20-000021-index.htm.","url":"https://asof.is/claim/clm_484275AB75BD","accessed":"2026-11-10"},"kind":"money","predicate":"cash_and_equivalents","value":"4,140,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_484275AB75BD","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:CashAndCashEquivalentsAtCarryingValue in 10-K FY2020, filed 2020-06-19"}},{"date":"2020-04-24","until":"2021-04-30","published":"2020-06-19","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Medtronic plc net income: 4,789,000,000 United States dollar\", as of 2020-04-24 (until 2021-04-30). Claim clm_65226BDA30E9, https://asof.is/claim/clm_65226BDA30E9, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/1613103/000161310320000021/0001613103-20-000021-index.htm.","url":"https://asof.is/claim/clm_65226BDA30E9","accessed":"2026-11-10"},"kind":"money","predicate":"net_income","value":"4,789,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_65226BDA30E9","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:NetIncomeLoss in 10-K FY2020, filed 2020-06-19"}},{"date":"2020-04-24","until":"2020-07-31","published":"2020-06-19","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Medtronic plc total equity: 50,737,000,000 United States dollar\", as of 2020-04-24 (until 2020-07-31). Claim clm_8B6CEF2B55E1, https://asof.is/claim/clm_8B6CEF2B55E1, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/1613103/000161310320000021/0001613103-20-000021-index.htm.","url":"https://asof.is/claim/clm_8B6CEF2B55E1","accessed":"2026-11-10"},"kind":"money","predicate":"total_equity","value":"50,737,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_8B6CEF2B55E1","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:StockholdersEquity in 10-K FY2020, filed 2020-06-19"}},{"date":"2020-04-24","until":"2020-07-31","published":"2020-06-19","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Medtronic plc total assets: 90,689,000,000 United States dollar\", as of 2020-04-24 (until 2020-07-31). Claim clm_8D457927A5B7, https://asof.is/claim/clm_8D457927A5B7, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/1613103/000161310320000021/0001613103-20-000021-index.htm.","url":"https://asof.is/claim/clm_8D457927A5B7","accessed":"2026-11-10"},"kind":"money","predicate":"total_assets","value":"90,689,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_8D457927A5B7","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:Assets in 10-K FY2020, filed 2020-06-19"}},{"date":"2020-04-24","until":"2021-04-30","published":"2020-06-19","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Medtronic plc operating income: 4,791,000,000 United States dollar\", as of 2020-04-24 (until 2021-04-30). Claim clm_BDBAC98C867D, https://asof.is/claim/clm_BDBAC98C867D, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/1613103/000161310320000021/0001613103-20-000021-index.htm.","url":"https://asof.is/claim/clm_BDBAC98C867D","accessed":"2026-11-10"},"kind":"money","predicate":"operating_income","value":"4,791,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_BDBAC98C867D","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:OperatingIncomeLoss in 10-K FY2020, filed 2020-06-19"}},{"date":"2020-06-17","until":"2020-09-02","published":"2020-06-19","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Medtronic plc shares outstanding: 1,341,298,882 shares\", as of 2020-06-17 (until 2020-09-02). Claim clm_335651A7E8CD, https://asof.is/claim/clm_335651A7E8CD, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/1613103/000161310320000021/0001613103-20-000021-index.htm.","url":"https://asof.is/claim/clm_335651A7E8CD","accessed":"2026-11-10"},"kind":"money","predicate":"shares_outstanding","value":"1,341,298,882 shares","status":"superseded","assertable":true,"id":"clm_335651A7E8CD","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"dei:EntityCommonStockSharesOutstanding in 10-K FY2020, filed 2020-06-19"}},{"date":"2020-07-31","until":"2020-10-30","published":"2020-09-03","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Medtronic plc total equity: 50,296,000,000 United States dollar\", as of 2020-07-31 (until 2020-10-30). Claim clm_3228B83890C4, https://asof.is/claim/clm_3228B83890C4, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/1613103/000161310320000033/0001613103-20-000033-index.htm.","url":"https://asof.is/claim/clm_3228B83890C4","accessed":"2026-11-10"},"kind":"money","predicate":"total_equity","value":"50,296,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_3228B83890C4","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:StockholdersEquity in 10-Q Q1 FY2021, filed 2020-09-03"}},{"date":"2020-07-31","until":"2020-10-30","published":"2020-09-03","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Medtronic plc quarterly revenue: 6,507,000,000 United States dollar\", as of 2020-07-31 (until 2020-10-30). Claim clm_45C9CDBEE989, https://asof.is/claim/clm_45C9CDBEE989, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/1613103/000161310320000033/0001613103-20-000033-index.htm.","url":"https://asof.is/claim/clm_45C9CDBEE989","accessed":"2026-11-10"},"kind":"money","predicate":"quarterly_revenue","value":"6,507,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_45C9CDBEE989","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax in 10-Q Q1 FY2021, filed 2020-09-03"}},{"date":"2020-07-31","until":"2020-10-30","published":"2020-09-03","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Medtronic plc quarterly net income: 487,000,000 United States dollar\", as of 2020-07-31 (until 2020-10-30). Claim clm_5C2596542785, https://asof.is/claim/clm_5C2596542785, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/1613103/000161310320000033/0001613103-20-000033-index.htm.","url":"https://asof.is/claim/clm_5C2596542785","accessed":"2026-11-10"},"kind":"money","predicate":"quarterly_net_income","value":"487,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_5C2596542785","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:NetIncomeLoss in 10-Q Q1 FY2021, filed 2020-09-03"}},{"date":"2020-07-31","until":"2020-10-30","published":"2020-09-03","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Medtronic plc cash and equivalents: 6,499,000,000 United States dollar\", as of 2020-07-31 (until 2020-10-30). Claim clm_884F4F7D95EB, https://asof.is/claim/clm_884F4F7D95EB, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/1613103/000161310320000033/0001613103-20-000033-index.htm.","url":"https://asof.is/claim/clm_884F4F7D95EB","accessed":"2026-11-10"},"kind":"money","predicate":"cash_and_equivalents","value":"6,499,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_884F4F7D95EB","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:CashAndCashEquivalentsAtCarryingValue in 10-Q Q1 FY2021, filed 2020-09-03"}},{"date":"2020-07-31","until":"2020-10-30","published":"2020-09-03","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Medtronic plc total assets: 93,906,000,000 United States dollar\", as of 2020-07-31 (until 2020-10-30). Claim clm_8EE9365C87A6, https://asof.is/claim/clm_8EE9365C87A6, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/1613103/000161310320000033/0001613103-20-000033-index.htm.","url":"https://asof.is/claim/clm_8EE9365C87A6","accessed":"2026-11-10"},"kind":"money","predicate":"total_assets","value":"93,906,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_8EE9365C87A6","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:Assets in 10-Q Q1 FY2021, filed 2020-09-03"}},{"date":"2020-07-31","until":"2020-10-30","published":"2020-09-03","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Medtronic plc quarterly operating income: 673,000,000 United States dollar\", as of 2020-07-31 (until 2020-10-30). Claim clm_FD0F5C98C138, https://asof.is/claim/clm_FD0F5C98C138, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/1613103/000161310320000033/0001613103-20-000033-index.htm.","url":"https://asof.is/claim/clm_FD0F5C98C138","accessed":"2026-11-10"},"kind":"money","predicate":"quarterly_operating_income","value":"673,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_FD0F5C98C138","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:OperatingIncomeLoss in 10-Q Q1 FY2021, filed 2020-09-03"}},{"date":"2020-09-02","until":"2020-12-01","published":"2020-09-03","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Medtronic plc shares outstanding: 1,344,215,261 shares\", as of 2020-09-02 (until 2020-12-01). Claim clm_A4D128FD3323, https://asof.is/claim/clm_A4D128FD3323, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/1613103/000161310320000033/0001613103-20-000033-index.htm.","url":"https://asof.is/claim/clm_A4D128FD3323","accessed":"2026-11-10"},"kind":"money","predicate":"shares_outstanding","value":"1,344,215,261 shares","status":"superseded","assertable":true,"id":"clm_A4D128FD3323","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"dei:EntityCommonStockSharesOutstanding in 10-Q Q1 FY2021, filed 2020-09-03"}},{"date":"2020-10-30","until":"2021-01-29","published":"2020-12-03","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Medtronic plc quarterly operating income: 930,000,000 United States dollar\", as of 2020-10-30 (until 2021-01-29). Claim clm_66AA1731C5F1, https://asof.is/claim/clm_66AA1731C5F1, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/1613103/000161310320000051/0001613103-20-000051-index.htm.","url":"https://asof.is/claim/clm_66AA1731C5F1","accessed":"2026-11-10"},"kind":"money","predicate":"quarterly_operating_income","value":"930,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_66AA1731C5F1","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:OperatingIncomeLoss in 10-Q Q2 FY2021, filed 2020-12-03"}},{"date":"2020-10-30","until":"2021-01-29","published":"2020-12-03","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Medtronic plc total assets: 95,886,000,000 United States dollar\", as of 2020-10-30 (until 2021-01-29). Claim clm_8040F98EE155, https://asof.is/claim/clm_8040F98EE155, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/1613103/000161310320000051/0001613103-20-000051-index.htm.","url":"https://asof.is/claim/clm_8040F98EE155","accessed":"2026-11-10"},"kind":"money","predicate":"total_assets","value":"95,886,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_8040F98EE155","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:Assets in 10-Q Q2 FY2021, filed 2020-12-03"}},{"date":"2020-10-30","until":"2021-01-29","published":"2020-12-03","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Medtronic plc cash and equivalents: 6,420,000,000 United States dollar\", as of 2020-10-30 (until 2021-01-29). Claim clm_AAEF9893423F, https://asof.is/claim/clm_AAEF9893423F, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/1613103/000161310320000051/0001613103-20-000051-index.htm.","url":"https://asof.is/claim/clm_AAEF9893423F","accessed":"2026-11-10"},"kind":"money","predicate":"cash_and_equivalents","value":"6,420,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_AAEF9893423F","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:CashAndCashEquivalentsAtCarryingValue in 10-Q Q2 FY2021, filed 2020-12-03"}},{"date":"2020-10-30","until":"2021-01-29","published":"2020-12-03","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Medtronic plc total equity: 50,164,000,000 United States dollar\", as of 2020-10-30 (until 2021-01-29). Claim clm_D02E140D3EE8, https://asof.is/claim/clm_D02E140D3EE8, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/1613103/000161310320000051/0001613103-20-000051-index.htm.","url":"https://asof.is/claim/clm_D02E140D3EE8","accessed":"2026-11-10"},"kind":"money","predicate":"total_equity","value":"50,164,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_D02E140D3EE8","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:StockholdersEquity in 10-Q Q2 FY2021, filed 2020-12-03"}},{"date":"2020-10-30","until":"2021-01-29","published":"2020-12-03","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Medtronic plc quarterly net income: 489,000,000 United States dollar\", as of 2020-10-30 (until 2021-01-29). Claim clm_E9FBD5EB73A3, https://asof.is/claim/clm_E9FBD5EB73A3, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/1613103/000161310320000051/0001613103-20-000051-index.htm.","url":"https://asof.is/claim/clm_E9FBD5EB73A3","accessed":"2026-11-10"},"kind":"money","predicate":"quarterly_net_income","value":"489,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_E9FBD5EB73A3","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:NetIncomeLoss in 10-Q Q2 FY2021, filed 2020-12-03"}},{"date":"2020-10-30","until":"2021-01-29","published":"2020-12-03","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Medtronic plc quarterly revenue: 7,647,000,000 United States dollar\", as of 2020-10-30 (until 2021-01-29). Claim clm_F9E042E33CD0, https://asof.is/claim/clm_F9E042E33CD0, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/1613103/000161310320000051/0001613103-20-000051-index.htm.","url":"https://asof.is/claim/clm_F9E042E33CD0","accessed":"2026-11-10"},"kind":"money","predicate":"quarterly_revenue","value":"7,647,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_F9E042E33CD0","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax in 10-Q Q2 FY2021, filed 2020-12-03"}},{"date":"2020-12-01","until":"2021-03-03","published":"2020-12-03","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Medtronic plc shares outstanding: 1,346,019,949 shares\", as of 2020-12-01 (until 2021-03-03). Claim clm_4A7EBAEF4C94, https://asof.is/claim/clm_4A7EBAEF4C94, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/1613103/000161310320000051/0001613103-20-000051-index.htm.","url":"https://asof.is/claim/clm_4A7EBAEF4C94","accessed":"2026-11-10"},"kind":"money","predicate":"shares_outstanding","value":"1,346,019,949 shares","status":"superseded","assertable":true,"id":"clm_4A7EBAEF4C94","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"dei:EntityCommonStockSharesOutstanding in 10-Q Q2 FY2021, filed 2020-12-03"}},{"date":"2021-01-29","until":"2021-04-30","published":"2021-03-05","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Medtronic plc total equity: 50,758,000,000 United States dollar\", as of 2021-01-29 (until 2021-04-30). Claim clm_03AB7E93D87D, https://asof.is/claim/clm_03AB7E93D87D, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/1613103/000161310321000009/0001613103-21-000009-index.htm.","url":"https://asof.is/claim/clm_03AB7E93D87D","accessed":"2026-11-10"},"kind":"money","predicate":"total_equity","value":"50,758,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_03AB7E93D87D","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:StockholdersEquity in 10-Q Q3 FY2021, filed 2021-03-05"}},{"date":"2021-01-29","until":"2021-04-30","published":"2021-03-05","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Medtronic plc cash and equivalents: 5,077,000,000 United States dollar\", as of 2021-01-29 (until 2021-04-30). Claim clm_0D06E25043F7, https://asof.is/claim/clm_0D06E25043F7, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/1613103/000161310321000009/0001613103-21-000009-index.htm.","url":"https://asof.is/claim/clm_0D06E25043F7","accessed":"2026-11-10"},"kind":"money","predicate":"cash_and_equivalents","value":"5,077,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_0D06E25043F7","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:CashAndCashEquivalentsAtCarryingValue in 10-Q Q3 FY2021, filed 2021-03-05"}},{"date":"2021-01-29","until":"2021-07-30","published":"2021-03-05","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Medtronic plc quarterly revenue: 7,775,000,000 United States dollar\", as of 2021-01-29 (until 2021-07-30). Claim clm_38D72F3B5EA6, https://asof.is/claim/clm_38D72F3B5EA6, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/1613103/000161310321000009/0001613103-21-000009-index.htm.","url":"https://asof.is/claim/clm_38D72F3B5EA6","accessed":"2026-11-10"},"kind":"money","predicate":"quarterly_revenue","value":"7,775,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_38D72F3B5EA6","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax in 10-Q Q3 FY2021, filed 2021-03-05"}},{"date":"2021-01-29","until":"2021-07-30","published":"2021-03-05","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Medtronic plc quarterly net income: 1,270,000,000 United States dollar\", as of 2021-01-29 (until 2021-07-30). Claim clm_44AC383E0F66, https://asof.is/claim/clm_44AC383E0F66, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/1613103/000161310321000009/0001613103-21-000009-index.htm.","url":"https://asof.is/claim/clm_44AC383E0F66","accessed":"2026-11-10"},"kind":"money","predicate":"quarterly_net_income","value":"1,270,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_44AC383E0F66","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:NetIncomeLoss in 10-Q Q3 FY2021, filed 2021-03-05"}},{"date":"2021-01-29","until":"2021-07-30","published":"2021-03-05","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Medtronic plc quarterly operating income: 1,277,000,000 United States dollar\", as of 2021-01-29 (until 2021-07-30). Claim clm_E500AE975EE6, https://asof.is/claim/clm_E500AE975EE6, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/1613103/000161310321000009/0001613103-21-000009-index.htm.","url":"https://asof.is/claim/clm_E500AE975EE6","accessed":"2026-11-10"},"kind":"money","predicate":"quarterly_operating_income","value":"1,277,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_E500AE975EE6","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:OperatingIncomeLoss in 10-Q Q3 FY2021, filed 2021-03-05"}},{"date":"2021-01-29","until":"2021-04-30","published":"2021-03-05","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Medtronic plc total assets: 97,270,000,000 United States dollar\", as of 2021-01-29 (until 2021-04-30). Claim clm_F0B071700C47, https://asof.is/claim/clm_F0B071700C47, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/1613103/000161310321000009/0001613103-21-000009-index.htm.","url":"https://asof.is/claim/clm_F0B071700C47","accessed":"2026-11-10"},"kind":"money","predicate":"total_assets","value":"97,270,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_F0B071700C47","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:Assets in 10-Q Q3 FY2021, filed 2021-03-05"}},{"date":"2021-03-03","until":"2021-06-23","published":"2021-03-05","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Medtronic plc shares outstanding: 1,348,072,847 shares\", as of 2021-03-03 (until 2021-06-23). Claim clm_B54273B3D0C4, https://asof.is/claim/clm_B54273B3D0C4, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/1613103/000161310321000009/0001613103-21-000009-index.htm.","url":"https://asof.is/claim/clm_B54273B3D0C4","accessed":"2026-11-10"},"kind":"money","predicate":"shares_outstanding","value":"1,348,072,847 shares","status":"superseded","assertable":true,"id":"clm_B54273B3D0C4","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"dei:EntityCommonStockSharesOutstanding in 10-Q Q3 FY2021, filed 2021-03-05"}},{"date":"2021-04-30","until":"2022-04-29","published":"2021-06-25","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Medtronic plc revenue: 30,117,000,000 United States dollar\", as of 2021-04-30 (until 2022-04-29). Claim clm_21F5424C6FF7, https://asof.is/claim/clm_21F5424C6FF7, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/1613103/000161310321000027/0001613103-21-000027-index.htm.","url":"https://asof.is/claim/clm_21F5424C6FF7","accessed":"2026-11-10"},"kind":"money","predicate":"revenue","value":"30,117,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_21F5424C6FF7","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax in 10-K FY2021, filed 2021-06-25"}},{"date":"2021-04-30","until":"2021-07-30","published":"2021-06-25","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Medtronic plc cash and equivalents: 3,593,000,000 United States dollar\", as of 2021-04-30 (until 2021-07-30). Claim clm_9C67FE84B8F8, https://asof.is/claim/clm_9C67FE84B8F8, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/1613103/000161310321000027/0001613103-21-000027-index.htm.","url":"https://asof.is/claim/clm_9C67FE84B8F8","accessed":"2026-11-10"},"kind":"money","predicate":"cash_and_equivalents","value":"3,593,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_9C67FE84B8F8","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:CashAndCashEquivalentsAtCarryingValue in 10-K FY2021, filed 2021-06-25"}},{"date":"2021-04-30","until":"2021-07-30","published":"2021-06-25","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Medtronic plc total assets: 93,083,000,000 United States dollar\", as of 2021-04-30 (until 2021-07-30). Claim clm_AA80913D2DAA, https://asof.is/claim/clm_AA80913D2DAA, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/1613103/000161310321000027/0001613103-21-000027-index.htm.","url":"https://asof.is/claim/clm_AA80913D2DAA","accessed":"2026-11-10"},"kind":"money","predicate":"total_assets","value":"93,083,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_AA80913D2DAA","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:Assets in 10-K FY2021, filed 2021-06-25"}},{"date":"2021-04-30","until":"2022-04-29","published":"2021-06-25","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Medtronic plc net income: 3,606,000,000 United States dollar\", as of 2021-04-30 (until 2022-04-29). Claim clm_CCCAA272438C, https://asof.is/claim/clm_CCCAA272438C, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/1613103/000161310321000027/0001613103-21-000027-index.htm.","url":"https://asof.is/claim/clm_CCCAA272438C","accessed":"2026-11-10"},"kind":"money","predicate":"net_income","value":"3,606,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_CCCAA272438C","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:NetIncomeLoss in 10-K FY2021, filed 2021-06-25"}},{"date":"2021-04-30","until":"2021-07-30","published":"2021-06-25","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Medtronic plc total equity: 51,428,000,000 United States dollar\", as of 2021-04-30 (until 2021-07-30). Claim clm_D4B8B943B869, https://asof.is/claim/clm_D4B8B943B869, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/1613103/000161310321000027/0001613103-21-000027-index.htm.","url":"https://asof.is/claim/clm_D4B8B943B869","accessed":"2026-11-10"},"kind":"money","predicate":"total_equity","value":"51,428,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_D4B8B943B869","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:StockholdersEquity in 10-K FY2021, filed 2021-06-25"}},{"date":"2021-04-30","until":"2022-04-29","published":"2021-06-25","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Medtronic plc operating income: 4,484,000,000 United States dollar\", as of 2021-04-30 (until 2022-04-29). Claim clm_ED09BC393B75, https://asof.is/claim/clm_ED09BC393B75, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/1613103/000161310321000027/0001613103-21-000027-index.htm.","url":"https://asof.is/claim/clm_ED09BC393B75","accessed":"2026-11-10"},"kind":"money","predicate":"operating_income","value":"4,484,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_ED09BC393B75","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:OperatingIncomeLoss in 10-K FY2021, filed 2021-06-25"}},{"date":"2021-06-23","until":"2021-08-31","published":"2021-06-25","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Medtronic plc shares outstanding: 1,343,904,180 shares\", as of 2021-06-23 (until 2021-08-31). Claim clm_90B6B6323F33, https://asof.is/claim/clm_90B6B6323F33, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/1613103/000161310321000027/0001613103-21-000027-index.htm.","url":"https://asof.is/claim/clm_90B6B6323F33","accessed":"2026-11-10"},"kind":"money","predicate":"shares_outstanding","value":"1,343,904,180 shares","status":"superseded","assertable":true,"id":"clm_90B6B6323F33","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"dei:EntityCommonStockSharesOutstanding in 10-K FY2021, filed 2021-06-25"}},{"date":"2021-07-30","until":"2021-10-29","published":"2021-09-02","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Medtronic plc total assets: 91,802,000,000 United States dollar\", as of 2021-07-30 (until 2021-10-29). Claim clm_0751291776A2, https://asof.is/claim/clm_0751291776A2, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/1613103/000161310321000042/0001613103-21-000042-index.htm.","url":"https://asof.is/claim/clm_0751291776A2","accessed":"2026-11-10"},"kind":"money","predicate":"total_assets","value":"91,802,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_0751291776A2","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:Assets in 10-Q Q1 FY2022, filed 2021-09-02"}},{"date":"2021-07-30","until":"2021-10-29","published":"2021-09-02","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Medtronic plc total equity: 51,486,000,000 United States dollar\", as of 2021-07-30 (until 2021-10-29). Claim clm_0B560A208E2D, https://asof.is/claim/clm_0B560A208E2D, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/1613103/000161310321000042/0001613103-21-000042-index.htm.","url":"https://asof.is/claim/clm_0B560A208E2D","accessed":"2026-11-10"},"kind":"money","predicate":"total_equity","value":"51,486,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_0B560A208E2D","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:StockholdersEquity in 10-Q Q1 FY2022, filed 2021-09-02"}},{"date":"2021-07-30","until":"2021-10-29","published":"2021-09-02","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Medtronic plc quarterly operating income: 859,000,000 United States dollar\", as of 2021-07-30 (until 2021-10-29). Claim clm_4341937231AF, https://asof.is/claim/clm_4341937231AF, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/1613103/000161310321000042/0001613103-21-000042-index.htm.","url":"https://asof.is/claim/clm_4341937231AF","accessed":"2026-11-10"},"kind":"money","predicate":"quarterly_operating_income","value":"859,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_4341937231AF","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:OperatingIncomeLoss in 10-Q Q1 FY2022, filed 2021-09-02"}},{"date":"2021-07-30","until":"2021-10-29","published":"2021-09-02","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Medtronic plc quarterly net income: 763,000,000 United States dollar\", as of 2021-07-30 (until 2021-10-29). Claim clm_ACA68B2970C3, https://asof.is/claim/clm_ACA68B2970C3, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/1613103/000161310321000042/0001613103-21-000042-index.htm.","url":"https://asof.is/claim/clm_ACA68B2970C3","accessed":"2026-11-10"},"kind":"money","predicate":"quarterly_net_income","value":"763,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_ACA68B2970C3","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:NetIncomeLoss in 10-Q Q1 FY2022, filed 2021-09-02"}},{"date":"2021-07-30","until":"2021-10-29","published":"2021-09-02","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Medtronic plc cash and equivalents: 3,004,000,000 United States dollar\", as of 2021-07-30 (until 2021-10-29). Claim clm_ACE13439B12D, https://asof.is/claim/clm_ACE13439B12D, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/1613103/000161310321000042/0001613103-21-000042-index.htm.","url":"https://asof.is/claim/clm_ACE13439B12D","accessed":"2026-11-10"},"kind":"money","predicate":"cash_and_equivalents","value":"3,004,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_ACE13439B12D","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:CashAndCashEquivalentsAtCarryingValue in 10-Q Q1 FY2022, filed 2021-09-02"}},{"date":"2021-07-30","until":"2021-10-29","published":"2021-09-02","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Medtronic plc quarterly revenue: 7,987,000,000 United States dollar\", as of 2021-07-30 (until 2021-10-29). Claim clm_B8688FDDE21E, https://asof.is/claim/clm_B8688FDDE21E, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/1613103/000161310321000042/0001613103-21-000042-index.htm.","url":"https://asof.is/claim/clm_B8688FDDE21E","accessed":"2026-11-10"},"kind":"money","predicate":"quarterly_revenue","value":"7,987,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_B8688FDDE21E","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax in 10-Q Q1 FY2022, filed 2021-09-02"}},{"date":"2021-08-31","until":"2021-11-30","published":"2021-09-02","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Medtronic plc shares outstanding: 1,345,809,975 shares\", as of 2021-08-31 (until 2021-11-30). Claim clm_82E3523793B9, https://asof.is/claim/clm_82E3523793B9, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/1613103/000161310321000042/0001613103-21-000042-index.htm.","url":"https://asof.is/claim/clm_82E3523793B9","accessed":"2026-11-10"},"kind":"money","predicate":"shares_outstanding","value":"1,345,809,975 shares","status":"superseded","assertable":true,"id":"clm_82E3523793B9","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"dei:EntityCommonStockSharesOutstanding in 10-Q Q1 FY2022, filed 2021-09-02"}},{"date":"2021-10-29","until":"2022-01-28","published":"2021-12-02","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Medtronic plc quarterly revenue: 7,847,000,000 United States dollar\", as of 2021-10-29 (until 2022-01-28). Claim clm_084EC07CD31E, https://asof.is/claim/clm_084EC07CD31E, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/1613103/000161310321000062/0001613103-21-000062-index.htm.","url":"https://asof.is/claim/clm_084EC07CD31E","accessed":"2026-11-10"},"kind":"money","predicate":"quarterly_revenue","value":"7,847,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_084EC07CD31E","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax in 10-Q Q2 FY2022, filed 2021-12-02"}},{"date":"2021-10-29","until":"2022-01-28","published":"2021-12-02","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Medtronic plc quarterly net income: 1,311,000,000 United States dollar\", as of 2021-10-29 (until 2022-01-28). Claim clm_16560E6520F1, https://asof.is/claim/clm_16560E6520F1, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/1613103/000161310321000062/0001613103-21-000062-index.htm.","url":"https://asof.is/claim/clm_16560E6520F1","accessed":"2026-11-10"},"kind":"money","predicate":"quarterly_net_income","value":"1,311,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_16560E6520F1","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:NetIncomeLoss in 10-Q Q2 FY2022, filed 2021-12-02"}},{"date":"2021-10-29","until":"2022-01-28","published":"2021-12-02","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Medtronic plc total equity: 51,991,000,000 United States dollar\", as of 2021-10-29 (until 2022-01-28). Claim clm_4CE22B5BFD44, https://asof.is/claim/clm_4CE22B5BFD44, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/1613103/000161310321000062/0001613103-21-000062-index.htm.","url":"https://asof.is/claim/clm_4CE22B5BFD44","accessed":"2026-11-10"},"kind":"money","predicate":"total_equity","value":"51,991,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_4CE22B5BFD44","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:StockholdersEquity in 10-Q Q2 FY2022, filed 2021-12-02"}},{"date":"2021-10-29","until":"2022-01-28","published":"2021-12-02","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Medtronic plc quarterly operating income: 1,563,000,000 United States dollar\", as of 2021-10-29 (until 2022-01-28). Claim clm_57424C88BD39, https://asof.is/claim/clm_57424C88BD39, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/1613103/000161310321000062/0001613103-21-000062-index.htm.","url":"https://asof.is/claim/clm_57424C88BD39","accessed":"2026-11-10"},"kind":"money","predicate":"quarterly_operating_income","value":"1,563,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_57424C88BD39","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:OperatingIncomeLoss in 10-Q Q2 FY2022, filed 2021-12-02"}},{"date":"2021-10-29","until":"2022-01-28","published":"2021-12-02","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Medtronic plc total assets: 91,756,000,000 United States dollar\", as of 2021-10-29 (until 2022-01-28). Claim clm_66FCE253BCC7, https://asof.is/claim/clm_66FCE253BCC7, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/1613103/000161310321000062/0001613103-21-000062-index.htm.","url":"https://asof.is/claim/clm_66FCE253BCC7","accessed":"2026-11-10"},"kind":"money","predicate":"total_assets","value":"91,756,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_66FCE253BCC7","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:Assets in 10-Q Q2 FY2022, filed 2021-12-02"}},{"date":"2021-10-29","until":"2022-01-28","published":"2021-12-02","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Medtronic plc cash and equivalents: 2,900,000,000 United States dollar\", as of 2021-10-29 (until 2022-01-28). Claim clm_B445A3C2B567, https://asof.is/claim/clm_B445A3C2B567, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/1613103/000161310321000062/0001613103-21-000062-index.htm.","url":"https://asof.is/claim/clm_B445A3C2B567","accessed":"2026-11-10"},"kind":"money","predicate":"cash_and_equivalents","value":"2,900,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_B445A3C2B567","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:CashAndCashEquivalentsAtCarryingValue in 10-Q Q2 FY2022, filed 2021-12-02"}},{"date":"2021-11-30","until":"2022-03-01","published":"2021-12-02","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Medtronic plc shares outstanding: 1,344,557,784 shares\", as of 2021-11-30 (until 2022-03-01). Claim clm_64EFE67007EA, https://asof.is/claim/clm_64EFE67007EA, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/1613103/000161310321000062/0001613103-21-000062-index.htm.","url":"https://asof.is/claim/clm_64EFE67007EA","accessed":"2026-11-10"},"kind":"money","predicate":"shares_outstanding","value":"1,344,557,784 shares","status":"superseded","assertable":true,"id":"clm_64EFE67007EA","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"dei:EntityCommonStockSharesOutstanding in 10-Q Q2 FY2022, filed 2021-12-02"}},{"date":"2022-01-28","until":"2022-04-29","published":"2022-03-03","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Medtronic plc total equity: 52,542,000,000 United States dollar\", as of 2022-01-28 (until 2022-04-29). Claim clm_0066321BEAA2, https://asof.is/claim/clm_0066321BEAA2, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/1613103/000161310322000011/0001613103-22-000011-index.htm.","url":"https://asof.is/claim/clm_0066321BEAA2","accessed":"2026-11-10"},"kind":"money","predicate":"total_equity","value":"52,542,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_0066321BEAA2","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:StockholdersEquity in 10-Q Q3 FY2022, filed 2022-03-03"}},{"date":"2022-01-28","until":"2022-07-29","published":"2022-03-03","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Medtronic plc quarterly revenue: 7,763,000,000 United States dollar\", as of 2022-01-28 (until 2022-07-29). Claim clm_1800FF129C25, https://asof.is/claim/clm_1800FF129C25, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/1613103/000161310322000011/0001613103-22-000011-index.htm.","url":"https://asof.is/claim/clm_1800FF129C25","accessed":"2026-11-10"},"kind":"money","predicate":"quarterly_revenue","value":"7,763,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_1800FF129C25","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax in 10-Q Q3 FY2022, filed 2022-03-03"}},{"date":"2022-01-28","until":"2022-07-29","published":"2022-03-03","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Medtronic plc quarterly net income: 1,480,000,000 United States dollar\", as of 2022-01-28 (until 2022-07-29). Claim clm_449010394AB6, https://asof.is/claim/clm_449010394AB6, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/1613103/000161310322000011/0001613103-22-000011-index.htm.","url":"https://asof.is/claim/clm_449010394AB6","accessed":"2026-11-10"},"kind":"money","predicate":"quarterly_net_income","value":"1,480,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_449010394AB6","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:NetIncomeLoss in 10-Q Q3 FY2022, filed 2022-03-03"}},{"date":"2022-01-28","until":"2022-04-29","published":"2022-03-03","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Medtronic plc total assets: 91,804,000,000 United States dollar\", as of 2022-01-28 (until 2022-04-29). Claim clm_61E60749CAE9, https://asof.is/claim/clm_61E60749CAE9, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/1613103/000161310322000011/0001613103-22-000011-index.htm.","url":"https://asof.is/claim/clm_61E60749CAE9","accessed":"2026-11-10"},"kind":"money","predicate":"total_assets","value":"91,804,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_61E60749CAE9","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:Assets in 10-Q Q3 FY2022, filed 2022-03-03"}},{"date":"2022-01-28","until":"2022-04-29","published":"2022-03-03","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Medtronic plc cash and equivalents: 3,479,000,000 United States dollar\", as of 2022-01-28 (until 2022-04-29). Claim clm_7873CBD8572E, https://asof.is/claim/clm_7873CBD8572E, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/1613103/000161310322000011/0001613103-22-000011-index.htm.","url":"https://asof.is/claim/clm_7873CBD8572E","accessed":"2026-11-10"},"kind":"money","predicate":"cash_and_equivalents","value":"3,479,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_7873CBD8572E","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:CashAndCashEquivalentsAtCarryingValue in 10-Q Q3 FY2022, filed 2022-03-03"}},{"date":"2022-01-28","until":"2022-07-29","published":"2022-03-03","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Medtronic plc quarterly operating income: 1,659,000,000 United States dollar\", as of 2022-01-28 (until 2022-07-29). Claim clm_9CBE4B5CE8EE, https://asof.is/claim/clm_9CBE4B5CE8EE, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/1613103/000161310322000011/0001613103-22-000011-index.htm.","url":"https://asof.is/claim/clm_9CBE4B5CE8EE","accessed":"2026-11-10"},"kind":"money","predicate":"quarterly_operating_income","value":"1,659,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_9CBE4B5CE8EE","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:OperatingIncomeLoss in 10-Q Q3 FY2022, filed 2022-03-03"}},{"date":"2022-03-01","until":"2022-06-20","published":"2022-03-03","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Medtronic plc shares outstanding: 1,341,539,178 shares\", as of 2022-03-01 (until 2022-06-20). Claim clm_463D688AE5CD, https://asof.is/claim/clm_463D688AE5CD, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/1613103/000161310322000011/0001613103-22-000011-index.htm.","url":"https://asof.is/claim/clm_463D688AE5CD","accessed":"2026-11-10"},"kind":"money","predicate":"shares_outstanding","value":"1,341,539,178 shares","status":"superseded","assertable":true,"id":"clm_463D688AE5CD","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"dei:EntityCommonStockSharesOutstanding in 10-Q Q3 FY2022, filed 2022-03-03"}},{"date":"2022-04-29","until":"2023-04-28","published":"2022-06-23","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Medtronic plc revenue: 31,686,000,000 United States dollar\", as of 2022-04-29 (until 2023-04-28). Claim clm_43D2691A3614, https://asof.is/claim/clm_43D2691A3614, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/1613103/000161310322000023/0001613103-22-000023-index.htm.","url":"https://asof.is/claim/clm_43D2691A3614","accessed":"2026-11-10"},"kind":"money","predicate":"revenue","value":"31,686,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_43D2691A3614","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax in 10-K FY2022, filed 2022-06-23"}},{"date":"2022-04-29","until":"2022-07-29","published":"2022-06-23","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Medtronic plc cash and equivalents: 3,714,000,000 United States dollar\", as of 2022-04-29 (until 2022-07-29). Claim clm_694E6E2BE37F, https://asof.is/claim/clm_694E6E2BE37F, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/1613103/000161310322000023/0001613103-22-000023-index.htm.","url":"https://asof.is/claim/clm_694E6E2BE37F","accessed":"2026-11-10"},"kind":"money","predicate":"cash_and_equivalents","value":"3,714,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_694E6E2BE37F","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:CashAndCashEquivalentsAtCarryingValue in 10-K FY2022, filed 2022-06-23"}},{"date":"2022-04-29","until":"2023-04-28","published":"2022-06-23","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Medtronic plc operating income: 5,752,000,000 United States dollar\", as of 2022-04-29 (until 2023-04-28). Claim clm_810EE4D11948, https://asof.is/claim/clm_810EE4D11948, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/1613103/000161310322000023/0001613103-22-000023-index.htm.","url":"https://asof.is/claim/clm_810EE4D11948","accessed":"2026-11-10"},"kind":"money","predicate":"operating_income","value":"5,752,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_810EE4D11948","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:OperatingIncomeLoss in 10-K FY2022, filed 2022-06-23"}},{"date":"2022-04-29","until":"2023-04-28","published":"2022-06-23","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Medtronic plc net income: 5,039,000,000 United States dollar\", as of 2022-04-29 (until 2023-04-28). Claim clm_8F034BEA8363, https://asof.is/claim/clm_8F034BEA8363, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/1613103/000161310322000023/0001613103-22-000023-index.htm.","url":"https://asof.is/claim/clm_8F034BEA8363","accessed":"2026-11-10"},"kind":"money","predicate":"net_income","value":"5,039,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_8F034BEA8363","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:NetIncomeLoss in 10-K FY2022, filed 2022-06-23"}},{"date":"2022-04-29","until":"2022-07-29","published":"2022-06-23","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Medtronic plc total equity: 52,551,000,000 United States dollar\", as of 2022-04-29 (until 2022-07-29). Claim clm_9F194A99A41C, https://asof.is/claim/clm_9F194A99A41C, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/1613103/000161310322000023/0001613103-22-000023-index.htm.","url":"https://asof.is/claim/clm_9F194A99A41C","accessed":"2026-11-10"},"kind":"money","predicate":"total_equity","value":"52,551,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_9F194A99A41C","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:StockholdersEquity in 10-K FY2022, filed 2022-06-23"}},{"date":"2022-04-29","until":"2022-07-29","published":"2022-06-23","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Medtronic plc total assets: 90,981,000,000 United States dollar\", as of 2022-04-29 (until 2022-07-29). Claim clm_FC280FE9F1F9, https://asof.is/claim/clm_FC280FE9F1F9, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/1613103/000161310322000023/0001613103-22-000023-index.htm.","url":"https://asof.is/claim/clm_FC280FE9F1F9","accessed":"2026-11-10"},"kind":"money","predicate":"total_assets","value":"90,981,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_FC280FE9F1F9","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:Assets in 10-K FY2022, filed 2022-06-23"}},{"date":"2022-06-20","until":"2022-08-29","published":"2022-06-23","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Medtronic plc shares outstanding: 1,328,709,310 shares\", as of 2022-06-20 (until 2022-08-29). Claim clm_B630217AE90C, https://asof.is/claim/clm_B630217AE90C, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/1613103/000161310322000023/0001613103-22-000023-index.htm.","url":"https://asof.is/claim/clm_B630217AE90C","accessed":"2026-11-10"},"kind":"money","predicate":"shares_outstanding","value":"1,328,709,310 shares","status":"superseded","assertable":true,"id":"clm_B630217AE90C","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"dei:EntityCommonStockSharesOutstanding in 10-K FY2022, filed 2022-06-23"}},{"date":"2022-07-29","until":"2022-10-28","published":"2022-09-01","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Medtronic plc total assets: 89,914,000,000 United States dollar\", as of 2022-07-29 (until 2022-10-28). Claim clm_0EB9275AF24B, https://asof.is/claim/clm_0EB9275AF24B, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/1613103/000161310322000046/0001613103-22-000046-index.htm.","url":"https://asof.is/claim/clm_0EB9275AF24B","accessed":"2026-11-10"},"kind":"money","predicate":"total_assets","value":"89,914,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_0EB9275AF24B","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:Assets in 10-Q Q1 FY2023, filed 2022-09-01"}},{"date":"2022-07-29","until":"2022-10-28","published":"2022-09-01","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Medtronic plc quarterly operating income: 1,125,000,000 United States dollar\", as of 2022-07-29 (until 2022-10-28). Claim clm_2EEA422F485E, https://asof.is/claim/clm_2EEA422F485E, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/1613103/000161310322000046/0001613103-22-000046-index.htm.","url":"https://asof.is/claim/clm_2EEA422F485E","accessed":"2026-11-10"},"kind":"money","predicate":"quarterly_operating_income","value":"1,125,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_2EEA422F485E","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:OperatingIncomeLoss in 10-Q Q1 FY2023, filed 2022-09-01"}},{"date":"2022-07-29","until":"2022-10-28","published":"2022-09-01","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Medtronic plc quarterly net income: 929,000,000 United States dollar\", as of 2022-07-29 (until 2022-10-28). Claim clm_3DDF91D057BF, https://asof.is/claim/clm_3DDF91D057BF, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/1613103/000161310322000046/0001613103-22-000046-index.htm.","url":"https://asof.is/claim/clm_3DDF91D057BF","accessed":"2026-11-10"},"kind":"money","predicate":"quarterly_net_income","value":"929,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_3DDF91D057BF","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:NetIncomeLoss in 10-Q Q1 FY2023, filed 2022-09-01"}},{"date":"2022-07-29","until":"2022-10-28","published":"2022-09-01","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Medtronic plc quarterly revenue: 7,371,000,000 United States dollar\", as of 2022-07-29 (until 2022-10-28). Claim clm_9A95F4D87E7E, https://asof.is/claim/clm_9A95F4D87E7E, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/1613103/000161310322000046/0001613103-22-000046-index.htm.","url":"https://asof.is/claim/clm_9A95F4D87E7E","accessed":"2026-11-10"},"kind":"money","predicate":"quarterly_revenue","value":"7,371,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_9A95F4D87E7E","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax in 10-Q Q1 FY2023, filed 2022-09-01"}},{"date":"2022-07-29","until":"2022-10-28","published":"2022-09-01","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Medtronic plc cash and equivalents: 2,140,000,000 United States dollar\", as of 2022-07-29 (until 2022-10-28). Claim clm_9B46D6B85D39, https://asof.is/claim/clm_9B46D6B85D39, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/1613103/000161310322000046/0001613103-22-000046-index.htm.","url":"https://asof.is/claim/clm_9B46D6B85D39","accessed":"2026-11-10"},"kind":"money","predicate":"cash_and_equivalents","value":"2,140,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_9B46D6B85D39","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:CashAndCashEquivalentsAtCarryingValue in 10-Q Q1 FY2023, filed 2022-09-01"}},{"date":"2022-07-29","until":"2022-10-28","published":"2022-09-01","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Medtronic plc total equity: 52,672,000,000 United States dollar\", as of 2022-07-29 (until 2022-10-28). Claim clm_DD40A12043A7, https://asof.is/claim/clm_DD40A12043A7, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/1613103/000161310322000046/0001613103-22-000046-index.htm.","url":"https://asof.is/claim/clm_DD40A12043A7","accessed":"2026-11-10"},"kind":"money","predicate":"total_equity","value":"52,672,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_DD40A12043A7","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:StockholdersEquity in 10-Q Q1 FY2023, filed 2022-09-01"}},{"date":"2022-08-29","until":"2022-11-28","published":"2022-09-01","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Medtronic plc shares outstanding: 1,329,153,289 shares\", as of 2022-08-29 (until 2022-11-28). Claim clm_2CAEB4A02916, https://asof.is/claim/clm_2CAEB4A02916, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/1613103/000161310322000046/0001613103-22-000046-index.htm.","url":"https://asof.is/claim/clm_2CAEB4A02916","accessed":"2026-11-10"},"kind":"money","predicate":"shares_outstanding","value":"1,329,153,289 shares","status":"superseded","assertable":true,"id":"clm_2CAEB4A02916","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"dei:EntityCommonStockSharesOutstanding in 10-Q Q1 FY2023, filed 2022-09-01"}},{"date":"2022-10-28","until":"2023-01-27","published":"2022-12-01","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Medtronic plc total equity: 51,880,000,000 United States dollar\", as of 2022-10-28 (until 2023-01-27). Claim clm_1279FA519D7B, https://asof.is/claim/clm_1279FA519D7B, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/1613103/000161310322000063/0001613103-22-000063-index.htm.","url":"https://asof.is/claim/clm_1279FA519D7B","accessed":"2026-11-10"},"kind":"money","predicate":"total_equity","value":"51,880,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_1279FA519D7B","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:StockholdersEquity in 10-Q Q2 FY2023, filed 2022-12-01"}},{"date":"2022-10-28","until":"2023-01-27","published":"2022-12-01","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Medtronic plc quarterly operating income: 1,404,000,000 United States dollar\", as of 2022-10-28 (until 2023-01-27). Claim clm_3C00CAE57B29, https://asof.is/claim/clm_3C00CAE57B29, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/1613103/000161310322000063/0001613103-22-000063-index.htm.","url":"https://asof.is/claim/clm_3C00CAE57B29","accessed":"2026-11-10"},"kind":"money","predicate":"quarterly_operating_income","value":"1,404,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_3C00CAE57B29","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:OperatingIncomeLoss in 10-Q Q2 FY2023, filed 2022-12-01"}},{"date":"2022-10-28","until":"2023-01-27","published":"2022-12-01","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Medtronic plc quarterly revenue: 7,585,000,000 United States dollar\", as of 2022-10-28 (until 2023-01-27). Claim clm_4ED13BF01446, https://asof.is/claim/clm_4ED13BF01446, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/1613103/000161310322000063/0001613103-22-000063-index.htm.","url":"https://asof.is/claim/clm_4ED13BF01446","accessed":"2026-11-10"},"kind":"money","predicate":"quarterly_revenue","value":"7,585,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_4ED13BF01446","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax in 10-Q Q2 FY2023, filed 2022-12-01"}},{"date":"2022-10-28","until":"2023-01-27","published":"2022-12-01","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Medtronic plc total assets: 93,241,000,000 United States dollar\", as of 2022-10-28 (until 2023-01-27). Claim clm_5B9B829E7019, https://asof.is/claim/clm_5B9B829E7019, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/1613103/000161310322000063/0001613103-22-000063-index.htm.","url":"https://asof.is/claim/clm_5B9B829E7019","accessed":"2026-11-10"},"kind":"money","predicate":"total_assets","value":"93,241,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_5B9B829E7019","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:Assets in 10-Q Q2 FY2023, filed 2022-12-01"}},{"date":"2022-10-28","until":"2023-01-27","published":"2022-12-01","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Medtronic plc quarterly net income: 427,000,000 United States dollar\", as of 2022-10-28 (until 2023-01-27). Claim clm_B6FEA1E7091A, https://asof.is/claim/clm_B6FEA1E7091A, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/1613103/000161310322000063/0001613103-22-000063-index.htm.","url":"https://asof.is/claim/clm_B6FEA1E7091A","accessed":"2026-11-10"},"kind":"money","predicate":"quarterly_net_income","value":"427,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_B6FEA1E7091A","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:NetIncomeLoss in 10-Q Q2 FY2023, filed 2022-12-01"}},{"date":"2022-10-28","until":"2023-01-27","published":"2022-12-01","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Medtronic plc cash and equivalents: 4,828,000,000 United States dollar\", as of 2022-10-28 (until 2023-01-27). Claim clm_E3E18401576F, https://asof.is/claim/clm_E3E18401576F, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/1613103/000161310322000063/0001613103-22-000063-index.htm.","url":"https://asof.is/claim/clm_E3E18401576F","accessed":"2026-11-10"},"kind":"money","predicate":"cash_and_equivalents","value":"4,828,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_E3E18401576F","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:CashAndCashEquivalentsAtCarryingValue in 10-Q Q2 FY2023, filed 2022-12-01"}},{"date":"2022-11-28","until":"2023-02-27","published":"2022-12-01","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Medtronic plc shares outstanding: 1,330,179,978 shares\", as of 2022-11-28 (until 2023-02-27). Claim clm_F47F14CDCCC3, https://asof.is/claim/clm_F47F14CDCCC3, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/1613103/000161310322000063/0001613103-22-000063-index.htm.","url":"https://asof.is/claim/clm_F47F14CDCCC3","accessed":"2026-11-10"},"kind":"money","predicate":"shares_outstanding","value":"1,330,179,978 shares","status":"superseded","assertable":true,"id":"clm_F47F14CDCCC3","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"dei:EntityCommonStockSharesOutstanding in 10-Q Q2 FY2023, filed 2022-12-01"}},{"date":"2023-01-27","until":"2023-07-28","published":"2023-03-01","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Medtronic plc quarterly net income: 1,222,000,000 United States dollar\", as of 2023-01-27 (until 2023-07-28). Claim clm_1C24082D315D, https://asof.is/claim/clm_1C24082D315D, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/1613103/000161310323000008/0001613103-23-000008-index.htm.","url":"https://asof.is/claim/clm_1C24082D315D","accessed":"2026-11-10"},"kind":"money","predicate":"quarterly_net_income","value":"1,222,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_1C24082D315D","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:NetIncomeLoss in 10-Q Q3 FY2023, filed 2023-03-01"}},{"date":"2023-01-27","until":"2023-07-28","published":"2023-03-01","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Medtronic plc quarterly revenue: 7,727,000,000 United States dollar\", as of 2023-01-27 (until 2023-07-28). Claim clm_6E25782CF337, https://asof.is/claim/clm_6E25782CF337, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/1613103/000161310323000008/0001613103-23-000008-index.htm.","url":"https://asof.is/claim/clm_6E25782CF337","accessed":"2026-11-10"},"kind":"money","predicate":"quarterly_revenue","value":"7,727,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_6E25782CF337","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax in 10-Q Q3 FY2023, filed 2023-03-01"}},{"date":"2023-01-27","until":"2023-04-28","published":"2023-03-01","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Medtronic plc cash and equivalents: 4,521,000,000 United States dollar\", as of 2023-01-27 (until 2023-04-28). Claim clm_766C3665AD97, https://asof.is/claim/clm_766C3665AD97, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/1613103/000161310323000008/0001613103-23-000008-index.htm.","url":"https://asof.is/claim/clm_766C3665AD97","accessed":"2026-11-10"},"kind":"money","predicate":"cash_and_equivalents","value":"4,521,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_766C3665AD97","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:CashAndCashEquivalentsAtCarryingValue in 10-Q Q3 FY2023, filed 2023-03-01"}},{"date":"2023-01-27","until":"2023-07-28","published":"2023-03-01","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Medtronic plc quarterly operating income: 1,392,000,000 United States dollar\", as of 2023-01-27 (until 2023-07-28). Claim clm_BD5B3AFA2F2E, https://asof.is/claim/clm_BD5B3AFA2F2E, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/1613103/000161310323000008/0001613103-23-000008-index.htm.","url":"https://asof.is/claim/clm_BD5B3AFA2F2E","accessed":"2026-11-10"},"kind":"money","predicate":"quarterly_operating_income","value":"1,392,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_BD5B3AFA2F2E","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:OperatingIncomeLoss in 10-Q Q3 FY2023, filed 2023-03-01"}},{"date":"2023-01-27","until":"2023-04-28","published":"2023-03-01","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Medtronic plc total assets: 94,134,000,000 United States dollar\", as of 2023-01-27 (until 2023-04-28). Claim clm_DD2BDC126321, https://asof.is/claim/clm_DD2BDC126321, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/1613103/000161310323000008/0001613103-23-000008-index.htm.","url":"https://asof.is/claim/clm_DD2BDC126321","accessed":"2026-11-10"},"kind":"money","predicate":"total_assets","value":"94,134,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_DD2BDC126321","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:Assets in 10-Q Q3 FY2023, filed 2023-03-01"}},{"date":"2023-01-27","until":"2023-04-28","published":"2023-03-01","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Medtronic plc total equity: 51,441,000,000 United States dollar\", as of 2023-01-27 (until 2023-04-28). Claim clm_EE889E63DD40, https://asof.is/claim/clm_EE889E63DD40, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/1613103/000161310323000008/0001613103-23-000008-index.htm.","url":"https://asof.is/claim/clm_EE889E63DD40","accessed":"2026-11-10"},"kind":"money","predicate":"total_equity","value":"51,441,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_EE889E63DD40","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:StockholdersEquity in 10-Q Q3 FY2023, filed 2023-03-01"}},{"date":"2023-02-27","until":"2023-06-16","published":"2023-03-01","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Medtronic plc shares outstanding: 1,330,423,708 shares\", as of 2023-02-27 (until 2023-06-16). Claim clm_151766BAADC7, https://asof.is/claim/clm_151766BAADC7, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/1613103/000161310323000008/0001613103-23-000008-index.htm.","url":"https://asof.is/claim/clm_151766BAADC7","accessed":"2026-11-10"},"kind":"money","predicate":"shares_outstanding","value":"1,330,423,708 shares","status":"superseded","assertable":true,"id":"clm_151766BAADC7","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"dei:EntityCommonStockSharesOutstanding in 10-Q Q3 FY2023, filed 2023-03-01"}},{"date":"2023-04-28","until":"2024-04-26","published":"2023-06-22","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Medtronic plc net income: 3,758,000,000 United States dollar\", as of 2023-04-28 (until 2024-04-26). Claim clm_23B51D64A953, https://asof.is/claim/clm_23B51D64A953, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/1613103/000161310323000040/0001613103-23-000040-index.htm.","url":"https://asof.is/claim/clm_23B51D64A953","accessed":"2026-11-10"},"kind":"money","predicate":"net_income","value":"3,758,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_23B51D64A953","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:NetIncomeLoss in 10-K FY2023, filed 2023-06-22"}},{"date":"2023-04-28","until":"2023-07-28","published":"2023-06-22","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Medtronic plc total assets: 90,948,000,000 United States dollar\", as of 2023-04-28 (until 2023-07-28). Claim clm_8B42B813BE0A, https://asof.is/claim/clm_8B42B813BE0A, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/1613103/000161310323000040/0001613103-23-000040-index.htm.","url":"https://asof.is/claim/clm_8B42B813BE0A","accessed":"2026-11-10"},"kind":"money","predicate":"total_assets","value":"90,948,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_8B42B813BE0A","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:Assets in 10-K FY2023, filed 2023-06-22"}},{"date":"2023-04-28","until":"2024-04-26","published":"2023-06-22","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Medtronic plc operating income: 5,485,000,000 United States dollar\", as of 2023-04-28 (until 2024-04-26). Claim clm_95AC1EAE0F90, https://asof.is/claim/clm_95AC1EAE0F90, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/1613103/000161310323000040/0001613103-23-000040-index.htm.","url":"https://asof.is/claim/clm_95AC1EAE0F90","accessed":"2026-11-10"},"kind":"money","predicate":"operating_income","value":"5,485,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_95AC1EAE0F90","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:OperatingIncomeLoss in 10-K FY2023, filed 2023-06-22"}},{"date":"2023-04-28","until":"2023-07-28","published":"2023-06-22","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Medtronic plc total equity: 51,483,000,000 United States dollar\", as of 2023-04-28 (until 2023-07-28). Claim clm_B7A3916E07AD, https://asof.is/claim/clm_B7A3916E07AD, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/1613103/000161310323000040/0001613103-23-000040-index.htm.","url":"https://asof.is/claim/clm_B7A3916E07AD","accessed":"2026-11-10"},"kind":"money","predicate":"total_equity","value":"51,483,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_B7A3916E07AD","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:StockholdersEquity in 10-K FY2023, filed 2023-06-22"}},{"date":"2023-04-28","until":"2024-04-26","published":"2023-06-22","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Medtronic plc revenue: 31,227,000,000 United States dollar\", as of 2023-04-28 (until 2024-04-26). Claim clm_DA0C7A0FA0B8, https://asof.is/claim/clm_DA0C7A0FA0B8, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/1613103/000161310323000040/0001613103-23-000040-index.htm.","url":"https://asof.is/claim/clm_DA0C7A0FA0B8","accessed":"2026-11-10"},"kind":"money","predicate":"revenue","value":"31,227,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_DA0C7A0FA0B8","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax in 10-K FY2023, filed 2023-06-22"}},{"date":"2023-04-28","until":"2023-07-28","published":"2023-06-22","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Medtronic plc cash and equivalents: 1,543,000,000 United States dollar\", as of 2023-04-28 (until 2023-07-28). Claim clm_FB0842C0C0B2, https://asof.is/claim/clm_FB0842C0C0B2, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/1613103/000161310323000040/0001613103-23-000040-index.htm.","url":"https://asof.is/claim/clm_FB0842C0C0B2","accessed":"2026-11-10"},"kind":"money","predicate":"cash_and_equivalents","value":"1,543,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_FB0842C0C0B2","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:CashAndCashEquivalentsAtCarryingValue in 10-K FY2023, filed 2023-06-22"}},{"date":"2023-06-16","until":"2023-08-25","published":"2023-06-22","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Medtronic plc shares outstanding: 1,330,405,428 shares\", as of 2023-06-16 (until 2023-08-25). Claim clm_87D3A4BAB877, https://asof.is/claim/clm_87D3A4BAB877, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/1613103/000161310323000040/0001613103-23-000040-index.htm.","url":"https://asof.is/claim/clm_87D3A4BAB877","accessed":"2026-11-10"},"kind":"money","predicate":"shares_outstanding","value":"1,330,405,428 shares","status":"superseded","assertable":true,"id":"clm_87D3A4BAB877","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"dei:EntityCommonStockSharesOutstanding in 10-K FY2023, filed 2023-06-22"}},{"date":"2023-07-28","until":"2023-10-27","published":"2023-08-31","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Medtronic plc quarterly revenue: 7,702,000,000 United States dollar\", as of 2023-07-28 (until 2023-10-27). Claim clm_2BA3F1974C73, https://asof.is/claim/clm_2BA3F1974C73, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/1613103/000161310323000128/0001613103-23-000128-index.htm.","url":"https://asof.is/claim/clm_2BA3F1974C73","accessed":"2026-11-10"},"kind":"money","predicate":"quarterly_revenue","value":"7,702,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_2BA3F1974C73","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax in 10-Q Q1 FY2024, filed 2023-08-31"}},{"date":"2023-07-28","until":"2023-10-27","published":"2023-08-31","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Medtronic plc quarterly operating income: 1,268,000,000 United States dollar\", as of 2023-07-28 (until 2023-10-27). Claim clm_A31F28636071, https://asof.is/claim/clm_A31F28636071, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/1613103/000161310323000128/0001613103-23-000128-index.htm.","url":"https://asof.is/claim/clm_A31F28636071","accessed":"2026-11-10"},"kind":"money","predicate":"quarterly_operating_income","value":"1,268,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_A31F28636071","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:OperatingIncomeLoss in 10-Q Q1 FY2024, filed 2023-08-31"}},{"date":"2023-07-28","until":"2023-10-27","published":"2023-08-31","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Medtronic plc cash and equivalents: 1,339,000,000 United States dollar\", as of 2023-07-28 (until 2023-10-27). Claim clm_B931396F2157, https://asof.is/claim/clm_B931396F2157, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/1613103/000161310323000128/0001613103-23-000128-index.htm.","url":"https://asof.is/claim/clm_B931396F2157","accessed":"2026-11-10"},"kind":"money","predicate":"cash_and_equivalents","value":"1,339,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_B931396F2157","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:CashAndCashEquivalentsAtCarryingValue in 10-Q Q1 FY2024, filed 2023-08-31"}},{"date":"2023-07-28","until":"2023-10-27","published":"2023-08-31","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Medtronic plc total assets: 90,776,000,000 United States dollar\", as of 2023-07-28 (until 2023-10-27). Claim clm_C357DDC988BA, https://asof.is/claim/clm_C357DDC988BA, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/1613103/000161310323000128/0001613103-23-000128-index.htm.","url":"https://asof.is/claim/clm_C357DDC988BA","accessed":"2026-11-10"},"kind":"money","predicate":"total_assets","value":"90,776,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_C357DDC988BA","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:Assets in 10-Q Q1 FY2024, filed 2023-08-31"}},{"date":"2023-07-28","until":"2023-10-27","published":"2023-08-31","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Medtronic plc total equity: 51,178,000,000 United States dollar\", as of 2023-07-28 (until 2023-10-27). Claim clm_DADE47B7DD6C, https://asof.is/claim/clm_DADE47B7DD6C, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/1613103/000161310323000128/0001613103-23-000128-index.htm.","url":"https://asof.is/claim/clm_DADE47B7DD6C","accessed":"2026-11-10"},"kind":"money","predicate":"total_equity","value":"51,178,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_DADE47B7DD6C","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:StockholdersEquity in 10-Q Q1 FY2024, filed 2023-08-31"}},{"date":"2023-07-28","until":"2023-10-27","published":"2023-08-31","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Medtronic plc quarterly net income: 791,000,000 United States dollar\", as of 2023-07-28 (until 2023-10-27). Claim clm_E61E5B826FDE, https://asof.is/claim/clm_E61E5B826FDE, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/1613103/000161310323000128/0001613103-23-000128-index.htm.","url":"https://asof.is/claim/clm_E61E5B826FDE","accessed":"2026-11-10"},"kind":"money","predicate":"quarterly_net_income","value":"791,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_E61E5B826FDE","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:NetIncomeLoss in 10-Q Q1 FY2024, filed 2023-08-31"}},{"date":"2023-08-25","until":"2023-11-24","published":"2023-08-31","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Medtronic plc shares outstanding: 1,330,533,713 shares\", as of 2023-08-25 (until 2023-11-24). Claim clm_ABCDBF642530, https://asof.is/claim/clm_ABCDBF642530, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/1613103/000161310323000128/0001613103-23-000128-index.htm.","url":"https://asof.is/claim/clm_ABCDBF642530","accessed":"2026-11-10"},"kind":"money","predicate":"shares_outstanding","value":"1,330,533,713 shares","status":"superseded","assertable":true,"id":"clm_ABCDBF642530","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"dei:EntityCommonStockSharesOutstanding in 10-Q Q1 FY2024, filed 2023-08-31"}},{"date":"2023-10-27","until":"2024-01-26","published":"2023-11-30","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Medtronic plc cash and equivalents: 1,311,000,000 United States dollar\", as of 2023-10-27 (until 2024-01-26). Claim clm_1CBD207D0426, https://asof.is/claim/clm_1CBD207D0426, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/1613103/000161310323000149/0001613103-23-000149-index.htm.","url":"https://asof.is/claim/clm_1CBD207D0426","accessed":"2026-11-10"},"kind":"money","predicate":"cash_and_equivalents","value":"1,311,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_1CBD207D0426","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:CashAndCashEquivalentsAtCarryingValue in 10-Q Q2 FY2024, filed 2023-11-30"}},{"date":"2023-10-27","until":"2024-01-26","published":"2023-11-30","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Medtronic plc quarterly net income: 909,000,000 United States dollar\", as of 2023-10-27 (until 2024-01-26). Claim clm_42CF26AE1CBA, https://asof.is/claim/clm_42CF26AE1CBA, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/1613103/000161310323000149/0001613103-23-000149-index.htm.","url":"https://asof.is/claim/clm_42CF26AE1CBA","accessed":"2026-11-10"},"kind":"money","predicate":"quarterly_net_income","value":"909,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_42CF26AE1CBA","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:NetIncomeLoss in 10-Q Q2 FY2024, filed 2023-11-30"}},{"date":"2023-10-27","until":"2024-01-26","published":"2023-11-30","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Medtronic plc total assets: 90,087,000,000 United States dollar\", as of 2023-10-27 (until 2024-01-26). Claim clm_5961178F7EA2, https://asof.is/claim/clm_5961178F7EA2, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/1613103/000161310323000149/0001613103-23-000149-index.htm.","url":"https://asof.is/claim/clm_5961178F7EA2","accessed":"2026-11-10"},"kind":"money","predicate":"total_assets","value":"90,087,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_5961178F7EA2","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:Assets in 10-Q Q2 FY2024, filed 2023-11-30"}},{"date":"2023-10-27","until":"2024-01-26","published":"2023-11-30","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Medtronic plc quarterly operating income: 1,340,000,000 United States dollar\", as of 2023-10-27 (until 2024-01-26). Claim clm_63778B6299A3, https://asof.is/claim/clm_63778B6299A3, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/1613103/000161310323000149/0001613103-23-000149-index.htm.","url":"https://asof.is/claim/clm_63778B6299A3","accessed":"2026-11-10"},"kind":"money","predicate":"quarterly_operating_income","value":"1,340,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_63778B6299A3","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:OperatingIncomeLoss in 10-Q Q2 FY2024, filed 2023-11-30"}},{"date":"2023-10-27","until":"2024-01-26","published":"2023-11-30","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Medtronic plc total equity: 51,460,000,000 United States dollar\", as of 2023-10-27 (until 2024-01-26). Claim clm_84AE3E6E2ED1, https://asof.is/claim/clm_84AE3E6E2ED1, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/1613103/000161310323000149/0001613103-23-000149-index.htm.","url":"https://asof.is/claim/clm_84AE3E6E2ED1","accessed":"2026-11-10"},"kind":"money","predicate":"total_equity","value":"51,460,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_84AE3E6E2ED1","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:StockholdersEquity in 10-Q Q2 FY2024, filed 2023-11-30"}},{"date":"2023-10-27","until":"2024-01-26","published":"2023-11-30","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Medtronic plc quarterly revenue: 7,984,000,000 United States dollar\", as of 2023-10-27 (until 2024-01-26). Claim clm_9D652E2083D2, https://asof.is/claim/clm_9D652E2083D2, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/1613103/000161310323000149/0001613103-23-000149-index.htm.","url":"https://asof.is/claim/clm_9D652E2083D2","accessed":"2026-11-10"},"kind":"money","predicate":"quarterly_revenue","value":"7,984,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_9D652E2083D2","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax in 10-Q Q2 FY2024, filed 2023-11-30"}},{"date":"2023-11-24","until":"2024-02-21","published":"2023-11-30","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Medtronic plc shares outstanding: 1,329,654,311 shares\", as of 2023-11-24 (until 2024-02-21). Claim clm_335F7D1CEB89, https://asof.is/claim/clm_335F7D1CEB89, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/1613103/000161310323000149/0001613103-23-000149-index.htm.","url":"https://asof.is/claim/clm_335F7D1CEB89","accessed":"2026-11-10"},"kind":"money","predicate":"shares_outstanding","value":"1,329,654,311 shares","status":"superseded","assertable":true,"id":"clm_335F7D1CEB89","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"dei:EntityCommonStockSharesOutstanding in 10-Q Q2 FY2024, filed 2023-11-30"}},{"date":"2024-01-26","until":"2024-07-26","published":"2024-02-27","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Medtronic plc quarterly net income: 1,322,000,000 United States dollar\", as of 2024-01-26 (until 2024-07-26). Claim clm_07DDB710D198, https://asof.is/claim/clm_07DDB710D198, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/1613103/000161310324000011/0001613103-24-000011-index.htm.","url":"https://asof.is/claim/clm_07DDB710D198","accessed":"2026-11-10"},"kind":"money","predicate":"quarterly_net_income","value":"1,322,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_07DDB710D198","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:NetIncomeLoss in 10-Q Q3 FY2024, filed 2024-02-27"}},{"date":"2024-01-26","until":"2024-07-26","published":"2024-02-27","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Medtronic plc quarterly revenue: 8,089,000,000 United States dollar\", as of 2024-01-26 (until 2024-07-26). Claim clm_161694F7F265, https://asof.is/claim/clm_161694F7F265, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/1613103/000161310324000011/0001613103-24-000011-index.htm.","url":"https://asof.is/claim/clm_161694F7F265","accessed":"2026-11-10"},"kind":"money","predicate":"quarterly_revenue","value":"8,089,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_161694F7F265","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax in 10-Q Q3 FY2024, filed 2024-02-27"}},{"date":"2024-01-26","until":"2024-04-26","published":"2024-02-27","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Medtronic plc total equity: 51,792,000,000 United States dollar\", as of 2024-01-26 (until 2024-04-26). Claim clm_4B788EE97A6A, https://asof.is/claim/clm_4B788EE97A6A, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/1613103/000161310324000011/0001613103-24-000011-index.htm.","url":"https://asof.is/claim/clm_4B788EE97A6A","accessed":"2026-11-10"},"kind":"money","predicate":"total_equity","value":"51,792,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_4B788EE97A6A","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:StockholdersEquity in 10-Q Q3 FY2024, filed 2024-02-27"}},{"date":"2024-01-26","until":"2024-04-26","published":"2024-02-27","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Medtronic plc cash and equivalents: 1,623,000,000 United States dollar\", as of 2024-01-26 (until 2024-04-26). Claim clm_653A6EBCA64D, https://asof.is/claim/clm_653A6EBCA64D, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/1613103/000161310324000011/0001613103-24-000011-index.htm.","url":"https://asof.is/claim/clm_653A6EBCA64D","accessed":"2026-11-10"},"kind":"money","predicate":"cash_and_equivalents","value":"1,623,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_653A6EBCA64D","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:CashAndCashEquivalentsAtCarryingValue in 10-Q Q3 FY2024, filed 2024-02-27"}},{"date":"2024-01-26","until":"2024-07-26","published":"2024-02-27","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Medtronic plc quarterly operating income: 1,483,000,000 United States dollar\", as of 2024-01-26 (until 2024-07-26). Claim clm_A0F94B567CF7, https://asof.is/claim/clm_A0F94B567CF7, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/1613103/000161310324000011/0001613103-24-000011-index.htm.","url":"https://asof.is/claim/clm_A0F94B567CF7","accessed":"2026-11-10"},"kind":"money","predicate":"quarterly_operating_income","value":"1,483,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_A0F94B567CF7","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:OperatingIncomeLoss in 10-Q Q3 FY2024, filed 2024-02-27"}},{"date":"2024-01-26","until":"2024-04-26","published":"2024-02-27","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Medtronic plc total assets: 90,836,000,000 United States dollar\", as of 2024-01-26 (until 2024-04-26). Claim clm_D9E0B3C3EFD5, https://asof.is/claim/clm_D9E0B3C3EFD5, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/1613103/000161310324000011/0001613103-24-000011-index.htm.","url":"https://asof.is/claim/clm_D9E0B3C3EFD5","accessed":"2026-11-10"},"kind":"money","predicate":"total_assets","value":"90,836,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_D9E0B3C3EFD5","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:Assets in 10-Q Q3 FY2024, filed 2024-02-27"}},{"date":"2024-02-21","until":"2024-06-17","published":"2024-02-27","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Medtronic plc shares outstanding: 1,327,822,539 shares\", as of 2024-02-21 (until 2024-06-17). Claim clm_B3A3C81B0783, https://asof.is/claim/clm_B3A3C81B0783, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/1613103/000161310324000011/0001613103-24-000011-index.htm.","url":"https://asof.is/claim/clm_B3A3C81B0783","accessed":"2026-11-10"},"kind":"money","predicate":"shares_outstanding","value":"1,327,822,539 shares","status":"superseded","assertable":true,"id":"clm_B3A3C81B0783","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"dei:EntityCommonStockSharesOutstanding in 10-Q Q3 FY2024, filed 2024-02-27"}},{"date":"2024-04-26","until":"2024-07-26","published":"2024-06-20","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Medtronic plc cash and equivalents: 1,284,000,000 United States dollar\", as of 2024-04-26 (until 2024-07-26). Claim clm_600621FE3E89, https://asof.is/claim/clm_600621FE3E89, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/1613103/000161310324000072/0001613103-24-000072-index.htm.","url":"https://asof.is/claim/clm_600621FE3E89","accessed":"2026-11-10"},"kind":"money","predicate":"cash_and_equivalents","value":"1,284,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_600621FE3E89","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:CashAndCashEquivalentsAtCarryingValue in 10-K FY2024, filed 2024-06-20"}},{"date":"2024-04-26","until":"2024-07-26","published":"2024-06-20","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Medtronic plc total assets: 89,981,000,000 United States dollar\", as of 2024-04-26 (until 2024-07-26). Claim clm_6ACEB375E090, https://asof.is/claim/clm_6ACEB375E090, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/1613103/000161310324000072/0001613103-24-000072-index.htm.","url":"https://asof.is/claim/clm_6ACEB375E090","accessed":"2026-11-10"},"kind":"money","predicate":"total_assets","value":"89,981,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_6ACEB375E090","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:Assets in 10-K FY2024, filed 2024-06-20"}},{"date":"2024-04-26","until":"2025-04-25","published":"2024-06-20","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Medtronic plc revenue: 32,364,000,000 United States dollar\", as of 2024-04-26 (until 2025-04-25). Claim clm_952B9596CC77, https://asof.is/claim/clm_952B9596CC77, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/1613103/000161310324000072/0001613103-24-000072-index.htm.","url":"https://asof.is/claim/clm_952B9596CC77","accessed":"2026-11-10"},"kind":"money","predicate":"revenue","value":"32,364,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_952B9596CC77","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax in 10-K FY2024, filed 2024-06-20"}},{"date":"2024-04-26","until":"2024-07-26","published":"2024-06-20","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Medtronic plc total equity: 50,214,000,000 United States dollar\", as of 2024-04-26 (until 2024-07-26). Claim clm_B0B10CE3853B, https://asof.is/claim/clm_B0B10CE3853B, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/1613103/000161310324000072/0001613103-24-000072-index.htm.","url":"https://asof.is/claim/clm_B0B10CE3853B","accessed":"2026-11-10"},"kind":"money","predicate":"total_equity","value":"50,214,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_B0B10CE3853B","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:StockholdersEquity in 10-K FY2024, filed 2024-06-20"}},{"date":"2024-04-26","until":"2025-04-25","published":"2024-06-20","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Medtronic plc net income: 3,676,000,000 United States dollar\", as of 2024-04-26 (until 2025-04-25). Claim clm_BF0630DE861E, https://asof.is/claim/clm_BF0630DE861E, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/1613103/000161310324000072/0001613103-24-000072-index.htm.","url":"https://asof.is/claim/clm_BF0630DE861E","accessed":"2026-11-10"},"kind":"money","predicate":"net_income","value":"3,676,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_BF0630DE861E","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:NetIncomeLoss in 10-K FY2024, filed 2024-06-20"}},{"date":"2024-04-26","until":"2025-04-25","published":"2024-06-20","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Medtronic plc operating income: 5,144,000,000 United States dollar\", as of 2024-04-26 (until 2025-04-25). Claim clm_DCA63AD2CEBA, https://asof.is/claim/clm_DCA63AD2CEBA, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/1613103/000161310324000072/0001613103-24-000072-index.htm.","url":"https://asof.is/claim/clm_DCA63AD2CEBA","accessed":"2026-11-10"},"kind":"money","predicate":"operating_income","value":"5,144,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_DCA63AD2CEBA","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:OperatingIncomeLoss in 10-K FY2024, filed 2024-06-20"}},{"date":"2024-06-17","until":"2024-08-22","published":"2024-06-20","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Medtronic plc shares outstanding: 1,282,269,783 shares\", as of 2024-06-17 (until 2024-08-22). Claim clm_A4A1CCDD3A31, https://asof.is/claim/clm_A4A1CCDD3A31, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/1613103/000161310324000072/0001613103-24-000072-index.htm.","url":"https://asof.is/claim/clm_A4A1CCDD3A31","accessed":"2026-11-10"},"kind":"money","predicate":"shares_outstanding","value":"1,282,269,783 shares","status":"superseded","assertable":true,"id":"clm_A4A1CCDD3A31","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"dei:EntityCommonStockSharesOutstanding in 10-K FY2024, filed 2024-06-20"}},{"date":"2024-07-26","until":"2024-10-25","published":"2024-08-27","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Medtronic plc total equity: 47,947,000,000 United States dollar\", as of 2024-07-26 (until 2024-10-25). Claim clm_3D86839E9EA8, https://asof.is/claim/clm_3D86839E9EA8, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/1613103/000161310324000147/0001613103-24-000147-index.htm.","url":"https://asof.is/claim/clm_3D86839E9EA8","accessed":"2026-11-10"},"kind":"money","predicate":"total_equity","value":"47,947,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_3D86839E9EA8","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:StockholdersEquity in 10-Q Q1 FY2025, filed 2024-08-27"}},{"date":"2024-07-26","until":"2024-10-25","published":"2024-08-27","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Medtronic plc quarterly operating income: 1,278,000,000 United States dollar\", as of 2024-07-26 (until 2024-10-25). Claim clm_7E55E13232E9, https://asof.is/claim/clm_7E55E13232E9, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/1613103/000161310324000147/0001613103-24-000147-index.htm.","url":"https://asof.is/claim/clm_7E55E13232E9","accessed":"2026-11-10"},"kind":"money","predicate":"quarterly_operating_income","value":"1,278,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_7E55E13232E9","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:OperatingIncomeLoss in 10-Q Q1 FY2025, filed 2024-08-27"}},{"date":"2024-07-26","until":"2024-10-25","published":"2024-08-27","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Medtronic plc quarterly revenue: 7,915,000,000 United States dollar\", as of 2024-07-26 (until 2024-10-25). Claim clm_851341DD32FB, https://asof.is/claim/clm_851341DD32FB, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/1613103/000161310324000147/0001613103-24-000147-index.htm.","url":"https://asof.is/claim/clm_851341DD32FB","accessed":"2026-11-10"},"kind":"money","predicate":"quarterly_revenue","value":"7,915,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_851341DD32FB","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax in 10-Q Q1 FY2025, filed 2024-08-27"}},{"date":"2024-07-26","until":"2024-10-25","published":"2024-08-27","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Medtronic plc quarterly net income: 1,042,000,000 United States dollar\", as of 2024-07-26 (until 2024-10-25). Claim clm_8ADDEF42124F, https://asof.is/claim/clm_8ADDEF42124F, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/1613103/000161310324000147/0001613103-24-000147-index.htm.","url":"https://asof.is/claim/clm_8ADDEF42124F","accessed":"2026-11-10"},"kind":"money","predicate":"quarterly_net_income","value":"1,042,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_8ADDEF42124F","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:NetIncomeLoss in 10-Q Q1 FY2025, filed 2024-08-27"}},{"date":"2024-07-26","until":"2024-10-25","published":"2024-08-27","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Medtronic plc total assets: 89,749,000,000 United States dollar\", as of 2024-07-26 (until 2024-10-25). Claim clm_D7380CA3CE92, https://asof.is/claim/clm_D7380CA3CE92, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/1613103/000161310324000147/0001613103-24-000147-index.htm.","url":"https://asof.is/claim/clm_D7380CA3CE92","accessed":"2026-11-10"},"kind":"money","predicate":"total_assets","value":"89,749,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_D7380CA3CE92","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:Assets in 10-Q Q1 FY2025, filed 2024-08-27"}},{"date":"2024-07-26","until":"2024-10-25","published":"2024-08-27","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Medtronic plc cash and equivalents: 1,311,000,000 United States dollar\", as of 2024-07-26 (until 2024-10-25). Claim clm_E1FDBF09C8E3, https://asof.is/claim/clm_E1FDBF09C8E3, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/1613103/000161310324000147/0001613103-24-000147-index.htm.","url":"https://asof.is/claim/clm_E1FDBF09C8E3","accessed":"2026-11-10"},"kind":"money","predicate":"cash_and_equivalents","value":"1,311,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_E1FDBF09C8E3","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:CashAndCashEquivalentsAtCarryingValue in 10-Q Q1 FY2025, filed 2024-08-27"}},{"date":"2024-08-22","until":"2024-11-20","published":"2024-08-27","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Medtronic plc shares outstanding: 1,282,490,493 shares\", as of 2024-08-22 (until 2024-11-20). Claim clm_7552682E7218, https://asof.is/claim/clm_7552682E7218, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/1613103/000161310324000147/0001613103-24-000147-index.htm.","url":"https://asof.is/claim/clm_7552682E7218","accessed":"2026-11-10"},"kind":"money","predicate":"shares_outstanding","value":"1,282,490,493 shares","status":"superseded","assertable":true,"id":"clm_7552682E7218","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"dei:EntityCommonStockSharesOutstanding in 10-Q Q1 FY2025, filed 2024-08-27"}},{"date":"2024-10-25","until":"2025-01-24","published":"2024-11-26","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Medtronic plc quarterly net income: 1,270,000,000 United States dollar\", as of 2024-10-25 (until 2025-01-24). Claim clm_0A017C4E9B47, https://asof.is/claim/clm_0A017C4E9B47, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/1613103/000161310324000165/0001613103-24-000165-index.htm.","url":"https://asof.is/claim/clm_0A017C4E9B47","accessed":"2026-11-10"},"kind":"money","predicate":"quarterly_net_income","value":"1,270,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_0A017C4E9B47","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:NetIncomeLoss in 10-Q Q2 FY2025, filed 2024-11-26"}},{"date":"2024-10-25","until":"2025-01-24","published":"2024-11-26","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Medtronic plc total assets: 90,042,000,000 United States dollar\", as of 2024-10-25 (until 2025-01-24). Claim clm_1B95F96CC7F6, https://asof.is/claim/clm_1B95F96CC7F6, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/1613103/000161310324000165/0001613103-24-000165-index.htm.","url":"https://asof.is/claim/clm_1B95F96CC7F6","accessed":"2026-11-10"},"kind":"money","predicate":"total_assets","value":"90,042,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_1B95F96CC7F6","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:Assets in 10-Q Q2 FY2025, filed 2024-11-26"}},{"date":"2024-10-25","until":"2025-01-24","published":"2024-11-26","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Medtronic plc quarterly revenue: 8,403,000,000 United States dollar\", as of 2024-10-25 (until 2025-01-24). Claim clm_2A47EF57D16F, https://asof.is/claim/clm_2A47EF57D16F, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/1613103/000161310324000165/0001613103-24-000165-index.htm.","url":"https://asof.is/claim/clm_2A47EF57D16F","accessed":"2026-11-10"},"kind":"money","predicate":"quarterly_revenue","value":"8,403,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_2A47EF57D16F","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax in 10-Q Q2 FY2025, filed 2024-11-26"}},{"date":"2024-10-25","until":"2025-01-24","published":"2024-11-26","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Medtronic plc cash and equivalents: 1,394,000,000 United States dollar\", as of 2024-10-25 (until 2025-01-24). Claim clm_427852836E22, https://asof.is/claim/clm_427852836E22, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/1613103/000161310324000165/0001613103-24-000165-index.htm.","url":"https://asof.is/claim/clm_427852836E22","accessed":"2026-11-10"},"kind":"money","predicate":"cash_and_equivalents","value":"1,394,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_427852836E22","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:CashAndCashEquivalentsAtCarryingValue in 10-Q Q2 FY2025, filed 2024-11-26"}},{"date":"2024-10-25","until":"2025-01-24","published":"2024-11-26","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Medtronic plc quarterly operating income: 1,595,000,000 United States dollar\", as of 2024-10-25 (until 2025-01-24). Claim clm_EE80D367549C, https://asof.is/claim/clm_EE80D367549C, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/1613103/000161310324000165/0001613103-24-000165-index.htm.","url":"https://asof.is/claim/clm_EE80D367549C","accessed":"2026-11-10"},"kind":"money","predicate":"quarterly_operating_income","value":"1,595,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_EE80D367549C","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:OperatingIncomeLoss in 10-Q Q2 FY2025, filed 2024-11-26"}},{"date":"2024-10-25","until":"2025-01-24","published":"2024-11-26","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Medtronic plc total equity: 48,494,000,000 United States dollar\", as of 2024-10-25 (until 2025-01-24). Claim clm_FA708EC24643, https://asof.is/claim/clm_FA708EC24643, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/1613103/000161310324000165/0001613103-24-000165-index.htm.","url":"https://asof.is/claim/clm_FA708EC24643","accessed":"2026-11-10"},"kind":"money","predicate":"total_equity","value":"48,494,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_FA708EC24643","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:StockholdersEquity in 10-Q Q2 FY2025, filed 2024-11-26"}},{"date":"2024-11-20","until":"2025-02-19","published":"2024-11-26","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Medtronic plc shares outstanding: 1,282,285,681 shares\", as of 2024-11-20 (until 2025-02-19). Claim clm_FE44128C57EF, https://asof.is/claim/clm_FE44128C57EF, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/1613103/000161310324000165/0001613103-24-000165-index.htm.","url":"https://asof.is/claim/clm_FE44128C57EF","accessed":"2026-11-10"},"kind":"money","predicate":"shares_outstanding","value":"1,282,285,681 shares","status":"superseded","assertable":true,"id":"clm_FE44128C57EF","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"dei:EntityCommonStockSharesOutstanding in 10-Q Q2 FY2025, filed 2024-11-26"}},{"date":"2025-01-24","until":"2025-04-25","published":"2025-02-25","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Medtronic plc cash and equivalents: 1,240,000,000 United States dollar\", as of 2025-01-24 (until 2025-04-25). Claim clm_04C48D2708F8, https://asof.is/claim/clm_04C48D2708F8, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/1613103/000161310325000022/0001613103-25-000022-index.htm.","url":"https://asof.is/claim/clm_04C48D2708F8","accessed":"2026-11-10"},"kind":"money","predicate":"cash_and_equivalents","value":"1,240,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_04C48D2708F8","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:CashAndCashEquivalentsAtCarryingValue in 10-Q Q3 FY2025, filed 2025-02-25"}},{"date":"2025-01-24","until":"2025-07-25","published":"2025-02-25","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Medtronic plc quarterly operating income: 1,646,000,000 United States dollar\", as of 2025-01-24 (until 2025-07-25). Claim clm_2FEBB6C97128, https://asof.is/claim/clm_2FEBB6C97128, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/1613103/000161310325000022/0001613103-25-000022-index.htm.","url":"https://asof.is/claim/clm_2FEBB6C97128","accessed":"2026-11-10"},"kind":"money","predicate":"quarterly_operating_income","value":"1,646,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_2FEBB6C97128","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:OperatingIncomeLoss in 10-Q Q3 FY2025, filed 2025-02-25"}},{"date":"2025-01-24","until":"2025-07-25","published":"2025-02-25","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Medtronic plc quarterly revenue: 8,292,000,000 United States dollar\", as of 2025-01-24 (until 2025-07-25). Claim clm_56D34613FEE0, https://asof.is/claim/clm_56D34613FEE0, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/1613103/000161310325000022/0001613103-25-000022-index.htm.","url":"https://asof.is/claim/clm_56D34613FEE0","accessed":"2026-11-10"},"kind":"money","predicate":"quarterly_revenue","value":"8,292,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_56D34613FEE0","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax in 10-Q Q3 FY2025, filed 2025-02-25"}},{"date":"2025-01-24","until":"2025-04-25","published":"2025-02-25","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Medtronic plc total assets: 89,973,000,000 United States dollar\", as of 2025-01-24 (until 2025-04-25). Claim clm_D4A59ACBA6DC, https://asof.is/claim/clm_D4A59ACBA6DC, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/1613103/000161310325000022/0001613103-25-000022-index.htm.","url":"https://asof.is/claim/clm_D4A59ACBA6DC","accessed":"2026-11-10"},"kind":"money","predicate":"total_assets","value":"89,973,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_D4A59ACBA6DC","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:Assets in 10-Q Q3 FY2025, filed 2025-02-25"}},{"date":"2025-01-24","until":"2025-07-25","published":"2025-02-25","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Medtronic plc quarterly net income: 1,294,000,000 United States dollar\", as of 2025-01-24 (until 2025-07-25). Claim clm_DAC198A9262F, https://asof.is/claim/clm_DAC198A9262F, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/1613103/000161310325000022/0001613103-25-000022-index.htm.","url":"https://asof.is/claim/clm_DAC198A9262F","accessed":"2026-11-10"},"kind":"money","predicate":"quarterly_net_income","value":"1,294,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_DAC198A9262F","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:NetIncomeLoss in 10-Q Q3 FY2025, filed 2025-02-25"}},{"date":"2025-01-24","until":"2025-04-25","published":"2025-02-25","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Medtronic plc total equity: 49,387,000,000 United States dollar\", as of 2025-01-24 (until 2025-04-25). Claim clm_E70A445E3E74, https://asof.is/claim/clm_E70A445E3E74, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/1613103/000161310325000022/0001613103-25-000022-index.htm.","url":"https://asof.is/claim/clm_E70A445E3E74","accessed":"2026-11-10"},"kind":"money","predicate":"total_equity","value":"49,387,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_E70A445E3E74","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:StockholdersEquity in 10-Q Q3 FY2025, filed 2025-02-25"}},{"date":"2025-02-19","until":"2025-06-17","published":"2025-02-25","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Medtronic plc shares outstanding: 1,282,543,505 shares\", as of 2025-02-19 (until 2025-06-17). Claim clm_991FE2B84ECE, https://asof.is/claim/clm_991FE2B84ECE, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/1613103/000161310325000022/0001613103-25-000022-index.htm.","url":"https://asof.is/claim/clm_991FE2B84ECE","accessed":"2026-11-10"},"kind":"money","predicate":"shares_outstanding","value":"1,282,543,505 shares","status":"superseded","assertable":true,"id":"clm_991FE2B84ECE","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"dei:EntityCommonStockSharesOutstanding in 10-Q Q3 FY2025, filed 2025-02-25"}},{"date":"2025-04-25","until":"2025-07-25","published":"2025-06-20","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Medtronic plc cash and equivalents: 2,218,000,000 United States dollar\", as of 2025-04-25 (until 2025-07-25). Claim clm_1E0CB0017D8B, https://asof.is/claim/clm_1E0CB0017D8B, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/1613103/000161310325000091/0001613103-25-000091-index.htm.","url":"https://asof.is/claim/clm_1E0CB0017D8B","accessed":"2026-11-10"},"kind":"money","predicate":"cash_and_equivalents","value":"2,218,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_1E0CB0017D8B","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:CashAndCashEquivalentsAtCarryingValue in 10-K FY2025, filed 2025-06-20"}},{"date":"2025-04-25","until":"2025-07-25","published":"2025-06-20","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Medtronic plc total equity: 48,024,000,000 United States dollar\", as of 2025-04-25 (until 2025-07-25). Claim clm_5678A68C012F, https://asof.is/claim/clm_5678A68C012F, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/1613103/000161310325000091/0001613103-25-000091-index.htm.","url":"https://asof.is/claim/clm_5678A68C012F","accessed":"2026-11-10"},"kind":"money","predicate":"total_equity","value":"48,024,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_5678A68C012F","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:StockholdersEquity in 10-K FY2025, filed 2025-06-20"}},{"date":"2025-04-25","until":"2025-07-25","published":"2025-06-20","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Medtronic plc total assets: 91,680,000,000 United States dollar\", as of 2025-04-25 (until 2025-07-25). Claim clm_6880B626EFDC, https://asof.is/claim/clm_6880B626EFDC, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/1613103/000161310325000091/0001613103-25-000091-index.htm.","url":"https://asof.is/claim/clm_6880B626EFDC","accessed":"2026-11-10"},"kind":"money","predicate":"total_assets","value":"91,680,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_6880B626EFDC","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:Assets in 10-K FY2025, filed 2025-06-20"}},{"date":"2025-04-25","until":"2026-04-24","published":"2025-06-20","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Medtronic plc revenue: 33,537,000,000 United States dollar\", as of 2025-04-25 (until 2026-04-24). Claim clm_BD95A4989472, https://asof.is/claim/clm_BD95A4989472, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/1613103/000161310325000091/0001613103-25-000091-index.htm.","url":"https://asof.is/claim/clm_BD95A4989472","accessed":"2026-11-10"},"kind":"money","predicate":"revenue","value":"33,537,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_BD95A4989472","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax in 10-K FY2025, filed 2025-06-20"}},{"date":"2025-04-25","until":"2026-04-24","published":"2025-06-20","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Medtronic plc net income: 4,662,000,000 United States dollar\", as of 2025-04-25 (until 2026-04-24). Claim clm_E6023C893EE6, https://asof.is/claim/clm_E6023C893EE6, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/1613103/000161310325000091/0001613103-25-000091-index.htm.","url":"https://asof.is/claim/clm_E6023C893EE6","accessed":"2026-11-10"},"kind":"money","predicate":"net_income","value":"4,662,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_E6023C893EE6","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:NetIncomeLoss in 10-K FY2025, filed 2025-06-20"}},{"date":"2025-04-25","until":"2026-04-24","published":"2025-06-20","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Medtronic plc operating income: 5,955,000,000 United States dollar\", as of 2025-04-25 (until 2026-04-24). Claim clm_F5637E2C48D0, https://asof.is/claim/clm_F5637E2C48D0, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/1613103/000161310325000091/0001613103-25-000091-index.htm.","url":"https://asof.is/claim/clm_F5637E2C48D0","accessed":"2026-11-10"},"kind":"money","predicate":"operating_income","value":"5,955,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_F5637E2C48D0","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:OperatingIncomeLoss in 10-K FY2025, filed 2025-06-20"}},{"date":"2025-06-17","until":"2025-08-20","published":"2025-06-20","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Medtronic plc shares outstanding: 1,281,264,703 shares\", as of 2025-06-17 (until 2025-08-20). Claim clm_D02C70FBD25B, https://asof.is/claim/clm_D02C70FBD25B, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/1613103/000161310325000091/0001613103-25-000091-index.htm.","url":"https://asof.is/claim/clm_D02C70FBD25B","accessed":"2026-11-10"},"kind":"money","predicate":"shares_outstanding","value":"1,281,264,703 shares","status":"superseded","assertable":true,"id":"clm_D02C70FBD25B","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"dei:EntityCommonStockSharesOutstanding in 10-K FY2025, filed 2025-06-20"}},{"date":"2025-07-25","until":"2025-10-24","published":"2025-08-26","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Medtronic plc cash and equivalents: 1,273,000,000 United States dollar\", as of 2025-07-25 (until 2025-10-24). Claim clm_014BFE0BCD90, https://asof.is/claim/clm_014BFE0BCD90, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/1613103/000161310325000161/0001613103-25-000161-index.htm.","url":"https://asof.is/claim/clm_014BFE0BCD90","accessed":"2026-11-10"},"kind":"money","predicate":"cash_and_equivalents","value":"1,273,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_014BFE0BCD90","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:CashAndCashEquivalentsAtCarryingValue in 10-Q Q1 FY2026, filed 2025-08-26"}},{"date":"2025-07-25","until":"2025-10-24","published":"2025-08-26","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Medtronic plc quarterly net income: 1,040,000,000 United States dollar\", as of 2025-07-25 (until 2025-10-24). Claim clm_057F0CBD33FC, https://asof.is/claim/clm_057F0CBD33FC, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/1613103/000161310325000161/0001613103-25-000161-index.htm.","url":"https://asof.is/claim/clm_057F0CBD33FC","accessed":"2026-11-10"},"kind":"money","predicate":"quarterly_net_income","value":"1,040,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_057F0CBD33FC","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:NetIncomeLoss in 10-Q Q1 FY2026, filed 2025-08-26"}},{"date":"2025-07-25","until":"2025-10-24","published":"2025-08-26","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Medtronic plc quarterly operating income: 1,445,000,000 United States dollar\", as of 2025-07-25 (until 2025-10-24). Claim clm_4CFFD5044F09, https://asof.is/claim/clm_4CFFD5044F09, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/1613103/000161310325000161/0001613103-25-000161-index.htm.","url":"https://asof.is/claim/clm_4CFFD5044F09","accessed":"2026-11-10"},"kind":"money","predicate":"quarterly_operating_income","value":"1,445,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_4CFFD5044F09","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:OperatingIncomeLoss in 10-Q Q1 FY2026, filed 2025-08-26"}},{"date":"2025-07-25","until":"2025-10-24","published":"2025-08-26","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Medtronic plc quarterly revenue: 8,578,000,000 United States dollar\", as of 2025-07-25 (until 2025-10-24). Claim clm_5C2762F7EEA3, https://asof.is/claim/clm_5C2762F7EEA3, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/1613103/000161310325000161/0001613103-25-000161-index.htm.","url":"https://asof.is/claim/clm_5C2762F7EEA3","accessed":"2026-11-10"},"kind":"money","predicate":"quarterly_revenue","value":"8,578,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_5C2762F7EEA3","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax in 10-Q Q1 FY2026, filed 2025-08-26"}},{"date":"2025-07-25","until":"2025-10-24","published":"2025-08-26","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Medtronic plc total equity: 47,893,000,000 United States dollar\", as of 2025-07-25 (until 2025-10-24). Claim clm_5EED07B34D7D, https://asof.is/claim/clm_5EED07B34D7D, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/1613103/000161310325000161/0001613103-25-000161-index.htm.","url":"https://asof.is/claim/clm_5EED07B34D7D","accessed":"2026-11-10"},"kind":"money","predicate":"total_equity","value":"47,893,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_5EED07B34D7D","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:StockholdersEquity in 10-Q Q1 FY2026, filed 2025-08-26"}},{"date":"2025-07-25","until":"2025-10-24","published":"2025-08-26","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Medtronic plc total assets: 90,972,000,000 United States dollar\", as of 2025-07-25 (until 2025-10-24). Claim clm_FCCA2A3973FC, https://asof.is/claim/clm_FCCA2A3973FC, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/1613103/000161310325000161/0001613103-25-000161-index.htm.","url":"https://asof.is/claim/clm_FCCA2A3973FC","accessed":"2026-11-10"},"kind":"money","predicate":"total_assets","value":"90,972,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_FCCA2A3973FC","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:Assets in 10-Q Q1 FY2026, filed 2025-08-26"}},{"date":"2025-08-20","until":"2025-11-19","published":"2025-08-26","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Medtronic plc shares outstanding: 1,282,685,882 shares\", as of 2025-08-20 (until 2025-11-19). Claim clm_87B312F89145, https://asof.is/claim/clm_87B312F89145, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/1613103/000161310325000161/0001613103-25-000161-index.htm.","url":"https://asof.is/claim/clm_87B312F89145","accessed":"2026-11-10"},"kind":"money","predicate":"shares_outstanding","value":"1,282,685,882 shares","status":"superseded","assertable":true,"id":"clm_87B312F89145","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"dei:EntityCommonStockSharesOutstanding in 10-Q Q1 FY2026, filed 2025-08-26"}},{"date":"2025-10-24","until":"2026-01-23","published":"2025-11-25","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Medtronic plc quarterly net income: 1,374,000,000 United States dollar\", as of 2025-10-24 (until 2026-01-23). Claim clm_118045E4DEEB, https://asof.is/claim/clm_118045E4DEEB, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/1613103/000162828025053988/0001628280-25-053988-index.htm.","url":"https://asof.is/claim/clm_118045E4DEEB","accessed":"2026-11-10"},"kind":"money","predicate":"quarterly_net_income","value":"1,374,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_118045E4DEEB","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:NetIncomeLoss in 10-Q Q2 FY2026, filed 2025-11-25"}},{"date":"2025-10-24","until":"2026-01-23","published":"2025-11-25","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Medtronic plc total equity: 48,652,000,000 United States dollar\", as of 2025-10-24 (until 2026-01-23). Claim clm_4F04018ED36E, https://asof.is/claim/clm_4F04018ED36E, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/1613103/000162828025053988/0001628280-25-053988-index.htm.","url":"https://asof.is/claim/clm_4F04018ED36E","accessed":"2026-11-10"},"kind":"money","predicate":"total_equity","value":"48,652,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_4F04018ED36E","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:StockholdersEquity in 10-Q Q2 FY2026, filed 2025-11-25"}},{"date":"2025-10-24","until":"2026-01-23","published":"2025-11-25","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Medtronic plc total assets: 91,346,000,000 United States dollar\", as of 2025-10-24 (until 2026-01-23). Claim clm_9525D576D532, https://asof.is/claim/clm_9525D576D532, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/1613103/000162828025053988/0001628280-25-053988-index.htm.","url":"https://asof.is/claim/clm_9525D576D532","accessed":"2026-11-10"},"kind":"money","predicate":"total_assets","value":"91,346,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_9525D576D532","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:Assets in 10-Q Q2 FY2026, filed 2025-11-25"}},{"date":"2025-10-24","until":"2026-01-23","published":"2025-11-25","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Medtronic plc quarterly revenue: 8,961,000,000 United States dollar\", as of 2025-10-24 (until 2026-01-23). Claim clm_AA279C6B64A0, https://asof.is/claim/clm_AA279C6B64A0, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/1613103/000162828025053988/0001628280-25-053988-index.htm.","url":"https://asof.is/claim/clm_AA279C6B64A0","accessed":"2026-11-10"},"kind":"money","predicate":"quarterly_revenue","value":"8,961,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_AA279C6B64A0","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax in 10-Q Q2 FY2026, filed 2025-11-25"}},{"date":"2025-10-24","until":"2026-01-23","published":"2025-11-25","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Medtronic plc quarterly operating income: 1,686,000,000 United States dollar\", as of 2025-10-24 (until 2026-01-23). Claim clm_BFF6E998E45F, https://asof.is/claim/clm_BFF6E998E45F, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/1613103/000162828025053988/0001628280-25-053988-index.htm.","url":"https://asof.is/claim/clm_BFF6E998E45F","accessed":"2026-11-10"},"kind":"money","predicate":"quarterly_operating_income","value":"1,686,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_BFF6E998E45F","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:OperatingIncomeLoss in 10-Q Q2 FY2026, filed 2025-11-25"}},{"date":"2025-10-24","until":"2026-01-23","published":"2025-11-25","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Medtronic plc cash and equivalents: 1,282,000,000 United States dollar\", as of 2025-10-24 (until 2026-01-23). Claim clm_C7B7213C07A8, https://asof.is/claim/clm_C7B7213C07A8, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/1613103/000162828025053988/0001628280-25-053988-index.htm.","url":"https://asof.is/claim/clm_C7B7213C07A8","accessed":"2026-11-10"},"kind":"money","predicate":"cash_and_equivalents","value":"1,282,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_C7B7213C07A8","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:CashAndCashEquivalentsAtCarryingValue in 10-Q Q2 FY2026, filed 2025-11-25"}},{"date":"2025-11-19","until":"2026-02-18","published":"2025-11-25","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Medtronic plc shares outstanding: 1,282,014,208 shares\", as of 2025-11-19 (until 2026-02-18). Claim clm_140F0E7AF0B7, https://asof.is/claim/clm_140F0E7AF0B7, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/1613103/000162828025053988/0001628280-25-053988-index.htm.","url":"https://asof.is/claim/clm_140F0E7AF0B7","accessed":"2026-11-10"},"kind":"money","predicate":"shares_outstanding","value":"1,282,014,208 shares","status":"superseded","assertable":true,"id":"clm_140F0E7AF0B7","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"dei:EntityCommonStockSharesOutstanding in 10-Q Q2 FY2026, filed 2025-11-25"}},{"date":"2026-01-23","until":"2026-04-24","published":"2026-02-24","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Medtronic plc total equity: 48,985,000,000 United States dollar\", as of 2026-01-23 (until 2026-04-24). Claim clm_28AC66A9C742, https://asof.is/claim/clm_28AC66A9C742, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/1613103/000162828026011107/0001628280-26-011107-index.htm.","url":"https://asof.is/claim/clm_28AC66A9C742","accessed":"2026-11-10"},"kind":"money","predicate":"total_equity","value":"48,985,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_28AC66A9C742","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:StockholdersEquity in 10-Q Q3 FY2026, filed 2026-02-24"}},{"date":"2026-01-23","until":"2026-07-31","published":"2026-02-24","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Medtronic plc quarterly net income: 1,143,000,000 United States dollar\", as of 2026-01-23 (until 2026-07-31). Claim clm_3D23FE7B2346, https://asof.is/claim/clm_3D23FE7B2346, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/1613103/000162828026011107/0001628280-26-011107-index.htm.","url":"https://asof.is/claim/clm_3D23FE7B2346","accessed":"2026-11-10"},"kind":"money","predicate":"quarterly_net_income","value":"1,143,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_3D23FE7B2346","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:NetIncomeLoss in 10-Q Q3 FY2026, filed 2026-02-24"}},{"date":"2026-01-23","until":"2026-07-31","published":"2026-02-24","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Medtronic plc quarterly revenue: 9,017,000,000 United States dollar\", as of 2026-01-23 (until 2026-07-31). Claim clm_3D738F205AB6, https://asof.is/claim/clm_3D738F205AB6, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/1613103/000162828026011107/0001628280-26-011107-index.htm.","url":"https://asof.is/claim/clm_3D738F205AB6","accessed":"2026-11-10"},"kind":"money","predicate":"quarterly_revenue","value":"9,017,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_3D738F205AB6","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax in 10-Q Q3 FY2026, filed 2026-02-24"}},{"date":"2026-01-23","until":"2026-07-31","published":"2026-02-24","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Medtronic plc quarterly operating income: 1,464,000,000 United States dollar\", as of 2026-01-23 (until 2026-07-31). Claim clm_6B05B9ABD791, https://asof.is/claim/clm_6B05B9ABD791, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/1613103/000162828026011107/0001628280-26-011107-index.htm.","url":"https://asof.is/claim/clm_6B05B9ABD791","accessed":"2026-11-10"},"kind":"money","predicate":"quarterly_operating_income","value":"1,464,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_6B05B9ABD791","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:OperatingIncomeLoss in 10-Q Q3 FY2026, filed 2026-02-24"}},{"date":"2026-01-23","until":"2026-04-24","published":"2026-02-24","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Medtronic plc cash and equivalents: 1,147,000,000 United States dollar\", as of 2026-01-23 (until 2026-04-24). Claim clm_BE1FF64F012F, https://asof.is/claim/clm_BE1FF64F012F, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/1613103/000162828026011107/0001628280-26-011107-index.htm.","url":"https://asof.is/claim/clm_BE1FF64F012F","accessed":"2026-11-10"},"kind":"money","predicate":"cash_and_equivalents","value":"1,147,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_BE1FF64F012F","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:CashAndCashEquivalentsAtCarryingValue in 10-Q Q3 FY2026, filed 2026-02-24"}},{"date":"2026-01-23","until":"2026-04-24","published":"2026-02-24","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Medtronic plc total assets: 91,485,000,000 United States dollar\", as of 2026-01-23 (until 2026-04-24). Claim clm_C2D96E5638A1, https://asof.is/claim/clm_C2D96E5638A1, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/1613103/000162828026011107/0001628280-26-011107-index.htm.","url":"https://asof.is/claim/clm_C2D96E5638A1","accessed":"2026-11-10"},"kind":"money","predicate":"total_assets","value":"91,485,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_C2D96E5638A1","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:Assets in 10-Q Q3 FY2026, filed 2026-02-24"}},{"date":"2026-02-18","until":"2026-06-12","published":"2026-02-24","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Medtronic plc shares outstanding: 1,283,884,964 shares\", as of 2026-02-18 (until 2026-06-12). Claim clm_3A995D7DDA51, https://asof.is/claim/clm_3A995D7DDA51, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/1613103/000162828026011107/0001628280-26-011107-index.htm.","url":"https://asof.is/claim/clm_3A995D7DDA51","accessed":"2026-11-10"},"kind":"money","predicate":"shares_outstanding","value":"1,283,884,964 shares","status":"superseded","assertable":true,"id":"clm_3A995D7DDA51","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"dei:EntityCommonStockSharesOutstanding in 10-Q Q3 FY2026, filed 2026-02-24"}},{"date":"2026-04-24","until":null,"published":"2026-06-18","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Medtronic plc revenue: 36,364,000,000 United States dollar\", as of 2026-04-24. Claim clm_415097FA3412, https://asof.is/claim/clm_415097FA3412, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/1613103/000162828026044354/0001628280-26-044354-index.htm.","url":"https://asof.is/claim/clm_415097FA3412","accessed":"2026-11-10"},"kind":"money","predicate":"revenue","value":"36,364,000,000 United States dollar","status":"valid","assertable":true,"id":"clm_415097FA3412","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax in 10-K FY2026, filed 2026-06-18"}},{"date":"2026-04-24","until":"2026-07-31","published":"2026-06-18","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Medtronic plc total equity: 49,463,000,000 United States dollar\", as of 2026-04-24 (until 2026-07-31). Claim clm_837519048D94, https://asof.is/claim/clm_837519048D94, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/1613103/000162828026044354/0001628280-26-044354-index.htm.","url":"https://asof.is/claim/clm_837519048D94","accessed":"2026-11-10"},"kind":"money","predicate":"total_equity","value":"49,463,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_837519048D94","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:StockholdersEquity in 10-K FY2026, filed 2026-06-18"}},{"date":"2026-04-24","until":"2026-07-31","published":"2026-06-18","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Medtronic plc total assets: 93,028,000,000 United States dollar\", as of 2026-04-24 (until 2026-07-31). Claim clm_8727C002D5B4, https://asof.is/claim/clm_8727C002D5B4, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/1613103/000162828026044354/0001628280-26-044354-index.htm.","url":"https://asof.is/claim/clm_8727C002D5B4","accessed":"2026-11-10"},"kind":"money","predicate":"total_assets","value":"93,028,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_8727C002D5B4","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:Assets in 10-K FY2026, filed 2026-06-18"}},{"date":"2026-04-24","until":null,"published":"2026-06-18","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Medtronic plc net income: 4,801,000,000 United States dollar\", as of 2026-04-24. Claim clm_92CDD59F4653, https://asof.is/claim/clm_92CDD59F4653, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/1613103/000162828026044354/0001628280-26-044354-index.htm.","url":"https://asof.is/claim/clm_92CDD59F4653","accessed":"2026-11-10"},"kind":"money","predicate":"net_income","value":"4,801,000,000 United States dollar","status":"valid","assertable":true,"id":"clm_92CDD59F4653","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:NetIncomeLoss in 10-K FY2026, filed 2026-06-18"}},{"date":"2026-04-24","until":null,"published":"2026-06-18","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Medtronic plc operating income: 6,467,000,000 United States dollar\", as of 2026-04-24. Claim clm_997A28ACE0D9, https://asof.is/claim/clm_997A28ACE0D9, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/1613103/000162828026044354/0001628280-26-044354-index.htm.","url":"https://asof.is/claim/clm_997A28ACE0D9","accessed":"2026-11-10"},"kind":"money","predicate":"operating_income","value":"6,467,000,000 United States dollar","status":"valid","assertable":true,"id":"clm_997A28ACE0D9","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:OperatingIncomeLoss in 10-K FY2026, filed 2026-06-18"}},{"date":"2026-04-24","until":"2026-07-31","published":"2026-06-18","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Medtronic plc cash and equivalents: 1,949,000,000 United States dollar\", as of 2026-04-24 (until 2026-07-31). Claim clm_F5EE13882810, https://asof.is/claim/clm_F5EE13882810, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/1613103/000162828026044354/0001628280-26-044354-index.htm.","url":"https://asof.is/claim/clm_F5EE13882810","accessed":"2026-11-10"},"kind":"money","predicate":"cash_and_equivalents","value":"1,949,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_F5EE13882810","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:CashAndCashEquivalentsAtCarryingValue in 10-K FY2026, filed 2026-06-18"}},{"date":"2026-06-12","until":"2026-08-28","published":"2026-06-18","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Medtronic plc shares outstanding: 1,280,045,190 shares\", as of 2026-06-12 (until 2026-08-28). Claim clm_7C472EEBBBE0, https://asof.is/claim/clm_7C472EEBBBE0, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/1613103/000162828026044354/0001628280-26-044354-index.htm.","url":"https://asof.is/claim/clm_7C472EEBBBE0","accessed":"2026-11-10"},"kind":"money","predicate":"shares_outstanding","value":"1,280,045,190 shares","status":"superseded","assertable":true,"id":"clm_7C472EEBBBE0","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"dei:EntityCommonStockSharesOutstanding in 10-K FY2026, filed 2026-06-18"}},{"date":"2026-07-31","until":null,"published":"2026-09-03","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Medtronic plc cash and equivalents: 1,691,000,000 United States dollar\", as of 2026-07-31. Claim clm_2CD52B076B03, https://asof.is/claim/clm_2CD52B076B03, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/1613103/000162828026060473/0001628280-26-060473-index.htm.","url":"https://asof.is/claim/clm_2CD52B076B03","accessed":"2026-11-10"},"kind":"money","predicate":"cash_and_equivalents","value":"1,691,000,000 United States dollar","status":"valid","assertable":true,"id":"clm_2CD52B076B03","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:CashAndCashEquivalentsAtCarryingValue in 10-Q Q1 FY2027, filed 2026-09-03"}},{"date":"2026-07-31","until":null,"published":"2026-09-03","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Medtronic plc total equity: 50,232,000,000 United States dollar\", as of 2026-07-31. Claim clm_48244293F242, https://asof.is/claim/clm_48244293F242, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/1613103/000162828026060473/0001628280-26-060473-index.htm.","url":"https://asof.is/claim/clm_48244293F242","accessed":"2026-11-10"},"kind":"money","predicate":"total_equity","value":"50,232,000,000 United States dollar","status":"valid","assertable":true,"id":"clm_48244293F242","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:StockholdersEquity in 10-Q Q1 FY2027, filed 2026-09-03"}},{"date":"2026-07-31","until":null,"published":"2026-09-03","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Medtronic plc quarterly revenue: 9,756,000,000 United States dollar\", as of 2026-07-31. Claim clm_91F66AE959A1, https://asof.is/claim/clm_91F66AE959A1, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/1613103/000162828026060473/0001628280-26-060473-index.htm.","url":"https://asof.is/claim/clm_91F66AE959A1","accessed":"2026-11-10"},"kind":"money","predicate":"quarterly_revenue","value":"9,756,000,000 United States dollar","status":"valid","assertable":true,"id":"clm_91F66AE959A1","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax in 10-Q Q1 FY2027, filed 2026-09-03"}},{"date":"2026-07-31","until":null,"published":"2026-09-03","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Medtronic plc total assets: 93,306,000,000 United States dollar\", as of 2026-07-31. Claim clm_92076A104DAA, https://asof.is/claim/clm_92076A104DAA, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/1613103/000162828026060473/0001628280-26-060473-index.htm.","url":"https://asof.is/claim/clm_92076A104DAA","accessed":"2026-11-10"},"kind":"money","predicate":"total_assets","value":"93,306,000,000 United States dollar","status":"valid","assertable":true,"id":"clm_92076A104DAA","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:Assets in 10-Q Q1 FY2027, filed 2026-09-03"}},{"date":"2026-07-31","until":null,"published":"2026-09-03","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Medtronic plc quarterly net income: 1,470,000,000 United States dollar\", as of 2026-07-31. Claim clm_9AE008BCBEB5, https://asof.is/claim/clm_9AE008BCBEB5, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/1613103/000162828026060473/0001628280-26-060473-index.htm.","url":"https://asof.is/claim/clm_9AE008BCBEB5","accessed":"2026-11-10"},"kind":"money","predicate":"quarterly_net_income","value":"1,470,000,000 United States dollar","status":"valid","assertable":true,"id":"clm_9AE008BCBEB5","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:NetIncomeLoss in 10-Q Q1 FY2027, filed 2026-09-03"}},{"date":"2026-07-31","until":null,"published":"2026-09-03","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Medtronic plc quarterly operating income: 1,764,000,000 United States dollar\", as of 2026-07-31. Claim clm_9DA82C15819F, https://asof.is/claim/clm_9DA82C15819F, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/1613103/000162828026060473/0001628280-26-060473-index.htm.","url":"https://asof.is/claim/clm_9DA82C15819F","accessed":"2026-11-10"},"kind":"money","predicate":"quarterly_operating_income","value":"1,764,000,000 United States dollar","status":"valid","assertable":true,"id":"clm_9DA82C15819F","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:OperatingIncomeLoss in 10-Q Q1 FY2027, filed 2026-09-03"}},{"date":"2026-08-28","until":null,"published":"2026-09-03","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Medtronic plc shares outstanding: 1,279,137,890 shares\", as of 2026-08-28. Claim clm_CBEA1FF4A351, https://asof.is/claim/clm_CBEA1FF4A351, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/1613103/000162828026060473/0001628280-26-060473-index.htm.","url":"https://asof.is/claim/clm_CBEA1FF4A351","accessed":"2026-11-10"},"kind":"money","predicate":"shares_outstanding","value":"1,279,137,890 shares","status":"valid","assertable":true,"id":"clm_CBEA1FF4A351","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"dei:EntityCommonStockSharesOutstanding in 10-Q Q1 FY2027, filed 2026-09-03"}}],"complete":true,"legend":{"dates":"valid_from: when the claim took effect (a period figure: the day its period closed). published: the earliest day a source on the record published it (a filing's filing date, a post's date; null when no source carries one). recorded: the day AsOf first held it. A figure can take effect weeks before it is published.","citation":"citation: how to cite the row (plain: one sentence with the value, its as-of date, the claim id and URL, the day answered and the primary source; url: the claim page; accessed: the day answered). APA and BibTeX forms are on the claim page.","why_not":{},"checked_by":{"sec-filing":"parsed from the SEC filing"}}}